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ABSTRACT 
 
The neonatal Fc receptor (FcRn) mediates the passive acquisition of humoral immunity in 
early pre- or post-natal mammals by transferring maternal IgG to the fetus or suckling 
newborn. In addition, FcRn serves to extend the serum half-life of IgG in adult mammals by 
protecting it from a default degradative pathway in vascular endothelial cells.  For both of 
these functions, FcRn binds the Fc domain of IgG with high affinity at the acidic pH (≤6.5) 
of the intestinal lumen and acidic endosomes, and releases the IgG at the slightly basic pH 
(~7.4) of blood.  While the ability of FcRn to transcytose IgG bidirectionally in polarized cell 
models has been well documented, the specific mechanism(s) by which endocytosed IgG is 
sorted from other vesicular cargo and directed through a progression of endosomal 
compartments ultimately leading to the apical or basolateral membrane are poorly 
understood.   
 
We wished to develop an in vitro system with which to study the trafficking behavior of rat 
FcRn in polarized epithelia.  I developed such a model system using Madin-Darby Canine 
Kidney cells stably-transfected with the rat FcRn.  The cells bind, endocytose, recycle and 
bidirectionally transcytose FcRn ligands, faithfully recapitulating the function of FcRn in the 
neonatal rodent gut.  We used these cells to test whether or not the presence of two FcRn 
binding sites on an Fc ligand are required for transport.  The results demonstrated that ligand 
bivalency is not strictly required for transport but does increase the transcytosis efficiency of 
the system, an interesting result in light of the fact that FcRn binds and transports a naturally 
monovalent ligand – serum albumin. 
 
 viii 
 
We have used the FcRn-MDCK cells to study trafficking of the receptor in living cells using 
spinning disk confocal microscopy.  For these studies I developed a recombinant Fc ligand 
containing a tandem dimer of fluorescent proteins on each chain and demonstrated that this 
ligand is brighter and more photostable than conventional chemically-labeled Fc molecules 
used in other confocal studies.  Our FcRn-MDCK cells have also been used to examine 
trafficking events at the plasma membrane leading up to exocytosis though use of total 
internal reflection microscopy (TIRFM). 
 
I also created a model system to study an avian Fc receptor present in yolk sac (FcRY).  
FcRY has been shown to bind IgY (the avian counterpart of IgG) with the same pH-
dependence that FcRn exhibits for IgG.  Transcytosis and recycling experiments using 
polarized rat inner medullary collecting duct (IMCD) cells stably transfected with the FcRY 
gene demonstrated that this receptor is a true functional equivalent of FcRn despite being 
structurally distinct from FcRn.  This presents a striking example of convergent evolution 
and demonstrates that certain versatile protein folds can play key roles in more than one 
functional context within a complex organism.   
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Introduction 
The evolution of complex organisms requires the successful integration of multiple themes.  
One of the simplest and yet most pervasive and vital of these is the theme of 
compartmentalization—the sequestration of specific biological components into distinct 
regions within a cell or organism.  This theme is so prevalent that it applies from the cellular 
level—where the molecular components required for cellular structure and function are 
maintained within the confines of the plasma membrane and many of these so-contained 
components are further sequestered into the various organelles that permit cellular function—
all the way up to the level of the whole organism—where different cell types and tissues 
associate with one another to produce organs and organ systems that are spatially and 
functionally separated from each other, and, more importantly, from the external world.  The 
protein and cellular components that create and maintain these separations, whether at the 
level of the cell or of the whole organism, do so by regulating physical or chemical barriers 
in such a way that maintains the integrity of the internal environment while allowing for 
regulated alteration of these barriers in response to conditional influences from the external 
environment. 
 
Polarized epithelia 
Higher animals must reconcile the requirement of maintaining a controlled internal 
environment with the need to participate in selective exchange with the external 
environment.  Epithelial cell barriers serve as a means for complex organisms to distinguish, 
both spatially and functionally, between the external environment and the underlying tissue.  
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A vital characteristic of such cellular barriers is their ability to selectively allow the passage 
of materials—such as ions, small molecules, peptides, lipids, and proteins—either by passive 
or active (receptor-mediated) transport mechanisms.  Polarized epithelial cells are joined to 
one another by a structured, oligomeric transmembrane protein complex known as the tight-
junction (TJ) (Simons and Wandinger-Ness, 1990).  Although many of the precise details of 
the TJ’s structure and composition remain to be elucidated, to date more than 50 proteins are 
known to be associated with the TJ (Gonzalez-Mariscal et al., 2003; Miyoshi and Takai, 
2005; Schneeberger and Lynch, 2004).  Tight junctions serve three purposes: 1) they hold 
adjacent cells together and provide structure to the monolayer; 2) they prevent the free 
diffusion of materials between the cells in the monolayer, thus requiring that materials enter 
the cells through diffusion or active transport in order to cross the tissue layer; and 3) they 
prevent the contents of the membranes above and below the TJ from mixing, thus allowing 
these respective membrane domains to maintain distinct protein and lipid compositions.  The 
two membrane faces created as a result of this physical separation are referred to as the apical 
(Ap) surface, which faces the external surface of the mucosae or the lumen of an organ, and 
the basolateral (BL) surface, which faces the serosal surface or bloodstream (Simons and 
Wandinger-Ness, 1990) (Figure 1).   
 
Transcytosis and cellular trafficking 
The apical and basolateral surfaces of polarized cells are connected to one another via a 
multivesicular transport pathway called transcytosis (Tuma and Hubbard, 2003).  
Transcytosis is mediated by transmembrane receptors that originate on either the apical or 
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basolateral cell surface.  This process requires that receptor-bound cargo be internalized into 
the endosomal membrane system and trafficked to its target destination as determined by 
motifs within the cytoplasmic tail of the receptor itself.  During the first step of receptor-
mediated transport—endocytosis—the cytoplasmic tail plays a central role by harboring the 
amino acid sequences necessary for the interaction of the receptor with cytosolic mediators 
such as AP-2, a tetrameric complex that serves as an adaptor between transmembrane 
receptors and components of the endocytic machinery.  Of central importance is the ability of 
AP-2 to provide a direct link between the receptor and the clathrin coat (Tuma and Hubbard, 
2003; Ungewickell and Hinrichsen, 2007), although clathrin-independent mechanisms of 
internalization do exist (Mayor and Pagano, 2007).  Subsequent to internalization via 
clathrin-coated pits, clathrin-coated vesicles (CCVs) are uncoated in an ATP-dependant 
manner by the uncoating enzyme Hsc70 (Eisenberg and Greene, 2007) allowing the now-
exposed membrane to be primed for fusion into the endosomal membrane network 
(Ungewickell and Hinrichsen, 2007).   
 
The endosomes of a cell are membrane-bound compartments that serve as the staging ground 
for intracellular trafficking and protein sorting (Sachse et al., 2002) (Figure 1).  The vast 
number of endosomes within the cell are classified into different subpopulations that 
maintain their identities based on unique combinations of traffic-regulating membrane 
proteins associated with them (Perret et al., 2005; Piper and Luzio, 2001; van Ijzendoorn, 
2006).  One of the larger classes of such proteins is the Rab family of small GTPases.  These 
small (~ 25 kDa) proteins exist in either the inactive GDP-bound or the active GTP-bound 
state (Deneka et al., 2003).  Rab proteins are soluble cytoplasmic proteins that are prenylated 
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in a regulated fashion by the enzyme Rab geranylgeranyl transferase (RabGG transferase), 
which in turn allows them to be inserted into endosomal membranes (Pereira-Leal et al., 
2001).  RabGG transferase adds two geranylgeranyl groups to cysteines at the C-terminus of 
Rab proteins (Pereira-Leal et al., 2001).  Because Rab proteins do not a bear the canonical 
CAAX box used for recognition for the two other principle prenylating enzymes in the cell 
(farnesyltransferase and geranylgeranyl transferase I), they must first be bound by the Rab 
escort protein (REP) at more conserved sites within the Rab protein for subsequent 
presentation to RabGG transferase (Leung et al., 2006; Pfeffer and Aivazian, 2004).  
Prenylation allows their insertion into endosomal membranes where they in turn carry out 
trafficking-related effector functions (Fukuda, 2007; Seabra et al., 2002; Smythe, 2002).  
Only after receptors and their bound cargo have entered endosomes can the processes of 
receptor sorting and trafficking be performed through a series of interactions between the 
receptor and the various membrane proteins, adaptor proteins, and cytoskeletal components 
that comprise the intracellular trafficking machinery (Tuma and Hubbard, 2003). It is this 
step-wise progression through the intracellular trafficking itinerary that allows for transport 
to be precisely regulated by the cell. 
 
The regulated transport of proteins within and across both polarized and non-polarized cells 
makes an essential contribution to the function of the immune system.  Because epithelial 
linings are vulnerable to infectious agents within the environment, the transport of antibodies 
into mucosal secretions plays a key role in first-line defense immunity (Lamm et al., 1992).  
Additionally, the transport of antibodies within non-polarized vascular endothelial cells is 
essential for maintaining their high levels in the circulation (Junghans and Anderson, 1996).  
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A detailed understanding of the receptors responsible for these trafficking roles and their 
properties has implications both for gaining a better understanding of immune function in 
general and for developing effective strategies to treat diseases resulting from their 
dysfunction.      
 
Immunoglobulin structure and function 
Immunoglobulins (Igs or antibodies) are the fundamental protein players of both innate and 
acquired immunity.  They are produced and secreted by a special class of lymphocytes called 
B-cells in response to the detection of a foreign agent (antigen) in their environment.  
Immunoglobulins are tetramers consisting of two light chains (LCs, ~ 25 kDa each) and two 
heavy chains (HCs, ~ 55 kDa each) arranged in a shape that resembles the letter “Y”.  The 
LCs contain an N-terminal variable domain and a C-terminal constant domain, while the 
heavy chains consist of a variable N-terminal domain and three to four C-terminal constant 
domains.  The Fab (Fragment antigen binding) domain is composed of the LC and the first 
two N-terminal domains of the HC.  The association of the LC and HC variable domains 
create an N-terminal combining site that confers the specificity of the antibody by virtue of 
the interaction of amino acids within the hypervariable regions of each variable domain with 
an antigen.  The Fc (Fragment crystalline) region is a dimer of the two or more C-terminal 
domains of the HC that are not part of the Fab.  Whereas the Fab is responsible for antigen 
recognition and binding, the Fc regulates the biological functions of the antibody by binding 
to Fc receptors and eliciting immune effector functions.  Binding to Fc receptors can also 
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mediate transport of antibodies within cells or protect them from proteolytic degradation 
(Kindt et al., 2007).   
 
Immunoglobulin isotypes 
Mature, naïve B-cells express a single clonal variant of IgD and IgM on their surface. After 
being stimulated by antigen these cells differentiate into plasma cells and begin secreting 
IgM or undergo “class switching” to secrete IgA, IgE, or IgG (Figure 2).  These isotypes 
differ from one another by amino acid sequences in their constant regions that confer class-
specific structural and functional characteristics upon the molecule.  Secreted IgM is a 
pentamer in which five monomeric IgM molecules are assembled together by disulfide bonds 
between each of their two C-terminal heavy chain domains.  The pentamer also contains J 
chain (joining chain), which is disulfide bonded to a terminal cysteine residue in two of the 
monomers and is required for assembly of the pentamer (Kindt et al., 2007).   
 
IgA is the most abundant Ig in external secretions such as mucus, tears, saliva, and breast 
milk.  While a small amount of monomeric IgA is present in serum (only 10%–15% of total 
serum Ig), IgA in secretions (secretory IgA) is a dimer or tetramer containing J chain (Lamm 
et al., 1992; Lycke, 2005).  Both IgM and IgA are delivered into mucosal secretions by the 
polymeric Ig receptor (pIgR) and provide a first line of defense against pathogens by 
inhibiting infection by viruses and colonization by bacteria. The secreted Ig oligomers are 
bound by a 70 kDa protein called secretory component (SC), which is proteolytically 
released from pIgR upon delivery of the Ig to the lumen of the relevant organ.  SC consists of 
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five Ig-like domains and binds to the Fc region of IgA or IgM, with domain five forming a 
disulfide bond with the Fc of IgA.  SC masks protease-sensitive sites in the Fc and allows 
secretory IgA and IgM to persist longer in the protease-rich environment of the mucosae 
(Brandtzaeg and Johansen, 2001; Rojas and Apodaca, 2002).   
 
Another Ig isotype, IgE, is responsible for mediating reaction to allergens, causing the 
symptoms of allergies.  IgE is present in serum at low concentrations (0.3 µg/mL) but is 
expressed on the surface of basophils and mast cells. When multiple IgE molecules on the 
surface of these cells are cross-linked by antigen the cells are stimulated to release stored 
granules containing histamine and other compounds that promote the allergic reaction (Kindt 
et al., 2007).   
 
In mammals, IgG is the most abundant Ig in serum (~ 80% of total serum Ig) and is the 
principle Ig that participates in the adaptive immune response.  There are four human IgG 
subclasses (IgG1, IgG2, IgG3, and IgG4) that are distinguished from one another by 
differences in the constant region of the heavy chain.  These sequence differences affect the 
length of the hinge region as well as the position and number of disulfide bonds between the 
two heavy chains of the IgG molecule (Kindt et al., 2007).  Additionally, different IgG 
subclasses bind to different Fc receptors with varying affinities.  Thus, IgGs of one subclass 
may be more or less efficient at eliciting certain effector functions than IgGs of another 
subclass.  For example, IgG3 is the most effective subclass at activating complement, 
followed by IgG1 and IgG2, whereas IgG4 cannot activate complement (Chatron and Pontet, 
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1992; Kindt et al., 2007; Smith, 1992).  Circulating IgG participates in adaptive immunity by 
binding to antigens in the circulation.  Antigens are then cleared through the subsequent 
activation of the complement cascade and/or other effector functions such as opsonization 
(phagocytosis of antigen/pathogen by macrophages and neutrophils) and antibody-dependent 
cell-mediated cytotoxicity (ADCC) (Kindt et al., 2007).  
 
Passive immunization of newborn and gestating mammals by the mother via receptor-
mediated transfer of IgG 
Adult mammals have the capacity to generate antibodies against environmental antigens that 
are encountered during their lifetime.  An animal that has generated an antibody response to 
an antigen is said to be actively immune to that antigen.  There is, however, a certain lag time 
after initial exposure to the antigen before antibodies appear in the blood.  This lag time 
appears to be about one week in mammals, during which the animal is vulnerable to the 
infectious agent (Kindt et al., 2007).  Alternatively, pre-formed antibodies from one 
individual can be transferred to another and confer immediate immunity to the antigen.  
Because the immune-rendered individual does not produce the antibodies themselves, this is 
refereed to as passive immunity.  
 
Passive acquistion of antibodies is particularly important in the case of rodents and several 
other mammals (see Table 1) whose young are unable to produce their own IgG for up to two 
weeks post-natally (Brambell, 1970), despite being exposed to the external environment 
during this time.  To compensate, these animals acquire passive immunity during early life 
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via IgG transferred from the mother.  IgG-rich colostrum is ingested and passes through the 
intestine where it is transferred across the polarized epithelial cell lining into the 
bloodstream.  This transfer is mediated by the class I major histocompatability complex 
(MHC)-related neonatal Fc receptor (FcRn).  FcRn is a heterodimeric type I transmembrane 
glycoprotein consisting of a heavy chain that is non-covalently associated with a light chain, 
β2-microglobulin (β2m), that also binds to class I MHC heavy chains (Rodewald and 
Kraehenbuhl, 1984; Simister and Rees, 1985).  High-resolution crystal structures of human 
and rat FcRn, as well as a complex structure of rat FcRn in complex with Fc have been 
obtained (Burmeister et al., 1994a; Burmeister et al., 1994b; Martin et al., 2001; West and 
Bjorkman, 2000).  FcRn is structurally similar to class I MHC molecules, although the 
counterpart of the MHC peptide-binding groove is narrowed and non-functional in FcRn.   
 
FcRn binds to the Fc region of IgG with nanomolar affinity at pH ≤ 6.0, but exhibits no 
binding at the basic pH of blood (pH 7.4) (Simister and Mostov, 1989).  This pH-dependent 
binding helps to promote the efficient unidirectional transfer of IgG from the acidic 
environment of the intestinal lumen to the blood stream of the neonate (Figure 3).  Unlike 
rodents, humans and non-human primates are born with the capacity to produce serum IgG, 
thus post-natal transfer of maternal IgG does not occur (Brambell, 1970; Oxelius and 
Svenningsen, 1984).  During gestation when the fetus is vulnerable, however, maternal IgG 
is transferred to the fetus via FcRn-mediated transcytosis across placental syncitiotrophoblast 
cells to provide the fetus with immunity to antigens encountered by the mother (Figure 4). 
The discovery that FcRn is expressed in the human fetal small intestine (Shah et al., 2003) 
suggests that maternal IgG in ingested amniotic fluid could also be delivered to the fetal 
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circulation by transport across intestinal epithelial cells, consistent with a common 
mechanism for passive immunization of human and rodent offspring. 
 
Unlike the case of post-natal intestinal transfer in rodents, trans-placental IgG transfer  in 
humans occurs in the absence of a net pH gradient.  In this process, rather than being taken 
up actively after binding to FcRn at the cell surface, IgG is taken up passively via fluid-phase 
endocytosis by syncitiotrophoblast cells.  Once within the acidic environment of endosomes, 
the IgG is bound by FcRn and transcytosed into the fetal circulation (Kristoffersen, 1996; 
Leach et al., 1996; Simister et al., 1996).  Thus, although acidic pH greatly facilitates the 
uptake of IgG by FcRn by allowing the receptor to bind ligand at the cell surface prior to 
internalization, acidity is not an absolute requirement for efficient IgG uptake provided that 
the cell internalizes a sufficient amount of fluid-phase material to allow binding and transfer 
of physiologically relevant quantities of IgG by FcRn.  
 
 
FcRn-mediated recycling of IgG and serum persistence 
FcRn also plays an integral role in maintaining high serum levels of IgG.  It has long been 
known that IgG has a long half-life relative to other serum proteins.  It was also established 
by Brambell that the extended half-life of IgG was inversely proportional to the serum 
concentration of IgG (that is, the effect was saturable), leading him to postulate the existence 
of a protection receptor (which came to be called the Brambell protection receptor or FcRB) 
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(Brambell et al., 1964).  Subsequent work demonstrated that FcRB and FcRn were, in fact, 
the same protein and that FcRn serves as a protection receptor by rescuing IgG that has been 
passively internalized via pinocytosis by vascular endothelial cells from a default catabolic 
pathway (Ghetie et al., 1996; Israel et al., 1996; Junghans and Anderson, 1996).  Similar to 
the mechanism of materno-fetal transfer during primate gestation, FcRn binds to pinocytosed 
IgG in the acidic environment of the endosomes (Figure 5).  However in this setting FcRn 
then recycles the IgG back to the cell surface where the IgG can dissociate and re-enter the 
circulation.  Mouse knockouts in which either the FcRn heavy chain or the β2-microglobulin 
light chain is deleted exhibit a greatly reduced serum IgG half-life (Ghetie et al., 1996; 
Junghans and Anderson, 1996).  As a result, many studies over the past several years have 
sought to improve the serum half-lives of therapeutic antibodies by modulating the FcRn-Fc 
interaction (Dall'Acqua et al., 2006; Ferl et al., 2005; Petkova et al., 2006).  An IgG that is 
capable of binding to FcRn with higher affinity at pH 6.0 but still dissociates readily at pH 
7.4 should persist longer in the circulation, thus requiring fewer administrations of less 
antibody to achieve the desired therapeutic effect.  Conversely, the use of peptide inhibitors 
against FcRn to block its IgG salvage capacity has shown promise as an alternative to 
conventional auto-immune disease therapies that involve intravenous administration of 
saturating doses of human IgG (IVIg) to promote the clearance of harmful endogenous host 
IgGs (Getman and Balthasar, 2005; Mezo et al., 2008). 
 
FcRn expression in the adult gut suggests a role in the adaptive immune response 
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The pattern and time course of FcRn expression differs greatly between rodents and humans.  
Rodents express FcRn on intestinal epithelia at high levels at birth and these levels dissipate 
after weaning.  By contrast, humans express the receptor in intestinal cells of both the fetus 
and adult (Israel et al., 1997; Roopenian and Akilesh, 2007).  Cultured adult intestinal 
carcinoma cells have been used as a model for hFcRn transcytosis (Dickinson et al., 1999).  
Interestingly, it was recently shown that human FcRn transgenically expressed in the adult 
mouse gut is capable of transcytosing IgG in the basolateral to apical direction for deposition 
into luminal secretions where it can bind to antigen.  Antigen-IgG complexes were then re-
internalized and transcytosed back to the lamina propria where they could interact with 
dendritic cells (DCs), which in turn were able to prime an antigen-specific T-cell response 
(Yoshida et al., 2004; Yoshida et al., 2006a; Yoshida et al., 2006b).  These results implicate 
FcRn as an important player in initial stages of the adaptive immune response.  Interestingly, 
the lack of FcRn expression in the normal adult rodent gut suggests that this function of FcRn 
is not characteristic in all species and may even be unique to humans and perhaps non-human 
primates. 
 
The role of FcRn in serum albumin salvage 
One of the more unexpected discoveries concerning FcRn function in recent years has been 
the observation that hFcRn is capable of binding to human serum albumin (HSA) in 
biochemical assays (Chaudhury et al., 2003).  The interaction exhibits the same pH-
dependence as the FcRn-IgG interaction, suggesting a possible role for FcRn in the 
intracellular transport of albumin.  This led researchers to investigate the effects of FcRn 
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heavy chain knockout mice on serum albumin levels.  FcRn-deficient mice exhibit both a 
shortened serum albumin half-life and an increased rate of albumin biosynthesis (likely due 
to feedback mechanisms that compensate for the lowered plasma oncotic pressure caused by 
low albumin levels) (Anderson et al., 2006; Chaudhury et al., 2006; Chaudhury et al., 2003).  
Consistent with these data, at least one case of familial hypoalbuminemia in humans has been 
shown to result from a single nucleotide transversion that disrupts the signal sequence of β2m 
(Wani et al., 2006).  Biochemical and biophysical studies have suggested that albumin and 
IgG bind to FcRn at distinct, non-cooperative sites (Chaudhury et al., 2006).  Interestingly, 
the FcRn-albumin interaction is inhibited by low concentration of the detergent Octyl-β-D-
Glucopyranoside, whereas the FcRn-IgG interaction is not (Chaudhury et al., 2003).  While 
the involvement of FcRn in the serum maintenance of albumin has been experimentally 
demonstrated in mice, Chapter 2 describes that in vitro experiments using rat FcRn expressed 
in polarized MDCK cells failed to demonstrated specific binding, transcytosis, or recycling 
of rat albumin by rFcRn. Thus whether or not the FcRn-albumin interaction is a universal 
feature of all species of FcRn is not yet clear.   
 
A structure-based hypothesis for FcRn trafficking 
An interesting feature of the FcRn-IgG interaction is that each IgG ligand contains two FcRn 
binding sites, one in the constant region of each heavy chain at the interface between the Cγ2 
and Cγ3 domains, allowing for the formation of FcRn:Fc complexes with a 2:1 stoichiometry 
in solution (Huber et al., 1993; Martin and Bjorkman, 1999). This is not characteristic of all 
Fc receptors, many of which have only a single binding site and thus form 1:1 receptor:Fc 
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complexes (Sondermann and Oosthuizen, 2002a, b).  While the benefit of a bivalent ligand 
seems apparent—two binding sites should yield a higher macroscopic dissociation constant 
(KD) due to avidity effects—it is interesting to note that another natural FcRn ligand, 
albumin, is a monovalent ligand.   
 
This raises the interesting question as to whether or not two sites are strictly required for 
transport of IgG for FcRn.  This question was made even more intriguing by the co-crystal 
structure of rat FcRn in complex with a recombinant Fc molecule from rat IgG2a (Burmeister 
et al., 1994b).  The structure showed an oligomeric array of FcRn dimers bridged to one 
another through homodimeric Fc (referred to as an “oligomeric ribbon”) yielding an overall 
2n:1n FcRn:Fc stoichiometry (Figure 6).  The natural question to ask was whether or not this 
oligomeric structure formed within trafficking vesicles and served as a signal to guide FcRn-
IgG complexes to their target destinations.  Two aspects of the structure made this possibility 
particularly appealing.  First, the formation of this structure would require the opposing 
membrane faces to be held in close (~ 200 Å) proximity to one another.  Indeed, long tubular 
vesicles are more prominently involved in transport and trafficking functions, whereas large 
spherical vesicles are generally associated more with degradative functions (Marsh et al., 
1986).  Second, formation of the oligomeric ribbon structure would induce a linearly ordered 
arrangement of FcRn cytoplasmic tails.  The cytosolic trafficking machinery might utilize 
one or both of these features as an indicator that the compartment bearing them is to be 
transcytosed or recycled rather than catabolized.   
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Formation of the ribbon structure requires the simultaneous occurrence of two separate 
phenomena: 1) FcRn dimerization, and 2) bridging of opposing membrane faces through the 
ligand molecules.  Conclusive evidence that both events occur at the same time in cells 
would constitute strong evidence for the existence of the oligomeric ribbon.  Conversely, 
successful demonstration that one phenomenon or the other is not required for FcRn 
mediated transport would not completely rule out the possibility of ribbon formation, but 
would show that it is not required for proper transport of FcRn-IgG complexes.  When I 
began my studies, one of the primary goals was to determine whether structural features of 
the FcRn-IgG interaction, such as the 2:1 FcRn:Fc stoichiometry, oligomeric ribbon 
formation, or receptor dimerization, were required for proper trafficking of these complexes.  
For example, it is possible that complex formation results in the emergence of unique 
structural features that are essential for proper recognition and movement of FcRn-IgG 
complexes by the intracellular trafficking machinery.  Conversely, it is possible that all 
information required to properly traffic FcRn-IgG complexes is constitutively presented by 
the receptor regardless of whether or not ligand is present.   
 
To address this question in a system that was amenable to experimental manipulations and 
perturbations, I generated an in vitro system based on stably transfected Madin-Darby canine 
kidney (MDCK) cells expressing rat FcRn.  These epithelial cells form well-polarized 
monolayers at confluence and have long served as an established model system for the study 
of protein trafficking in polarized cells (Rojas and Apodaca, 2002; Simmons, 1982).  Chapter 
2 describes the generation and characterization of this cell line. Using recombinantly - 
expressed rat Fc molecules containing two, one, or zero FcRn binding sites, I addressed the 
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question of whether 2:1 complex formation and/or ribbon formation are required for proper 
transport of FcRn-Fc complexes using in vitro transcytosis and recycling assays.  My results 
show that the presence of two FcRn-binding sites on a ligand molecule are not a strict 
requirement for FcRn-mediated trafficking, but that the resulting avidity effect makes 
transport of a bivalent ligand more efficient.  Appendix I describes attempts to determine if 
FcRn dimerizes on the cell membrane using fluorescence resonance energy transfer (FRET) 
and bimolecular fluorescence complementation (BiFC).   
 
Investigation of FcRn trafficking pathways in neonatal rat gut by electron tomography 
Electron tomography (ET) is an electron microscopy (EM) technique used to obtain three-
dimensional data from an EM sample (Donohoe et al., 2006; Frey et al., 2006; Subramaniam, 
2005).  The technique involves collecting  a series of two-dimensional images from a thinly 
sectioned sample while tilting the specimen.  This series of 2D images is then used to 
computationally reconstruct the specimen in 3D.  A variety of factors limit the maximum 
quality of reconstruction that can be obtained by ET, but a resolution of ~ 4 nm is generally 
attainable (Donohoe et al., 2006; Frey et al., 2006; Subramaniam, 2005).  Chapter 3 describes 
my early work in the generation of 1.4 nm gold cluster-labeled Fc molecules (Au-Fc) for use 
as an electron-dense marker for FcRn trafficking in ET studies.  The preparation of this 
reagent served as a basis for later work in the lab.  In experiments performed by Wanzhong 
He, a postdoctoral scholar in the laboratory, Au-Fc was fed to neonatal rats to allow FcRn-
mediated uptake of the labeled ligand in the intestine, mimicking the transfer of maternal IgG 
across the intestine of the newborn.  Electron tomography performed on harvested intestinal 
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samples revealed many Au-Fc-containing endosomes possessing distinct morphologies in 
different regions of the cell.   
 
One of the more surprising observations from the electron tomography studies was the 
presence of clathrin-coated vesicles containing Au-Fc that appeared to be fusing with the 
lateral plasma membrane (He, et al. 2008).  While clathrin is classically believed to be 
involved in only endocytosis via coated pits and some intracellular trafficking functions, its 
involvement in exocytosis was previously not considered a possibility because it has long 
been believed that the clathrin coats on trafficking vesicles are shed prior to membrane fusion 
(Altstiel and Branton, 1983; Brodsky et al., 2001; Conner and Schmid, 2003).  However, two 
lines of evidence suggested that these clathrin-coated structures could not be endocytosing 
Au-Fc.  First, the pH in the lateral intracellular space (LIS) should not be permissive for 
FcRn binding, as this space is contiguous with the circulation (pH 7.4).  Second, the 
concentration of Au-Fc in the blood of the rat should not be high enough to permit binding to 
FcRn and should furthermore be competed away by the high concentration of unlabeled, 
endogenous IgG in the circulation.  For these reasons we hypothesized that clathrin-coated 
vesicles containing FcRn-ligand complexes can partially uncoat and fuse with the target 
membrane.  Subsequently, the vesicle may fully uncoat, releasing the FcRn molecules into 
the target membrane and allowing for its bound cargo to dissociate into the extracellular 
space.  Alternatively, the partially clathrin-coated vesicle may remain at the membrane, 
allowing diffusion of ligand through the opening of the partially fused vesicle in a process 
akin to so-called “kiss-and-run” (Fesce et al., 1994) or “prolonged release” (Ober et al., 
2004) before pinching back off and transporting the free receptor back to the apical surface to 
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acquire more ligand.  The later model has the advantage of conserving the energy that would 
be required to fully uncoat the vesicle (and ATP-dependent process) and to reassemble the 
endocytic machinery required to return ligand-free FcRn back to the apical surface for 
subsequent round of transcytosis.  Chapter 4 describes collaborative work I performed in the 
laboratory of Professor Sandy Simon at The Rockefeller University using total internal 
reflection fluorescence microscopy (TIRFM) to examine the dynamics of FcRn and clathrin 
during exocytosis at the plasma membrane of living MDCK cells.   
 
An avian functional homologue of FcRn 
While all classes of vertebrates have the capacity to mount an immune response, a majority 
of what is known about the complexities of these processes is limited to mammals and birds.  
Birds have long been known to possess highly developed cellular and serological immunity 
(Brambell, 1970).  It is perhaps not surprising, therefore, that the transfer of passive 
immunity from mother to young is not a phenomenon unique to mammals.  Indeed, the 
transfer of passive immunity to tetanus toxin in birds was first described by Klemperer in 
1893, just one year after the same phenomenon was described in mammals by Ehlrich 
(Brambell, 1970).  During avian development the gestating fetus has all of its nutritional 
requirements met by the yolk, which also contains a significant store of IgY (the avian and 
reptilian equivalent to IgG) from the mother.  Transport of IgY from the yolk to the chick 
occurs across the yolk sac membranes and confers passive immunity to antigens encountered 
by the mother, despite the fetus having no direct contact with the mother (Kowalczyk et al., 
1985).  Persistence of maternal antibodies in fish (carp, Cyprinus carpi) and reptile (the 
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desert tortoise, Gopherus agassizii) hatchlings has also been described (Grindstaff et al., 
2003).   
 
Whereas the MHC in mammals is organized within a single locus, in birds the class I and 
class II MHC are arranged in at least two gene clusters that contain both MHC class I and 
class II B genes (Wittzell et al., 1998).  In light of these differences in MHC organization, it 
is of clear interest to know if the receptor responsible for the transfer of IgY from the yolk to 
the fetus (and possibly responsible for transporting IgY from the mother into the ovum that 
eventually gives rise to the yolk) is truly a functional equivalent of FcRn and if it shares 
structural similarities with its mammalian homologue.  The first step towards answering this 
question came when a protein fraction was isolated from chicken egg yolk sacs that bound to 
IgY in a pH-dependent fashion (West et al., 2004).  Because of its expression in yolk sac and 
its pH-dependent binding properties reminiscent of the FcRn-IgG interaction, the receptor 
was believed to be the avian functional equivalent of FcRn and was named FcRY.   
 
Surprisingly, FcRY shares no homology with class I MHC molecules or FcRn, but is instead 
a homolog of the mammalian phospholipase A2 receptor (PLA2R), a member of the mannose 
receptor (MR) family (East and Isacke, 2002) (Figure 7).  The four members of the 
mammalian MR family mediate a variety of functions, including roles in the innate and 
adaptive immune systems (MR), internalization of soluble PLA2 enzymes (PLA2R), 
presentation of antigens to T cells (DEC-205), and remodeling of the extracellular matrix 
(Endo180). FcRY shares structural features with other MR family members, which consist of 
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an N-terminal cysteine-rich domain, a single fibronectin type II (FNII) domain, eight to ten 
tandem C-type lectin-like domains (CTLDs), a single-pass transmembrane region, and a 
short cytoplasmic tail (East and Isacke, 2002). The presence of tandem lectin-like domains 
does not necessarily imply carbohydrate-binding lectin activity, since only the MR and 
Endo180 bind to monosaccharide. Indeed the CTLDs in PLA2R mediate a protein-protein 
interaction independently of carbohydrate (East and Isacke, 2002) and FcRY is thought to 
recognize IgY through a protein-protein interaction (West et al., 2004).   
 
While other members of the MR family can mediate trafficking functions such as 
endocytosis, recycling, and delivery of internalized contents to lysosomes for antigen 
processing and presentation, no experimental evaluation of the trafficking behavior of FcRY 
had been performed since it was first isolated.  Chapter 3 describes the demonstration of true 
functional equivalence between FcRn and FcRY using stably transfected rat inner medullary 
collecting duct (IMCD) cells as a model for polarized epithelia.  These cells have been used 
previously to investigate the trafficking of FcRn (McCarthy et al., 2001; McCarthy et al., 
2000; Wu and Simister, 2001), making them a useful model for comparison of the function 
of these two receptors in a similar cellular context.  My results show that FcRY is able to 
endocytose, recycle, and transcytose FcY and IgY in polarized cells.  Faithfully 
recapitulating the behavior of mammalian FcRn in the same cellular context. 
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Figure 1.  Schematic representation of endosomal trafficking pathways in a polarized 
epithelia cell.  The apical and basolateral surfaces of epithelia are separated by tight junctions 
(TJs) which allow these domains to maintain distinct protein and lipid compositions.  
Transfer of materials across epithelia occur through diffusion for small materials such as 
ions, or through receptor-mediated transcytosis processes for large molecules such as 
proteins.  For receptor-mediated transcytosis, ligands are bound by their cognate receptors 
and internalized through clathrin-coated pits (CCPs).  Motifs in the receptor cytoplasmic tail 
communicate with the cellular trafficking machinery which regulates the navigation of 
receptor-ligand complexes through the various subpopulations of membrane-bound 
compartments that constitute the endosomal network. (Adapted from Rojas and Apodaca, 
2002) 
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Figure 2.  Immunoglobulin isotypes.  IgD and monomeric IgM are displayed on the surface 
of naïve B-cells.  After exposure to antigen and activation by helper T-cells the B-cell will 
begin secreting pentameric IgM or undergo class switching, after which the cell will secrete 
IgA, IgE, or IgG.  IgA exists as both a monomer in serum and as a dimer (dIgA) in mucosal 
secretions in which two IgA monomers are attached by J chain.  IgE attaches to the surface of 
mast cells where it mediates the allergic response.  IgG is the most abundant immunoglobulin 
in serum and plays the most prominent role in the adaptive immune response.  Both IgE and 
IgG exist only as monomers. (Adapted from Rojas and Apodaca, 2002) 
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Figure 3. Schematic representation of FcRn function in the neonatal rodent gut.  IgG present 
in maternal milk passing through the acidic environment of the intestinal lumen is bound by 
FcRn at the apical surface of polarized intestinal epithelial cells.  Subsequent internalization 
and transcytosis of the IgG allows it to dissociate from FcRn upon exposure to the slightly 
basic pH of the newborn blood, thus entering the circulation.  This process confers passive 
immunity to antigens encountered by the mother. (Adapted from Simister, et al., 1997) 
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Figure 4.  Placental transfer of IgG in the gestating primate. FcRn present in placental 
syncitiotrophoblast cells binds to fluid-phase internalized IgG in acidic endosomes.  FcRn-
IgG complexes are transcytosed across the placental tissue layer into the fetal circulation.  
The route of transfer is seen in both humans and non-human primates.  (Adapted from 
Biochem. Soc. Trans. 25:481-487) 
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Figure 5.  FcRn-mediated recycling of IgG.  Circulating IgG is internalized via the fluid-
phase by vascular endothelial cells.  Fluid-phase material is targeted for destruction by a 
default catabolic pathway.  FcRn present in acidic endosomes binds to IgG and transports it 
back to the cell surface where it can re-enter the circulation.  This process confers a long 
serum half-life upon IgG relative to other serum proteins.  A similar process has been 
proposed for FcRn-mediated salvage of albumin.  (Adapted from Biochem. Soc. Trans. 25: 
481-487) 
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 Figure 6.  The “oligomeric ribbon” seen in the co-crystal structure of rat FcRn in complex 
with rat Fc.  The structure is an array of FcRn dimers (α-chain in blue, β2m in green) bridged 
by homodimeric Fc (red).  In the top view the membrane would be in the plane of the page.  
The side view is rotated 90 degress towards the viewer.  Arrows indicate where FcRn would 
attach to the membrane. (Adapted from Burmeister, et al. 1994) 
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Figure 7.  Structural comparison between FcRY and mannose receptor (MR) family 
members.  FcRY exhibits a high degree of sequence identity to the mammalian PLA2R.  All 
MR family members contain multiple C-type lectin-like domains and N-terminal Fibronectin 
type II and cysteine-rich domains.  FcRY is structurally distinct from the class I MHC-related 
FcRn. (West, A.P., 2002) 
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Table 1. Timeframes and transmission routes of passive immunity across different species. 
 
41
 
 
 
 
 
 
 
Chapter 2: 
 
Ligand Valency Affects Transcytosis, 
 
Recycling, and Intracellular Trafficking 
 
Mediated by the Neonatal Fc Receptor 
 
In the paper we describe the importance of ligand bivalency for the efficient FcRn-mediated 
transport of Fc and IgG.  Noreen Tiangco assisted in the isolation and maintenance of cell 
lines used in the transport experiments and in the production of recombinant Fc proteins. 
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The neonatal Fc receptor (FcRn) transports IgG across
epithelial cell barriers to provide maternal antibodies to
offspring and serves as a protection receptor by rescuing
endocytosed IgG and albumin from lysosomal degradation.
Here we describe the generation of polarized Madin–Darby
canine kidney (MDCK) cells expressing rat FcRn (rFcRn) to
investigate the potential requirement for ligand bivalency
in FcRn-mediated transport. The rFcRn-MDCK cells bind,
internalize and bidirectionally transcytose the bivalent
ligands IgG and Fc across polarized cell monolayers.
However, they cannot be used to study FcRn-mediated
transport of the monovalent ligand albumin, as we
observe no specific binding, internalization or transcyto-
sis of rat albumin. To address whether ligand bivalency
is required for transport, the ability of rFcRn to trans-
cytose and recycle wild-type Fc homodimers (wtFc; two
FcRn-binding sites) and a heterodimeric Fc (hdFc; one
FcRn-binding site) was compared. We show that ligand
bivalency is not required for transcytosis or recycling, but
that wtFc is transported more efficiently than hdFc,
particularly at lower concentrations. We also demon-
strate that hdFc and wtFc have different intracellular
fates, with more hdFc than wtFc being trafficked to
lysosomes and degraded, suggesting a role for avidity
effects in FcRn-mediated IgG transport.
Key words: apical, basolateral, FcRn, FcRn-GFP, hetero-
dimeric Fc (hdFc), IgG, Madin–Darby canine kidney
(MDCK) cells, transcytosis
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The plasma membranes of epithelial cell barriers are
segregated into two spatially and functionally distinct
domains that serve as a means for complex organisms
to distinguish between the external environment and the
underlying tissue. A vital characteristic of such cellular
barriers is their ability to selectively allow the passage of
materials, such as ions, small molecules, peptides, lipids
and proteins, either by passive or active (receptor medi-
ated) transport mechanisms. The neonatal Fc receptor
(FcRn), a class I major histocompatibility complex (MHC)-
related protein that associates with theMHC light chain b2-
microglobulin (b2m), mediates the transfer of maternal IgG
across epithelial cell barriers to the fetus or newborn (1,2).
In newborn suckling rodents, FcRn is expressed in the
polarized epithelium of the intestine. The FcRn present at
the apical surface of the intestinal cells binds to maternal
IgG from ingested milk, transcytoses it across the epithe-
lium and releases it into circulation from the basolateral cell
surface (1). This process confers passive humoral immu-
nity to the newborn during the first weeks of independent
life. The difference in pH between the intestinal lumen
(pH 6.0) and the bloodstream (pH 7.4) promotes the
efficient unidirectional transport of IgG, as FcRn binds IgG
at pH values 6.5, but not at neutral or higher pH (1,3).
The FcRn-mediated transport of IgG can also occur in the
absence of a pH gradient. In gestating primates, IgG in the
maternal bloodstream is transferred to the fetal blood-
stream in a process that consists of passive uptake of IgG
by syncitiotrophoblast cells, followed by transcytotic deliv-
ery to the fetal bloodstream on the opposite surface (4–6).
In adult mammals, FcRn plays a key role in serum IgG
homeostasis by protecting IgG taken up by vascular
endothelial cells from a default degradative pathway
(7–9). For both these functions, it is believed that IgG
internalized at pH 7.4 via fluid-phase endocytosis is bound
by FcRn in acidic endosomes. This results in FcRn–IgG
complexes being transcytosed in the case of maternofetal
IgG transfer, or returned to the cell surface rather than
catabolized in the case of serum IgG homeostasis.
We previously described a structure-based hypothesis to
account for the ability of cells to distinguish endosomes
containing FcRn–IgG complexes destined for recycling or
transcytosis from endosomes destined for a degradative
pathway (10). The hypothesis suggests that an oligomeric
ribbon of FcRn dimers bridged by the homodimeric Fc
regions of IgG molecules, as seen in the crystal structure
of an rFcRn/Fc complex (11), forms inside acidic trafficking
vesicles. Formation of the oligomeric ribbon between the
Re-use of this article is permitted in accordance with the Creative
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adjacent membranes of a tubular endosome could act as
an intracellular trafficking signal, designating vesicles con-
taining such complexes for entry into the transcytotic or
recycling pathways. A requirement for the formation of the
oligomeric ribbon is a homodimeric Fc or IgG molecule
capable of bridging between FcRn proteins on opposing
membrane faces. Consistent with this hypothesis, pre-
vious studies demonstrated that a heterodimeric Fc mol-
ecule (hdFc), which contains one FcRn-binding chain and
one non-FcRn-binding chain, is less efficiently transcy-
tosed across neonatal mouse intestine (12) and exhibits
a shorter serum half-life (13) than a wild-type homodimeric
Fc molecule (wtFc). These results indicate that two FcRn-
binding sites on a ligand are required for the purposeful
movement of vesicles containing FcRn–ligand complexes
through the transcytotic and protection pathways. How-
ever, recent studies have demonstrated that human and
rodent FcRn bind amonomeric ligand, serum albumin, with
a similar pH dependency as the FcRn–IgG interaction, and
that mice lacking either the FcRn heavy or light chain
exhibit a shortened half-life for albumin in the circulation
(14,15). These studies support a model in which FcRn acts
as a protection receptor for a monomeric protein, albumin,
as well as for dimeric IgG and Fc ligands.
Here we describe an in vitro system using transfected
Madin–Darby canine kidney (MDCK) cells to compare the
transport of dimeric and monomeric FcRn ligands. The
MDCK cells expressing rat FcRn (rFcRn) transcytose Fc
and IgG in both the apical to basolateral and basolateral to
apical directions, consistent with previous studies of
human FcRn (hFcRn) and rFcRn expressed in MDCK cells
or other polarized cell lines (16–23). We do not observe
specific binding, uptake or transcytosis of a naturally
occurring monovalent FcRn ligand, rat albumin. We there-
fore used variant forms of rat Fc containing two, one or
zero FcRn-binding site (24) to assess the effects of ligand
valency on FcRn-mediated transport. We show that the
presence of two binding sites on the internalized Fc is not
strictly required for the transcytosis or recycling to occur,
but a bivalent Fc with two FcRn-binding sites (wtFc) is
trafficked more efficiently than its monovalent cognate
(hdFc), particularly at lower concentrations. Analysis by
confocal microscopy of wtFc and hdFc trafficking following
internalization reveals that the two ligands have different
intracellular fates such that more internalized hdFc than
wtFc colocalizes with markers for early endosomes (EEA1)
and lysosomes, consistent with quantitative studies dem-
onstrating that more hdFc than wtFc is degraded after
internalization. These results suggest that avidity effects
play a key role in FcRn-mediated ligand transport.
Results
Functional expression of rFcRn in MDCK cells
Our laboratory previously described the generation ofMDCK
cell lines expressing rFcRn and an rFcRn-green fluorescent
protein (GFP) chimeric protein (25). In the course of con-
ducting new experiments with the previously described
rFcRn-GFP-MDCK cell line, we discovered that we could
not replicate some of the published properties of the cell line
(26). It had been reported that the rFcRn-GFP-MDCK cells
functioned in transport of Fc when ligand was added at both
permissive (acidic) and nonpermissive (basic) pH values for
the rFcRn–IgG interaction and that rFcRn-GFP fluorescence
underwent a striking redistribution upon addition of ligand
at either pH (25). In recent experiments, however, we found
that the rFcRn-GFP-MDCK cell line, although positive by
antibody staining for both the rFcRn heavy and light chains
(data not shown), did not take up significant amounts of Fc or
IgG at basic pH, and the distribution of rFcRn-GFP did not
change upon ligand addition (26).
To resolve these discrepancies, we generated newMDCK
cell lines stably expressing rat b2m (rb2m) together with
the full-length rFcRn heavy chain or with an rFcRn-GFP
chimera in which GFP was added C-terminal to the rFcRn
cytoplasmic tail. Drug-resistant transfected cells were
screened by Western blot and by pH-dependent uptake
of fluorescent rat Fc. A drug-resistant cell line transfected
with an empty expression vector (vector-only MDCK) was
used as a negative control. The rFcRn-MDCK and rFcRn-
GFP-MDCK cells used in the present studies exhibited
transepithelial electrical resistance (TEER) values of250–
300 Vcm2 when grown as polarized monolayers on filter
supports. The high TEER value is important, as the rFcRn-
GFP-MDCK cell line described previously (25) was sub-
sequently found to have low TEER values (50–75 Vcm2),
consistent with our later finding that the cells were leaky
to radiolabeled ligands (our unpublished results).
Expression of rFcRn and rFcRn-GFP in the newly gener-
ated MDCK cell lines was verified in cell lysates by
Western blot. An anti-rFcRn antiserum detected two
bands migrating with apparent molecular masses of 50
and 65 kDa in the rFcRn-MDCK cell lysate and 80 and
95 kDa in the rFcRn-GFP-MDCK cell lysate (Figure 1A).
The upper and lower bands likely represent mature and
incompletely glycosylated forms of rFcRn, respectively, as
previously observed for hFcRn expressed in MDCK (16)
cells and rFcRn expressed in rat inner medullary collecting
duct (IMCD) cells (22). To verify IgG binding by rFcRn in
MDCK cells, whole-cell lysates were incubated with
human IgG-Sepharose beads at acidic or basic pH, and
the bound proteins were eluted and analyzed by Western
blot. The rFcRn and rFcRn-GFP were detected in IgG
pull-downs conducted at acidic but not at basic pH
(Figure 1B), although both proteins were detectable in
blots of total cell lysates from rFcRn-MDCK and rFcRn-
GFP-MDCK at both pH 6 and 8 (data not shown). Addition-
ally, no rFcRn or rFcRn-GFP is detected in IgG pull-downs
performed at pH 6 and subsequently washed at pH 8
(data not shown), demonstrating that both forms of
rFcRn bind IgG at pH 6 and dissociate from the ligand at
pH 8.
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Confocal analyses of rFcRn-MDCK and rFcRn-GFP-MDCK
cells showed intracellular compartments that are labeled
by antibodies against the heavy and light chains of rFcRn
(Figure 1C). The stainings for rFcRn and rb2m are colocalized,
consistent with proper association between the two
chains, and both the anti-rFcRn and the anti-rb2m fluores-
cence colocalize with GFP fluorescence in the rFcRn-GFP-
MDCK cell line, indicating that GFP can be used as amarker
for rFcRn expression in this cell line.
The ability of rFcRn-MDCK and rFcRn-GFP-MDCK cells to
uptake wtFc, a recombinant rat Fc (24), was evaluated by a
quantitative radioligand endocytosis assay. As shown in
Figure 2, rFcRn-MDCK and rFcRn-GFP-MDCK cells internal-
ized a significant amount of [125I]wtFc at pH 6 but not at pH 8.
Internalization was saturable, as inclusion of the unlabeled
wtFc or IgG reduced the uptake to background levels, and
was also specific, as significant uptake of a recombinant
rat Fc with substitutions in both chains that prevent binding
to rFcRn (nonbinding Fc; nbFc) (24) was not observed in
either the rFcRn-MDCK or the rFcRn-GFP-MDCK cells.
Labeled hdFc, a recombinant rat Fc composed of one wild-
type Fc chain and one nbFc chain (24), was also endo-
cytosed by the rFcRn-MDCK cells in a saturable and
pH-dependant manner, although at lower levels than wtFc
(Figure 2). Taken together, these results show that rFcRn
expressed in MDCK cells undergoes proper posttransla-
tional modifications, binds IgG with the expected pH
dependence and mediates specific and saturable uptake
of Fc ligands at acidic pH.
To observe the subcellular localization of endocytosed Fc,
the apical surfaces of polarized rFcRn-MDCK, rFcRn-GFP-
MDCK or vector-only MDCK cell monolayers were incu-
bated with wtFc (1 mM) at acidic or basic pH and processed
for immunofluorescence microscopy. Confocal images
Figure 1: Expression of rFcRn and rFcRn-GFP in MDCK cells. (A) Western blot using anti-rFcRn antiserum of detergent lysates from
rFcRn-MDCK, rFcRn-GFP-MDCK and vector-only MDCK cells. Two bands, likely representing the mature and incompletely glycosylated
rFcRn heavy chains, are detected in rFcRn-expressing cells, but not in control cells. (B) Western blot of detergent lysates after a pull-down
with human IgG-Sepharose at pH 6 or pH 8. Bands corresponding to the rFcRn and rFcRn-GFP heavy chains are present in samples from pull-
downs at pH 6. No bands are detected in samples pulled down at pH 6 and subsequently washed at pH 8 (data not shown). (C) Confocal
images of rFcRn-MDCK and rFcRn-GFP cells stained with fluorescently labeled anti-rFcRn (green or blue) or anti-rb2m (red) antibodies.
Staining of rFcRn-MDCK cells shows that rFcRn-positive compartments colocalize with rb2m-positive compartments, and staining of rFcRn-
GFP-MDCK cells shows that fluorescence from GFP colocalized with fluorescence from both the anti-rFcRn and anti-rb2m antibodies.
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(Figure 3) show that internalized wtFc (red fluorescence) is
present in rFcRn-positive compartments (green fluores-
cence) in rFcRn-MDCK and rFcRn-GFP-MDCK cells incu-
bated with ligand at pH 6. The distribution of rFcRn and
rFcRn-GFP was not significantly different in the absence of
wtFc or IgG compared to when these ligands were present
at concentrations ranging from 20 nM to 1 mM (data not
shown), contradicting the previous report (25). Also in
contrast to the previous study (25), substantially less
uptake was observed when the cells were incubated with
wtFc at basic pH (pH 7.4) versus at acidic pH (shown for
rFcRn-MDCK; Figure 3), indicating that an acidic extracel-
lular environment greatly enhances uptake by allowing Fc
to bind rFcRn at the cell surface prior to internalization. The
vector-only MDCK cells did not stain with the 1G3 antibody
and showed only low levels of internalized wtFc (Figure 3),
likely resulting from trace internalization via the fluid phase.
Bidirectional transcytosis of IgG and Fc
Radiolabeled rat wtFc (20 nM) was added to the apical
surface of the polarized rFcRn-MDCK or rFcRn-GFP-MDCK
monolayers at pH 6, while the basolateral surface was
maintained at pH 8. The amount of transcytosed ligand in
the basolateral reservoir was measured after 90 min.
Significantly more wtFc is transported by the rFcRn-MDCK
cells than the control MDCK cells (Figure 4A). The pres-
ence of a 500-fold excess of competitor (unlabeled rat IgG
or wtFc) reduces transcytosis to background levels ob-
served for [125I]nbFc.
Surprisingly, rFcRn-GFP-MDCK cells do not mediate spe-
cific transport of [125I]wtFc (Figure 4A). This lack of detect-
able transport was observed in at least three other clones
of rFcRn-GFP-MDCK cells, and in transcytosis experi-
ments performed in both the apical to basolateral and
basolateral to apical directions (data not shown). Because
the rFcRn-GFP-MDCK cells do appear to function in a pH-
dependent uptake of wtFc (Figure 2), these data suggest
that addition of the GFP tag to the rFcRn cytoplasmic tail
does not prevent endocytosis, but interferes with post-
internalization trafficking events. Further experiments
were therefore conducted using only the rFcRn-MDCK
cells and vector-only control MDCK cells.
We next compared the ability of rFcRn-MDCK cells to
transcytose IgG and Fc ligands in both the apical to baso-
lateral and basolateral to apical directions (Figure 4B). These
experiments were conducted using [125I]human IgG and
[125I]human Fc because radiolabeled human IgG is trans-
cytosed more efficiently than radiolabeled versions of other
commercially available IgGs (data not shown). We find that
both IgG and Fc are transcytosed bidirectionally across the
rFcRn-MDCK cells when the loading surface is maintained
at pH 6 and the nonloading surface is maintained at pH 8
(Figure 4B). When either ligand is prevented from binding to
cell-surface rFcRn bymaintaining the loading surface at pH 8,
or by saturating surface receptors with unlabeled ligand,
we see only background levels of transcytosis. Fc is
transported more efficiently than intact IgG in both direc-
tions. The lower efficiency of IgG transcytosis as com-
pared with Fc transcytosis may result from steric effects,
i.e., the Fab arms present on intact IgG could clash with the
membrane when rFcRn is in a ‘standing up’ conformation
(11). This is consistent with our observation that intact rat
IgG competes less efficiently for endocytosis and trans-
cytosis of [125I]wtFc than does wtFc (Figures 2 and 4A).
Binding, endocytosis and transport studies using
rat albumin as an rFcRn ligand
IgG and Fc are both bivalent ligands of FcRn, that is, each
contains two potential FcRn-binding sites. To determine
whether rFcRn expressed in MDCK cells can act as
a functional receptor for a monovalent ligand, rat serum
albumin (RSA), we conducted binding, endocytosis and
transcytosis assays using [125I]RSA. Because RSA has
a more acidic pH optimum than IgG for binding to rFcRn
(14,27), cell-surface binding assays were performed at pH
5.0. Although rFcRn-MDCK cells incubated at pH 5 specif-
ically bind [125I]wtFc (data not shown), cells incubated with
[125I]RSA and then washed at pH 5 do not bind more RSA
than cells washed at pH 8 (Figure 5A); thus, we see no
specific binding of RSA to rFcRn-MDCK cells.
Wenext tested the possibility that binding to cell-surface rFcRn
that is undetectable in a binding assay could promote endocy-
tosis of RSA into rFcRn-MDCK cells. A high concentration
(3 mM) of [125I]RSAwas added at pH 5 or 8 to rFcRn-MDCK or
to vector-onlyMDCK cells in the presence or absence of a 100-
fold excess of unlabeled RSA. We find that both the rFcRn-
MDCK and vector-only cells internalize a high level of labeled
RSA at pH 5 and at pH 8, with the greatest amount of
internalization being observedwhen [125I]RSA is added at pH 5
without competitor (Figure 5B). Although slightly more RSA is
internalized at pH 5 by the rFcRn-MDCK cells than by the
vector-onlyMDCK cells, perhaps representing rFcRn-mediated
endocytosis of RSA, the difference is very small compared to
the absolute amount of RSA internalized by either cell line.
We also investigated whether the rFcRn-MDCK cells can
transcytose RSA. To account for the relatively low affinity
of the RSA–rFcRn interaction (14,27), a high concentration
of [125I]RSA (10 mM) was incubated at the apical surface of
Figure 2: Endocytosis of rFcRn ligands by rFcRn and rFcRn-
GFP expressed in MDCK cells. Subconfluent rFcRn-MDCK,
FcRn-GFP-MDCK or vector-only MDCK were incubated with
radiolabeled Fc ligands (recombinant wtFc, hdFc and nbFc derived
from rat IgG2a at a concentration of 20 nM) at pH 6 or pH 8 in the
presence or absence of a 500-fold excess of unlabeled competitor
protein, and levels of radioactivity were determined in cell lysates.
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Figure 3: Distribution of internalized wtFc in rFcRn-MDCK, rFcRn-GFP-MDCK and vector-only MDCK cells. Filter-grown mono-
layers were incubated with 1 mM wtFc (recombinant Fc derived from rat IgG2a) for 1 h at pH 6 or pH 7.4 and processed for immuno-
fluorescence using antibodies against wtFc (red) and the tight junction marker ZO-1 (blue). The heavy chain of rFcRn (green) was detected
using GFP fluorescence (rFcRn-GFP-MDCK cells) or an antibody against the rFcRn heavy chain (rFcRn-MDCK and vector-only MDCK cells).
Optical sections were taken every 2 mm below the level of the tight junctions.
Traffic 2006; 7: 1–16 5
Rat FcRn Trafficking in MDCK Cells
47
rFcRn-MDCK or vector-only-MDCK cells at pH 5 or pH 8.
Control experiments using labeled wtFc and nbFc demon-
strated that incubation at pH 5 does not disrupt trans-
cytosis of a functional ligand (wtFc) or result in leakage of
nbFc across the monolayer (Figure 5C). In the experiments
using labeled RSA, we see no evidence of rFcRn-mediated
transcytosis. Instead, we observe a high level of transport
across both the rFcRn-MDCK and control cells at both
acidic and basic pH, with transport being slightly higher for
both cell lines at basic pH (Figure 5C). Similar results were
obtained in experiments using lower concentrations of
[125I]RSA (data not shown). The lack of observed trans-
cytosis of RSA in the rFcRn-MDCK cells is consistent with
a previous demonstration that little or no albumin is trans-
cytosed across the proximal intestine of neonatal rats
under conditions in which 10–35% of the administered
IgG is transported into the blood (28).
Relative affinities of wtFc and hdFc
for cell-surface rFcRn
Because we did not observe binding or transyctosis of
albumin, a naturally occurring monovalent ligand for FcRn,
Figure 4: Bidirectional transcytosis of Fc and IgG ligands by rFcRn-MDCK cells. Radiolabeled Fc or IgG was added to the loading
surface (apical in panel A and apical or basolateral in panel B) of polarized cell monolayers and levels of radioactivity in the media from the
nonloading surface were measured after 90 min. Bars represent the mean and standard deviation of triplicate filters. (A) Comparison of
apical to basolateral transcytosis of wtFc in three different cell lines. rFcRn-MDCK, rFcRn-GFP-MDCK and vector-only MDCK cells were
incubated on the apical surfacewith 20 nM of [125I]wtFc (recombinant Fc derived from rat IgG2a), [125I]wtFc plus 500-fold excess unlabeled
wtFc or rat IgG (rIgG), or [125I]nbFc. (B) Comparison of bidirectional transcytosis of Fc and IgG. rFcRn-MDCK and vector-only MDCK cells
were incubated with 20 nM [125I]human Fc (hFc) or [125I]human IgG (hIgG) on the apical or basolateral surface. Control experiments were
performed in the presence of 500-fold excess unlabeled hFc or at pH 8 as indicated.
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we used hdFc as a monovalent ligand for comparative
studies with wtFc, a bivalent ligand. We first compared the
binding of radiolabeled wtFc and hdFc to rFcRn on the
surface of rFcRn-MDCK cells. Equilibrium dissociation con-
stants (KD) were determined by nonlinear regression analy-
sis from plots of bound Fc as a function of Fc concentration
(Figure 6A). The wtFc binding data were fit to a two-site
bindingmodel assuming two independent classes of binding
sites (a high-affinity class, which takes avidity effects into
account, and a low-affinity class), yielding KD values of 1.6
and 13 nM. The hdFc binding data cannot be fit to a two-site
binding model (data not shown), consistent with its single
FcRn-binding site. These data were therefore fit to a 1:1
binding model, from which a KD of 120 nM was derived.
Transcytosis and recycling efficiencies
of monovalent and bivalent Fc proteins
We next compared the transcytosis and recycling efficien-
cies of the two forms of rat Fc. First, radiolabeled versions
of wtFc and hdFc were added at pH 6 to the apical surface
of rFcRn-MDCK monolayers at a range of concentrations.
The amount of transcytosed Fc released into the basolateral
medium after 90 min was plotted as a function of Fc
concentration (Figure 6B), yielding curves that are analo-
gous to the binding isotherms in Figure 6A. At concentra-
tions below 1 mM, wtFc is transported in significantly
greater amounts than hdFc. Transcytosis of both proteins
is comparable at approximately 1 mM, and for values greater
than 1 mM, more hdFc than wtFc is transported to the
basolateral media. Nonlinear regression analysis performed
on the trancytosis data was used to extract the concentra-
tion at which half-maximal transcytosis occurs (T1/2max),
which is analogous to a KD, the concentration at which half-
maximal binding of a ligand to its receptor occurs. As
described for the binding data, the wtFc transcytosis data
were fit to a two-site model, yielding two T1/2max values,
5.2 nM (high-affinity population) and 26 nM (low-affinity
population), and the data for hdFc were fit to a one-site
model, yielding a single T1/2max value (1.6 mM). The fact
that the T1/2max value for the high-affinity population of
receptors that bind wtFc (5.2 nM) is lower than the T1/2max
value for hdFc (1.6 mM) indicates that bivalency of the Fc
ligand contributes to the efficient transcytosis of cargo,
particularly at lower ligand concentrations, but that ligand
bivalency is not absolutely required for FcRn-mediated
transcytosis.
Figure 5: Albumin binding, endocytosis and transport experiments. (A) Cell-surface binding. rFcRn-MDCK cells were incubated at pH 5
with [125I]RSA at a range of concentrations. For each concentration of labeled RSA, quadruplicate samples were washed at either pH 8 or
pH 5 after the incubations, and the radioactivity bound at basic pH was subtracted from the radioactivity bound at acidic pH to determine
the amount of specifically bound RSA at each concentration. (B) Endocytosis of RSA. Subconfluent rFcRn-MDCK and vector-only MDCK
cells were incubated with 3 mM [125I]RSA at pH 5 in the presence or absence of 2 mM unlabeled RSA, or at pH 8, and levels of radioactivity
were determined in cell lysates. (C) Apical to basolateral transcytosis of RSA. The apical surfaces of filter-grown cell monolayers were
incubated with 10 mM [125I]RSA at pH 5 or pH 8 as indicated. Some filters were treated with 30 nM [125I]wtFc or [125I]nbFc as positive and
negative controls, respectively. The levels of radioactivity in the basolateral media were determined after 90 min.
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Apical recycling was evaluated by measuring the amount
of radioligand returned to the apical media after internali-
zation from the apical surface of rFcRn-MDCK cells. As
described for the transcytosis assay, the amounts of
recycled wtFc and hdFc were plotted as a function of
concentration, and the concentrations at which half-
maximal recycling occurs (R1/2max) were determined from
the data by nonlinear regression analyses using a two-site
Figure 6: Comparison of binding and transport of wtFc and hdFc by rFcRn-MDCK cells. Binding, transcytosis and recycling data are
presented separately for wtFc and hdFc (recombinant Fc proteins derived from rat IgG2a) as a linear function of concentration (left and center
graphs in panels A–C), and together as a function of the logarithm of the input concentration (right graphs in panels A–C). Data points represent
the mean and standard error for quadruplicate (panel A) or triplicate (panels B and C) measurements. The data for wtFc were fit to a two-site
binding model, therefore yielding two half-maximal values per graph: half-maximal binding (KD), half-maximal transport (T1/2max) or half-maximal
recycling (R1/2max). The data for hdFc were fit to a one-site binding model, yielding one half-maximal value per graph (see Materials and
Methods). (A) Cell-surface binding of wtFc and hdFc. The amounts of wtFc and hdFc bound to cell-surface rFcRn were determined using
500 000 cells at each input concentration. Assuming that each wtFc or hdFc molecule is bound by a single rFcRn molecule at saturating
concentrations, there are 150 fmol of ligand binding sites in each binding experiment, which corresponds to 180 000 surface-accessible
sites/cell. (B) Apical to basolateral transcytosis of wtFc and hdFc. (C) Apical recycling of wtFc and hdFc. (D) Comparison of T1/2max to KD and
R1/2max to KD ratios for wtFc and hdFc. These ratios are predicted to be 1.0 in a perfectly efficient transport or recycling system.
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Figure 7: Comparisonof intracellular localization anddegradationofwtFc andhdFc. (A andB) The apical surface of rFcRn-MDCKcellswas
incubated with 1 mMwtFc or hdFc (recombinant Fcs derived from rat IgG2a) at pH 6 for 1 h, then fixed and processed for immunofluorescence
using labeled antibodies against rat Fc and specific markers. The degree of colocalization of the Fcs with EEA1 (panel A) or LAMP-2 (panel B) is
shown as a function of distance from the apical pole on the left of each panel (n ¼ 3 or 4 for each data point). The percentage of above-
threshold Fc pixels colocalizing with above-threshold EEA1 or LAMP-2 pixels was determined in each optical section as described in the
Materials and Methods. Confocal images of the distributions of wtFc or hdFc (green) and EEA1 (red) (panel A) or wtFc or hdFc (green) and
canine LAMP-2 (red) (panel B) are shown for a subapical optical section on the right of each panel. Regions of colocalization appear yellow in
the merged images. (C) Averages of the colocalization coefficients for five optical sections spanning the whole cell. Significantly more
(p < 0.0001) hdFc than wtFc colocalizes with EEA1 (n ¼ 15 and n ¼ 19, respectively) and with LAMP-2 (n ¼ 20). (D) Comparison of
degradation of wtFc and hdFc. [125I]labeledwtFc or hdFcwas internalized at pH 6 from the apical surface of rFcRn-MDCK cells for 1 h, after
which the cells were washed at pH 8. The cells were returned to 378C for the indicated time points, after which acid-soluble radioactivity in
the media was measured. The percent of each Fc that was degraded was determined as described in the Materials and Methods.
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binding model (wtFc) or a one-site binding model (hdFc)
(Figure 6C). The R1/2max values for recycling of wtFc
(R1/2max1) and hdFc are 22 nM and 3.3 mM, respectively,
indicating that bivalency of the Fc ligand also contributes to
the efficiency of the recycling process.
To compare the affinities of the two forms of Fc to their
transport efficiencies, we calculated the T1/2max/KD and
R1/2max/KD ratios for each Fc. For comparisons of wtFc
transcytosis and recycling with binding, we are interested
in the KD, T1/2max and R1/2max values representing the high-
affinity population of receptors that are affected by avidity
(KD1, T1/2max1 and R1/2max in Figure 6A–C). The T1/2max1/KD1
ratio for wtFc is 3.2, which is significantly smaller than the
T1/2max/KD ratio for hdFc (~14) (Figure 6D); thus, the less
efficient transport of hdFc versus wtFc is not fully explained
by the differences in affinity. Similarly, the R1/2max1/KD1
ratio for wtFc (~14) is smaller than the R1/2max/KD ratio for
hdFc (~28) (Figure 6D).
Although the T1/2max and R1/2max values demonstrate that
higher concentrations of hdFc than wtFc are required to
achieve half-maximal transcytosis or recycling rates, the
absolute amounts of hdFc that are transcytosed and
recycled are higher than the analogous amounts of wtFc
as the concentration of Fc approaches saturation (values
above 1 mM) (Figure 6B,C). The reason for the higher
levels of hdFc transport is unclear. It may result from the
fact that a given number of receptors can transport twice
as many hdFc molecules as wtFc because hdFc can be
bound and transported by only one receptor, whereas
wtFc can be bound and transported by two receptors. In
addition, allowing each receptor to act as an independent
trafficking unit may increase the overall rate at which
individual receptors can complete one full round of ligand
internalization and transport as compared to when the
receptors are required to transport cargo in sets of two.
Comparison of localization of wtFc and hdFc
in rFcRn-MDCK cells
To address whether the increased efficiency of wtFc over
hdFc transport results from different intracellular fates of
the two forms of Fc, we compared the intracellular local-
izations of internalized wtFc and hdFc with a marker for
early endosomes (EEA1) and with a marker for lysosomes
(the lysosomal membrane protein LAMP-2).
After 1 h of internalization from the apical surface, both
wtFc and hdFc are present in discrete compartments
throughout the cell (Figure 7A,B), including EEA1-positive
compartments (Figure 7A), demonstrating that rFcRn-
bound Fc proteins enter the endosomal network after being
endocytosed. Although the mean intensity of the wtFc and
hdFc staining is similar (see Materials and Methods), more
hdFc than wtFc is colocalized with EEA1, as demonstrated
by quantitative analysis of the confocal image data to
determine the percent colocalization of above-threshold
fluorescence for each type of Fc with EEA1 (see Materials
andMethods). The degree of hdFc colocalization with EEA1
is consistently higher throughout the cell than the colocal-
ization of wtFc with EEA1, with the most significant differ-
ences observed in the apical sections of the monolayer
(left, Figure 7A). Averaged over the entire cell, 64  3.0%
of the hdFc fluorescence colocalizes with EEA1-positive
compartments compared with 49  1.4% of the wtFc
fluorescence (Figure 7C). A more striking difference is
observed for colocalization of the two Fcs with the lyso-
somal marker LAMP-2 (Figure 7B), in which 59  2.8% of
hdFc fluorescence colocalizes with LAMP-2-positive com-
partments compared with 34  1.7% of wtFc fluorescence
(Figure 7C).
The observation that more hdFc than wtFc is present in
LAMP-2-positive compartments suggests that more hdFc
than wtFc is degraded following internalization. To test this
possibility, we measured the amounts of degraded Fc
(acid-soluble radioactivity) released as a function of time by
cells incubated with 1 mM wtFc or hdFc. As shown in
Figure 7D, more degraded radioligand is released from
hdFc-treated cells than from wtFc-treated cells. This
difference is significant for postincubation times of
30 min or more, confirming that a substantially greater
fraction of a single cohort of internalized hdFc is degraded
compared to wtFc.
Discussion
Ligand valency is a critical feature of many receptor–ligand
interactions. While many receptors that mediate intracel-
lular signal transduction bind bivalent ligands to form 2:1
receptor:ligand complexes (e.g., platelet-derived growth
factor receptor, colony-stimulating factor 1 receptor and
stem cell factor receptor) [reviewed by Heldin (29)],
receptors involved in ligand transcytosis and transport
more commonly bind monovalent ligands to form 1:1
complexes (e.g., pIgR, low-density lipoprotein receptor
and transferrin receptor) [reviewed by Tuma and Hubbard
(30)]. FcRn was first identified as a receptor for IgG,
a bivalent ligand, and the crystal structure of rFcRn in
complex with wtFc showed that two FcRn molecules can
bind simultaneously to a dimeric Fc (11). Studies of purified
proteins in solution confirmed a 2:1 FcRn:Fc stoichiometry
(24,31–33), and in vivo studies in mice showed that both
FcRn-binding sites on Fc are required for efficient trans-
cytosis and protection from catabolism (12,13). However,
the discovery that FcRn also serves as a protection re-
ceptor for serum albumin (14,34), a monovalent ligand,
suggests that ligand bivalency is not a general requirement
for FcRn-mediated ligand trafficking.
Here we investigate the effects of valency on FcRn-
mediated ligand trafficking to determine whether bivalency
of an FcRn ligand is a strict requirement for proper
trafficking, or if it merely acts to increase the efficiency
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of the trafficking process. In the former case, one would
expect the binding of the Fc or IgG ligand by two FcRn
molecules to act as a signal, perhaps by bringing the
receptors into close spatial proximity to facilitate interac-
tions with cytosolic trafficking components. In the latter
case, the binding of each ligand by two receptors would
facilitate transport through an avidity effect, ensuring that
the ligand molecule, once bound and internalized, remains
in complex with its receptor throughout the transport
process.
To evaluate the effects of ligand valency on FcRn-mediated
transport, we generated stable MDCK cell lines expressing
rFcRn that can be used as a model system for studies of
FcRn-mediated transport of IgG and Fc ligands. Two cell
lines were generated: rFcRn-MDCK, which expresses full-
length rFcRn and the rFcRn light chain rb2m, and rFcRn-
GFP-MDCK, which expresses an rFcRn-GFP chimeric
protein together with rb2m. The expressed rFcRn proteins
both bind to IgG at acidic but not at basic pH (Figure 1B),
the characteristic pH dependency of the FcRn–IgG inter-
action (3). Functional binding and internalization of Fc
ligands were demonstrated in polarized rFcRn-MDCK and
rFcRn-GFP-MDCK monolayers at acidic pH (Figure 2). We
observe only background amounts of wtFc internalized
at pH 8, suggesting that fluid-phase uptake at basic pH is
not significant at the relatively low concentration (20 nM)
used for these experiments. Thus, an acidic extracellular
environment greatly enhances the efficiency of ligand
uptake, most likely by allowing IgG or Fc to bind rFcRn
molecules transiently exposed to the cell surface prior
to reinternalization. However, confocal analyses of rFcRn-
MDCK cells that have internalized Fc ligands at a sig-
nificantly higher concentration (1 mM) indicate that a low,
but detectable, amount of wtFc is internalized at pH
7.4 (Figure 3), consistent with the assumption that non-
receptor-mediated uptake of IgG at basic pH occurs in
FcRn-mediated placental transport and in FcRn-mediated
recycling of IgG by vascular endothelial cells (35). In these in
vivo situations, the high concentration of IgG in the blood
(50–100 mM) (36) likely facilitates fluid-phase uptake of IgG.
The rFcRn-MDCK cells transport IgG and Fc in both
the apical to basolateral and basolateral to apical direc-
tions when the loading surface is incubated at acidic pH
(Figure 4) as previously observed for hFcRn-transfected
MDCK cells (16–18), rFcRn-transfected IMCD cells (20–22)
and rat alveolar cells (23). Interestingly, in contrast to the
studies on hFcRn in MDCK cells, in which higher levels of
transcytosis occurred in the basolateral to apical direction
(16,17), rFcRn expressed in IMCD and rat alveolar cells
transports more ligand in the apical to basolateral direction
(20,23). Consistent with these results, the rFcRn-MDCK
cells described here transport more Fc in the apical to
basolateral direction and roughly equal amounts of IgG
bidirectionally (Figure 4), suggesting fundamental differ-
ences in the preferred directionality of ligand transport by
the rat and human receptors.
Although the rFcRn-MDCK cells function in transcytosis of
IgG and Fc ligands, we do not observe significant levels of
wtFc transport in the rFcRn-GFP-MDCK cells (Figure 4A).
The most likely explanation is that the addition of GFP to
the C-terminus of the rFcRn cytoplasmic tail interferes
with the binding of downstream effectors responsible for
mediating intracellular trafficking processes. This is sur-
prising, as a C-terminal GFP fusion of hFcRn has been
shown to function in recycling of IgG ligands in the human
endothelial cell line HMEC-1.CDC (35,37). Whether this
discrepancy is due to differences in the interactions
required for transcytosis versus recycling, differences in the
behavior of the receptors when expressed in HMEC-1.CDC
versus MDCK cells or fundamental differences between
the hFcRn and rFcRn proteins is not clear. However, the
fact that rFcRn-GFP-MDCK cells function in specific uptake
of Fc ligands (Figure 2) suggests that signals responsible
for endocytosis are intact, implying different signalingmech-
anisms for endocytosis versus transcytosis, or that rFcRn
can internalize bound ligand via non-specific membrane
flow after binding to ligand molecules at the cell surface.
Having demonstrated that rFcRn expressed in MDCK cells
functions in binding, endocytosis and transcytosis of Fc
and IgG ligands, both of which are naturally bivalent, we
sought to study the interaction of rFcRn with RSA, a mono-
valent ligand that binds to rFcRn with the same pH
dependency as the FcRn–IgG interaction and for which
FcRn acts as a protection receptor in vivo (14,34). Despite
using high ligand concentrations (10 mM) and low pH (pH 5)
to facilitate binding (14,27), we were not able to detect
specific binding of radiolabeled RSA to rFcRn (Figure 5A).
We note, however, that although the experiments were
performed at concentrations near or above the KD of
hFcRn for albumin (1–5 mM) (27), we could not perform
experiments at the concentration of albumin in serum
(270 mM) (38) because of background problems. When
incubated at 3 mM, rFcRn-MDCK cells did not internalize
significantly more RSA than control cells that do not
express rFcRn (Figure 5B). However, both cell lines inter-
nalized less labeled RSA in the presence of competing
unlabeled RSA, suggesting that much of the observed
internalization was due to non-rFcRn-dependent binding
of the labeled RSA to constituents of the cell surface. In
addition, the levels of apical to basolateral transport of
labeled RSA were similar in rFcRn-expressing and control
cell lines, and the degree of transport was not significantly
altered in either cell line by incubating the loading surface
at pH 8 rather than at pH 5 (Figure 5C). Taken together,
these results suggest that RSA binds non-specifically to
components present on the surface of MDCK cells; thus,
these cells are not an appropriate system in which to study
the interaction of rFcRn with RSA.
To investigate the potential requirement for two FcRn-
binding sites on an FcRn ligand, we compared the ability
of rFcRn-MDCK cells to transcytose and recycle mono-
valent and bivalent forms of rat Fc (hdFc and wtFc, which
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contain one and two FcRn-binding sites, respectively)
(Figure 6B,C). The experiments were performed over
a wide range of concentrations (0.15 nM–10 mM) to com-
pensate for avidity affects that favor binding of wtFc over
hdFc at low concentrations. The results revealed that hdFc
is specifically transcytosed and recycled by rFcRn, but that
more wtFc than hdFc is transported at low concentrations
(<1 mM). Previous studies suggesting that two FcRn-
binding sites on mouse Fc are required for FcRn-mediated
rescue from catabolism (13) and transcytosis across the
intestine of neonatal mice (12) are consistent with the
present results if the Fc concentrations used in the in vivo
studies fell within the range in which wtFc is more
efficiently transported by FcRn than hdFc. The present
study reveals that the amount of wtFc transcytosed
reaches a relatively constant level at concentrations above
150 nM, whereas the amount of hdFc transcytosed con-
tinues to increase with concentration, such that more hdFc
than wtFc is transcytosed at concentrations above 1 mM
(Figure 6B). At a concentration of 10 mM, at least twice as
much hdFc is transcytosed or recycled as wtFc. This
suggests that two rFcRn molecules are bound to each
wtFc during the transport process, whereas only one
rFcRn molecule is bound to each hdFc, resulting in twice
as many available receptors to transport the monovalent
hdFc as there are for the transport of the bivalent wtFc.
To determine how the differences in rFcRn-mediated
transport of wtFc versus hdFc are related to the apparent
affinity of rFcRn for each ligand, we compared the con-
centrations of each protein that result in half-maximal
binding to cell-surface rFcRn (KD) with the concentrations
that result in half-maximal transcytosis across a polarized
monolayer (T1/2max) and with the concentrations that result
in half-maximal recycling of ligand back to the apical
surface (R1/2max). In a perfectly efficient transcytosis
system, each binding event would result in a single trans-
cytosis event, and T1/2max would equal KD. In the present
study, we observe that the T1/2max/KD ratio for wtFc
transcytosis is 3, whereas the ratio for hdFc transcytosis
is 14 (Figure 6D). For the recycling experiments, the
R1/2max/KD ratio for wtFc is14, whereas the ratio for hdFc
is28. Thus, a greater number of individual binding events
result in successful transcytosis or recycling of the bivalent
wtFc, whereas transcytosis or recycling of the monovalent
hdFc requires the input of more ligand to achieve satura-
tion of the transport system. Interestingly, the T1/2max/KD
and R1/2max/KD values suggest that a given Fc molecule,
once bound to FcRn at the apical surface, is more likely to
be transcytosed than recycled.
The observed differences in the relative efficiencies of
transport of the bivalent and monovalent Fcs could be
related to differences in the subcellular fates of the two
molecules during rFcRn-mediated trafficking. For example,
a higher proportion of endocytosed hdFc molecules may
enter a degradative pathway, whereas a higher proportion
of wtFc molecules are transcytosed or recycled. Consis-
tent with this hypothesis, we observed a greater amount
of hdFc in both lysosomal (LAMP-2 positive) and early
endosomal (EEA1 positive) compartments as compared to
wtFc (Figure 7), suggesting that more wtFc than hdFc is
transported to compartments downstream of the early
endosomes and that less wtFc than hdFc is sent to
degradative compartments. The quantitative colocalization
experiments were conducted using a ligand concentration
of 1 mM, a concentration at which roughly equal amounts
of wtFc and hdFc are bound and transported by rFcRn-
expressing MDCK cells (Figure 6A–C). Under these con-
ditions, we presume that all wtFc or hdFcmolecules on the
cell surface are initially bound by a single rFcRn molecule
prior to internalization and that the amount of each ligand
entering the cell is approximately equal. Consistent with
this assumption, digital image analysis shows that the
average mean pixel intensities for Fc fluorescence in all
images used in these experiments are similar (seeMateri-
als and Methods). Therefore, the higher proportion of hdFc
seen in LAMP-2- and EEA1-positive structures is not the
result of greater absolute amounts of hdFc entering into
the cell. Instead, the data are consistent with a model
whereby equal amounts of both wtFc and hdFc initially
enter the cell but, subsequent to internalization and
delivery to EEA1-positive early endosomes, a greater pro-
portion of wtFc than hdFc molecules remain bound to
FcRn and are transported to downstream compartments
involved in transcytosis and/or recycling. Conversely, a
greater proportion of hdFc molecules remain in early endo-
somes prior to being transferred to the lysosomal degra-
dation pathway along with other fluid-phase components.
This model is also supported by our demonstration that,
following internalization of a single cohort of wtFc or hdFc
ligand, a higher percentage of hdFc is released from rFcRn-
MDCK cells as degraded (acid-soluble) material (Figure 7D).
The observation that an Fc ligand containing only one
FcRn-binding site is preferentially trafficked to lysosomes
and degraded compared with a bivalent Fc ligand can be
explained by an avidity effect; because the hdFc cannot be
cross-linked by adjacent FcRn molecules, it is predicted to
dissociate more readily from FcRn inside endosomes, and
unbound hdFc could then enter a default degradative
pathway with other molecules in the fluid phase. The
present demonstration that FcRn-mediated transcytosis
and recycling of hdFc occur, although at a lower efficiency
than transcytosis and recycling of wtFc, does not address
whether an oligomeric structure of FcRn dimers linked by
homodimeric Fc or IgG molecules (10,11) is present inside
endosomes, but rules out that it is required for proper
transport of vesicles containing FcRn–IgG or FcRn–Fc
complexes.
Materials and Methods
Construction of expression vectors
The gene encoding rFcRnwasmodified by polymerase chain reaction (PCR)
to incorporate 50 Asp718 and 30 HindIII restriction sites and subsequently
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subcloned with an Asp718/HindIII double digest into the mammalian cell
expression vector pCB6-HindIII (kindly provided by Ira Mellman, Yale
University), which carries a neomycin resistance gene for G418 selection.
To make the FcRn–GFP fusion construct, the enhanced GFP (EGFP) gene
was amplified from the pEGFP-1 vector (Clontech, Mountain View, CA,
USA) via PCR to remove the start codon and to introduce a 50 in-frame XhoI
site and a 30 HindIII site and subcloned into the pBluescript II SK vector
(Stratagene, La Jolla, CA, USA). Polymerase chain reaction was used to
introduce a 50 Asp718 site and an in-frame 30 XhoI site at the 30 end of the
rFcRn gene, which was then subcloned into the EGFP Bluescript vector.
The resulting open reading frame, which encoded the entire rFcRn amino
acid sequence, a leucine-glutamate linker region and EGFP without its
N-terminal methionine, was subcloned with a Asp718/HindIII double digest
into the expression vector pCB6-HindIII. We used a previously described
rb2m expression vector (39), which does not contain a selectable marker, to
coexpress rb2m along with full-length rFcRn and the rFcRn-GFP chimeric
protein.
Antibodies
The mouse monoclonal antibodies 1G3 (anti-rFcRn heavy chain) and 4C9
(anti-rb2m) were generated in our laboratory (40) and can be purchased from
the American Tissue Culture Collection. 2B10C11, a mouse monoclonal
antibody against rb2m, was the kind gift of Lennart Lo¨gdberg. 1G3, 4C9 and
2B10C11 were directly conjugated to AlexaFluor488-NHS, AlexaFluor546-
NHS or AlexaFluor633-NHS (Molecular Probes, Carlsbad, CA, USA) accord-
ing to the manufacturer‘s protocol and used for immunofluorescence (1G3
and 4C9) and flow cytometry (2B10C11) experiments. Labeled antibodies
were separated from unconjugated dye using 10 000-kDa cutoff dextran
desalting columns (Pierce, Rockford, IL, USA), and the concentration and
degree of labeling were determined spectrophotometrically using an extinc-
tion coefficient at 280 nm of 202 000 M1 cm1 for the antibodies. A poly-
clonal rabbit antiserum used for Western blotting was raised against purified
rFcRn/rb2m heterodimers. Polyclonal rabbit anti-ZO1 was from Zymed (San
Francisco, CA, USA). Mouse monoclonal anti-EEA1 was from BD Trans-
duction Labs (San Jose, CA, USA), and themouse monoclonal antibody AC17
against the canine lysosomal membrane protein lamp-2 (41,42) was a kind gift
from Dr E. Rodriguez-Boulan (Weill Medical College, Cornell University).
AlexaFluor488-, 546-, and 647-labeled secondary antibodies (goat anti-mouse,
goat anti-rabbit and goat anti-rat) were purchased from Molecular Probes.
Maintenance and transfection of cell lines
MDCK type II cells (generously provided by Keith Mostov, UCSF) were
maintained in MEM (GibcoBRL, Carlsbad, CA, USA) supplemented with
10% FBS (HyClone, Logan, UT, USA) at 378C, 5% CO2. Cells were fed
every other day and passaged once weekly. MDCK II cells were cotrans-
fected with expression vectors encoding full-length rFcRn or rFcRn-GFP
and rb2m using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) and
selected with 0.5 mg/mL G418 (Invitrogen). Resistant colonies were tested
for uptake of fluorescently labeled rat Fc at pH 6.0. Colonies from each
transfection were picked with cloning cylinders and expanded for further
analysis. Colonies were analyzed by flow cytometry for binding to
Alexa488-conjugated 1G3 (anti-rFcRn) (40) and/or Alexa633-conjugated
2B10C11 (anti-rb2m). At least three clones from each transfection were
assayed by immunofluorescence for expression of both the heavy and light
chains of rFcRn as well as for the ability to endocytose and transcytose
radiolabeled rat Fc at acidic pH. We also generated MDCK II cells trans-
fected with the pCB6H vector lacking an inserted gene to serve as
a negative control (vector-only MDCK cells). All cell lines were maintained
under constant drug selection.
The integrity of filter-grown, cell-transfected MDCK monolayers was
evaluated by seeding cells at superconfluent density on filter supports
and recording daily measurements of the TEER. The TEER typically
plateaued after 3 or 4 days at 250–300 Vcm2, a characteristic range for
polarized MDCK II cells (43).
For experiments requiring polarized cell monolayers, cells were seeded at
superconfluent density (1  106 cells/mL) onto 12-mm Transwell polyester
filters (Corning Costar, Acton, MA, USA), with 0.5 and 1.5 mL of media in
the apical and basolateral reservoirs, respectively. Cells were fed daily
beginning 2 days after initial seeding and used for experiments on the
fourth or fifth day postplating.
Western blot and IgG binding analyses
Western blot analyses to evaluate FcRn expression were performed after
denaturing lysis of transfected cells by boiling in 0.5% SDS and vortexing.
After centrifuging to remove insolublematerial, samples of each lysate [10 mg
of total protein as determined by bicinchoninic acid (BCA) assay from Pierce]
were loaded onto a 15% SDS polyacrylamide gel and run under reducing
conditions. Proteins were transferred to nitrocellulose, probed with a 1:2000
dilution of a polyclonal rabbit antiserum against the rFcRn ectodomain and
then treatedwith peroxidase-conjugated goat anti-mouse secondary antibody
(Jackson Immunoresearch Laboratories,West Grove, PA, USA) and detected
by enhanced chemiluminescence (Amersham, Piscataway, NJ, USA).
For evaluations of IgG binding, cells were lysed in 5 mg/mL 3-[(3-
Cholamidopropyl)dimethylammonia]-1-propanesulfonate (CHAPS), 130 mM
NaCl, 20 mM ethylenediaminetetraacetic acid (EDTA), pH 5.9 (15 mM 2-
(N-Morpholino)ethanesulfonic acid [MES]) or pH 8.0 (15 mM 4-(2-
Hydroxyethyl)piperazine-1-ethanesulfonic acid [HEPES]), supplemented with
a protease inhibitor cocktail for mammalian cells (Sigma, St Louis, MO, USA).
After centrifuging to remove insoluble material, lysates were incubated
with 50 mL human IgG-Sepharose (Amersham) pre-equilibrated to pH 5.9 or
pH 8.0 in lysis buffer overnight at 48C. The complexes were washed four
times with 1 mg/mL CHAPS, 30 mM NaCl, 20 mM EDTA, pH 5.9 or 8.0.
Bound proteins were eluted by boiling in double-strength sample buffer and
processed for SDS-PAGE and Western blotting to detect rFcRn as
described above.
Preparation of FcRn ligands for uptake and
transport assays
Rat FcRn binds all four subclasses of rat, human and mouse IgGs with
roughly equal affinities (44); therefore, IgGs and Fcs from these three
species were used for different experiments based on availability or
convenience.
Three forms of rat Fc, wtFc, hdFc and nbFc, were expressed in Chinese
hamster ovary (CHO) cells and purified as previously described (45). The Fc-
expressing CHO cell line was generated by transfection of expression
vectors encoding wtFc (rat IgG2a residues 223–447) and nbFc (IgG2a
residues 223–447 with mutations that disrupt FcRn binding (Thr-252 to Gly,
Ile-253 to Gly, Thr-254 to Gly, His-310 to Glu, His-433 to Glu and His-435 to
Glu) and a C-terminal factor Xa cleavage site and 6x-His tag). The hdFc and
nbFc were purified from supernatants of CHO cells secreting a mixture of
wtFc, hdFc and nbFc as described (24). Briefly, CHO supernatants were
first passed over a nickel-nitrilotriacetic acid (Ni-NTA) column, allowing
separation of wtFc from 6x-His tagged species. The hdFc and nbFc were
eluted from the Ni-NTA column, then passed over an FcRn affinity column
at pH 6.0. The hdFc was eluted from the FcRn column at pH 8.0, and nbFc
was recovered from the flowthrough.
Human Fc and rat and human IgGs, each a mixture of the four IgG sub-
classes, were purchased from Jackson Immunoresearch Laboratories.
Purified samples of the monoclonal antibodies 12C7 (anti-Drosophila
methuselah) and 1C5 (anti-Zn-a2-glycoprotein) (46) were used as mouse
IgG1 proteins. Rat serum albumin was purchased from Sigma. All proteins
were passed over a Superdex 200 gel filtration column (Amersham) to
remove oligomeric species prior to experiments.
Human IgG, rat IgG, mouse IgG1 monoclonal antibodies, human Fc, the
recombinant rat Fcs (wtFc, hdFc and nbFc) and RSA were iodinated to
a specific activity of 2–5 mCi/mg using Na[125I] (MP Biomedicals, Irvine, CA,
USA) and IODO-GEN (Pierce). Radiolabeled ligands were buffer exchanged
into HEPES buffered saline (25 mM HEPES, 150 mM NaCl, pH 7.4) by two
subsequent passages over Bio-Spin 30 prepacked acrylamide columns
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(30 000 molecular weight cutoff) (BioRad, Hercules, CA, USA). Protein
concentrations were determined by BCA assay (Pierce) using bovine serum
albumin or bovine g-globulin as standards.
Quantitative endocytosis assay
Cells were grown in 12-well tissue culture plates until 80–90% confluent.
Prior to incubations with ligand, the cells were serum starved for 20–30 min
in Hanks’ balanced salt solution, 1.3 mM CaCl2, 0.8 mM MgSO4 (HBSSþ)
adjusted to either pH 5.9 or pH 8.0 with MES or HEPES (10 mM each),
respectively. [125I]wtFc was added to a final concentration of 20 nM in
HBSSþ pH 5.9, and plates were incubated in a 378C circulating water bath
for the indicated amounts of time. For competitor studies, 10 mMunlabeled
wtFc or rat IgG was added during the preincubation. The cells were cooled
on ice, washed four times with ice-cold HBSSþ pH 8.0 to remove surface-
bound ligand and then lysed in 0.1 N NaOH. The radioactivity present in the
lysates was counted on a Beckman 5500 g-counter and converted to
fmoles of protein using the specific activity of the radiolabeled ligand.
Quantitative endocytosis assays involving [125I]RSA were done as de-
scribed above, except that the concentrations of [125I]RSA and unlabeled
RSA were 3 mM and 2 mM, respectively, and the incubations were per-
formed at pH 5.0.
Cell-surface binding assay
For assays of Fc binding to cell-surface FcRn, subconfluent rFcRn-MDCK
cells were lifted from plates by incubating in calcium/magnesium-free
HBSS and 4 mM EDTA. Cells were washed twice in binding buffer
(HBSSþ/1% ovalbumin/1 mM KI/10 mM MES, pH 5.9), and triplicate
samples of 500 000 cells were incubated with serial threefold dilutions
of radiolabeled Fc (0.4–900 nM) in a 100 mL volume for 1 h at 48C with
shaking. The binding reactions were collected onto a 96-well filter plate
(Durapore membrane, 0.65- mm pore size) (Millipore, Billerica, MA, USA) by
centrifugation at 1500  g for 1 min. The filter wells were washed four
times with 250 mL of binding buffer at pH 5.9, and the filter circles were
punched out into glass vials and counted for radioactivity. A duplicate set of
binding reactions performed in parallel were washed four times with
HBSSþ/1% ovalbumin/1 mM KI/10 mM HEPES, pH 8.0, to serve as
a control for non-specific binding. The amount of radioactivity bound to
samples washed at pH 8 was subtracted from the corresponding values for
samples washed at acidic pH to yield values for specific binding of the
radiolabeled ligand.
The RSA binding assays were conducted as described above, except
that the binding reactions were performed at pH 5.0 and washed at pH 5.0
or 8.0 (control experiments), and the concentration of [125I]RSA ranged
from 4 nM to 10 mM.
Radioligand transcytosis and recycling assays
For transport assays involving only Fc (Figure 4A), we used radiolabeled rat
wtFc. For assays comparing IgG and Fc transport, we used radiolabeled
human IgG and human Fc (Figure 4B) because radiolabeled human IgG was
transported more efficiently than radiolabeled versions of either rat IgG or
two different mouse monoclonal antibodies (data not shown). Human IgG
binds as well as rat IgG to rFcRn (44).
For transcytosis experiments involving IgG and Fc ligands, polarized cell
monolayers were washed once with HBSSþ/1% ovalbumin/1 mM KI
buffered to pH 5.9 (loading surface) or pH 8.0 (nonloading surface or
loading surface for pH 8 control experiments). Filters were preincubated for
20 min with HBSSþ pH 5.9 on the loading surface (or pH 8.0 for control
experiments) and HBSSþ pH 8.0 on the nonloading surface. For compe-
tition experiments, the unlabeled competing ligand was present in the
loading surface medium during the preincubation step. [125I]Fc (rat or
human) or [125I]IgG (rat or human) was added directly to the loading media
to a final concentration of 20 nM at pH 5.9 or 8.0. Plates were incubated
for 90 min in a 378C circulating water bath, after which media from the
nonloading surface were collected and precipitated at 48C with 10%
(vol/vol) trichloroacidic acid (TCA). The TCA-insoluble (intact ligand) fractions
were counted on a Beckman 5500 g-counter. For experiments comparing the
relative transport efficiencies of [125I]wtFc, -hdFc or -nbFc, the radiolabeled
proteins were added at concentrations ranging from 0.15 nM to 10 mM. The
amount of [125I]nbFc that moved across the monolayers for a given concen-
tration was assumed to represent non-specific transport or leakage across
the monolayer and was subtracted from the corresponding values for wtFc
and hdFc to yield values for specific rFcRn-mediated transport.
Quantitative transcytosis assays involving [125I]RSA were done as de-
scribed above, except that the concentration of [125I]RSA was 10 mM,
and the apical surface was maintained at pH 5.0 or at pH 8.0 (control
experiments). Filters incubated with 30nM [125I]nbFc at pH 5.0 served as
a control for the integrity of themonolayer, and filters incubated with 30 nM
[125I]wtFc at pH 5.0 served as a positive control for the ability of the cells to
function in FcRn-mediated transcytosis at pH 5.0.
For apical recycling experiments involving labeled Fcs, filter-grown mono-
layers were washed and preincubated as described above for the IgG and
Fc transcytosis assays. [125I]labeled wtFc, hdFc or nbFc was added to the
apical surface at pH 5.9 at concentrations ranging from 0.15 nM to 10 mM,
while the basolateral surface was maintained at pH 8.0. After a 30-min
incubation at 378C, the cells were cooled on ice and washed rapidly five
times with ice-cold HBSSþ pH 8.0. Prewarmed HBSSþ pH 8.0 was then
added to the apical and basolateral surfaces. After a 60-min incubation at
378C, media from the apical surface were collected and TCA precipitated,
and the TCA-insoluble fractions were counted as described above.
Analyses of data for binding and transport assays
The amount of specifically bound or transported Fcwas plotted as a function
of concentration, and nonlinear regression analyses of the data were
performed using GraphPad Prism version 4.0b for Macintosh (GraphPad
Software, San Diego, CA, USA). As previously described for biosensor-
based binding data (24), half-maximal binding (KD), transcytosis (T1/2max) or
recycling (R1/2max) values were derived by fitting the wtFc data to a two-site
model, which assumes two independent classes of receptors (a high-
affinity class and a low-affinity class), and the hdFc data to a one-site model.
Preparation of samples for
immunofluorescence experiments
Cells were grown on permeable filter supports for 3–4 days to allow
formation of a polarized monolayer. The filters were preincubated in
HBSSþ pH 8.0 for 20–30 min. The loading surface was then washed with
HBSSþ pH 5.9, and ligands were added to the loading surface at the
indicated concentrations in the same buffer. The nonloading surface was
maintained in HBSSþ pH 7.4 throughout the experiment. Filter plates were
incubated at 378C in a circulating water bath for the indicated times after
which the cells were placed on ice and processed for immunofluorescence.
For immunofluorescence staining, cells were washed briefly with ice-cold
PBSþ (PBS supplemented with 1 mM CaCl2, 0.5 mMMgCl2 and 0.25 mM
MgSO4) and fixed using a pH-shift protocol (47). Briefly, cells were
incubated for 5 min at room temperature in 4% paraformaldehyde (PFA)
in 80 mM 1,4-piperazinebis-(ethanesulphonic acid) (PIPES), pH 6.5, 5 mM
EGTA and 2.0 mM MgCl2, and then transferred to 4% PFA, 100 mM
sodium borate, pH 11.0 for 10 min. After quenching excess aldehyde with
freshly prepared 75 mM NH4Cl and 20 mM glycine in PBS for 10 min, the
cells were washed twice with PBS and blocked for 30 min at room
temperature in PBS containing 8% normal goat serum and 0.025%
saponin. Cells were then incubated overnight at 48C in blocking buffer
containing one or more of the following primary antibodies: fluorescently
conjugated 1G3 or 4C9 (5 mg/mL), mouse anti-EEA1 (1:100 dilution), rabbit
anti-ZO1 (1:25 dilution) or AC17 (1:500). Cells were washed and then
incubated with the appropriate AlexaFluor-conjugated secondary antibodies
diluted 1:500 in blocking buffer for 1 h at room temperature. For experi-
ments involving localization of internalized Fc proteins, unlabeled ligands
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were detected after internalization using AlexaFluor-conjugated goat anti-
rat IgG antibodies. After extensive washing with PBS, cells were treated
with 0.1% Triton X-100 for 5 min, washed once with PBS and then
postfixed with 4% PFA in 100 mM sodium cacodylate, pH 7.4 for 30 min
at room temperature. The cells were washed twice more with PBS, and the
filters were cut out of their holders using a scalpel and a fine-tipped pair of
forceps. Excised filters were mounted on glass slides using ProLong Gold
antifade medium (Molecular Probes), sealed with beeswax and stored at
208C until viewing on a confocal microscope.
Confocal microscopy
All experiments were conducted using an inverted Zeiss LSM META
confocal microscope equipped with a Zeiss Plan-Apochromat 100 oil
objective (numerical aperture 1.4). Green fluorophores were excited with
the 488-nm line of an argon ion laser. Orange and far-red dyes were excited
with the 543 and 633- nm lines of a He-Ne laser, respectively. Fluorescence
was detected through a variable confocal pinhole set to 1.0 Airy units for the
longest wavelength used within a given experiment, and the pinholes of
other channels were adjusted to maintain a constant optical section
thickness across all channels. The gain and offset of the photomultipliers
was adjusted for each channel individually so that the observed fluores-
cence signal filled the linear range of the detectors, with the background
being slightly positive and saturation being minimized.
Image processing and quantitative
colocalization studies
Image processing was performed using the Zeiss LSM Examiner software
(version 3.2). Quantitative colocalization measurements were performed
using the colocalization tool within the Zeiss LSM Examiner package. Four
colocalization experiments were conducted: wtFc with EEA1 and with
AC17, and hdFc with EEA1 and with AC17. For each experiment, we
analyzed five optical sections from approximately five different regions,
each containing 5–10 cells. Different optical sections within the same
region were spaced 2 mm apart to ensure that each represented a unique
image plane within the volume. Thresholds for the two channels in each
image were set to be 2 standard deviations above the mean pixel intensity.
Weighted colocalization coefficients (M) were calculated by summing the
intensities of the above-threshold Fc-positive pixels that colocalized with
above-threshold marker-positive pixels and dividing that number by the sum
of all above-threshold Fc pixel intensities as follows:
M ¼
+
i
Fci,coloc
+
i
Fci,total
,
where Fci,coloc represents the intensity of a colocalized above-threshold
pixel in the Fc channel, and Fci,total represents the intensity of any above-
threshold pixel in the Fc channel. The value of M can range from 0 (no
colocalization) to 1.0 (all pixels colocalize). The mean intensities of the
labeled proteins were calculated to rule out that potential differences in
colocalization coefficients resulted from higher levels of one labeled pro-
tein relative to another. The mean intensity values were wtFc and hdFc in
the EEA1 colocalization: 1969  342 and 2055  713; wtFc and hdFc in the
lamp-2 colocalization: 2088  476 and 2346  436; EEA1 in the wtFc and
hdFc colocalizations: 1472  414 and 1332  454; lamp-2 in the wtFc and
hdFc colocalizations: 1473  629 and 1433  396.
Degradation assay
The apical surface of rFcRn-MDCK monolayers were incubated for 1 h with
1 mM [125I]labeled wtFc or hdFc at pH 5.9 as described for the immunoflu-
orescence and transcytosis assays. Cells were cooled on ice and then
washed four times with ice-cold pH 8.0 buffer. Prewarmed pH 8.0 buffer
was added, and the cells were returned to 378C for various times, after
which cells were again cooled on ice. Media from the apical and basolateral
surfaces were pooled and TCA precipitated, and the levels of radioactivity in
TCA-soluble and TCA-insoluble fractions were determined. Cell-associated
radioactivity was determined after lysis of cells in 0.1 N NaOH. The percent
of an Fc ligand that was degraded at each time point was derived as
[c.p.m.TCA-soluble/(c.p.m.TCA-soluble þ c.p.m.TCA-insoluble þ c.p.m.cell-associated)]
 100.
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In mammals the transfer of passive immunity from mother to young is mediated by the MHC-related receptor FcRn,
which transports maternal IgG across epithelial cell barriers. In birds, maternal IgY in egg yolk is transferred across the
yolk sac to passively immunize chicks during gestation and early independent life. The chicken yolk sac IgY receptor
(FcRY) is the ortholog of the mammalian phospholipase A2 receptor, a mannose receptor family member, rather than an
FcRn or MHC homolog. FcRn and FcRY both exhibit ligand binding at the acidic pH of endosomes and ligand release at
the slightly basic pH of blood. Here we show that FcRY expressed in polarized mammalian epithelial cells functioned in
endocytosis, bidirectional transcytosis, and recycling of chicken FcY/IgY. Confocal immunofluorescence studies demon-
strated that IgY binding and endocytosis occurred at acidic but not basic pH, mimicking pH-dependent uptake of IgG by
FcRn. Colocalization studies showed FcRY-mediated internalization via clathrin-coated pits and transport involving early
and recycling endosomes. Disruption of microtubules partially inhibited apical-to-basolateral and basolateral-to-apical
transcytosis, but not recycling, suggesting the use of different trafficking machinery. Our results represent the first cell
biological evidence of functional equivalence between FcRY and FcRn and provide an intriguing example of how
evolution can give rise to systems in which similar biological requirements in different species are satisfied utilizing
distinct protein folds.
INTRODUCTION
The transfer of maternal antibodies to the gestating fetus or
neonate allows for the passive acquisition of humoral im-
munity to antigens encountered by the mother. In mammals,
this process is mediated by the neonatal Fc receptor (FcRn).
FcRn was first isolated from the neonatal rodent gut (Simister
and Rees, 1985) and was later shown by sequence analysis to
be related to class I major histocompatibility complex (MHC)
molecules (Simister and Mostov, 1989). Subsequent struc-
tural analyses demonstrated that FcRn has a narrowed and
nonfunctional counterpart of the MHC peptide-binding groove
and interacts with Fc in a manner that differs from MHC
interactions with peptides, T-cell receptors, and other mac-
romolecules (Burmeister et al., 1994; Martin et al., 2001). FcRn
has since been identified in other mammals, including humans
(Leach et al., 1996), nonhuman primates (Spiekermann et al.,
2002), ruminants (Mayer et al., 2002, 2004), and marsupials
(Western et al., 2003). FcRn also plays a key role in serum
IgG homeostasis by serving as a protection receptor for IgG
internalized via fluid phase endocytosis by the vascular
endothelium, causing it to be recycled and released at the
plasma membrane rather than lysosomally degraded (for
review see Ghetie and Ward, 2002). The expression of FcRn
across many different mammalian species coupled with its
roles in bidirectional transcytosis and recycling have made it
a widely used model for studies of intracellular transport
(Praetor et al., 1999; McCarthy et al., 2000, 2001; Zhu et al.,
2002; Ward et al., 2003; Claypool et al., 2004; Ober et al.,
2004a,b; Lencer and Blumberg, 2005; Tesar et al., 2006).
Transfer of maternal immunoglobulin to offspring has
long been known to occur in birds as well as mammals
(Brambell, 1970). IgY, the avian and reptilian counterpart of
IgG, is packaged into egg yolk and transported across yolk
sac membranes during development (Kowalczyk et al.,
1985). Yolk sac membranes isolated from chicken exhibit
IgY-binding properties similar to those of FcRn for IgG—
high-affinity binding at acidic pH and no observable binding
at neutral or basic pH (Linden and Roth, 1978; Tressler and
Roth, 1987)—suggesting the existence of a functionally
equivalent receptor in avian species. Recently, our labora-
tory isolated a chicken yolk sac IgY receptor (FcRY) that
exhibits pH-dependent binding to IgY (West et al., 2004).
Surprisingly, FcRY shared no homology with class I MHC
molecules or FcRn, but was instead a homolog of the
mammalian phospholipase A2 receptor (PLA2R), a mem-
ber of the mannose receptor (MR) family (East and Isacke,
2002). Mammalian MR family members mediate a variety of
functions, including roles in the innate and adaptive im-
mune systems (MR), internalization of soluble PLA2 en-
zymes (PLA2R), presentation of antigens to T-cells (DEC-
205), and remodeling of the extracellular matrix (Endo180).
FcRY shares a common domain organization with other MR
family members, which consists of an N-terminal cysteine-
rich domain, a single fibronectin type II (FNII) domain, 8 to
10 tandem C-type lectin-like domains (CTLDs), a single-pass
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transmembrane region and a short cytoplasmic tail (East and
Isacke, 2002). The presence of tandem lectin-like domains
does not necessarily imply lectin activity because only the
MR and Endo180 bind to monosaccharides. Indeed, the
CTLDs in PLA2R mediate a protein-protein interaction in-
dependently of carbohydrates (East and Isacke, 2002), and
FcRY is thought to recognize IgY through a protein–protein
interaction (West et al., 2004).
None of the mammalian MR family members are known
to function as immunoglobulin and/or transcytotic recep-
tors, but all exhibit clathrin-mediated endocytosis, resulting
in either recycling back to the plasma membrane or delivery
of cargo to the late endosome/lysosomal pathway (East and
Isacke, 2002). The cytoplasmic tails of mammalian MR fam-
ily members contain two putative internalization motifs: an
acid-based dihydrophobic motif (Exxx) and a low density
lipoprotein receptor (LDLR)-like tyrosine-based internaliza-
tion motif (xNxxY; East and Isacke, 2002). The cytoplasmic
tail of FcRY also includes these motifs, although the tyrosine
in the LDL-like motif is substituted by a phenylalanine.
Although FcRY appeared to fill all criteria for being the
functional equivalent of mammalian FcRn (West et al., 2004),
it had not been directly demonstrated to endocytose and
transcytose IgY. Here we report creation of a cell-based
model system to probe questions regarding the function of
FcRY in relation to other known members of the MR family
and present direct evidence that FcRY functions in endocy-
tosis and transcytosis of IgY. These studies establish FcRY as
an intriguing model of receptor-mediated transport in polar-
ized cells and demonstrate an increased diversity of functional
possibilities within the MR family.
MATERIALS AND METHODS
Antibodies and Proteins
Mouse monoclonal anti-Rab11, anti-clathrin heavy chain, and anti-EEA1 an-
tibodies were purchased from BD Transduction Laboratories (San Jose, CA).
Alexa Fluor 546– and 568—conjugated goat anti-mouse and Alexa Fluor
647–conjugated goat anti-chicken secondary antibodies were from Molecular
Probes (Eugene, OR). Chicken IgY and FcY were obtained from Jackson
ImmunoResearch Laboratories (West Grove, PA) and passed over a Superdex
200 column to remove aggregates.
The purified FcRY ectodomain, expressed in baculovirus-infected insect
cells and purified as described (West et al., 2004), was used as an immunogen
for the production of polyclonal ascites as described previously (Ou et al.,
1993). The Fc fragment of rat IgG2a (Fc) was expressed in Chinese hamster
ovary cells and purified from culture supernatants as described (Martin and
Bjorkman, 1999). For quantitative endocytosis and transport experiments, FcY
and Fc were iodinated to a specific activity of 30 Ci/g using Na[125I] (MP
Biomedicals, Solon, OH) and IODO-GEN (Pierce, Rockford, IL). Radiolabeled
ligands were buffer exchanged into HBS (25 mM HEPES, 150 mM NaCl, pH
7.4) by two subsequent passages over Zeba Desalting spin columns (Pierce).
Protein concentrations were determined by BCA assay (Pierce) using bovine
-globulin as a standard.
Cell Culture and Generation of Stable Cell Lines
Rat inner medullary collecting duct (IMCD) cells (a kind gift from Neil
Simister, Brandeis University) were cultured in DMEM supplemented with
10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 mg/ml strepto-
mycin under 5% CO2. Cells were fed every other day and passaged weekly.
The cDNA encoding the full-length FcRY gene was subcloned into the
pIRES2-EGFP mammalian expression vector (Clontech, Mountain View, CA)
and transfected into IMCD cells using Lipofectamine 2000 (Invitrogen, Carls-
bad, CA). Stable clones were selected with 500 g/ml G418 (Invitrogen). For
experiments requiring polarized cell monolayers, cells were seeded at super-
confluent density (1  106 cells/ml) onto 12-mm Transwell polyester filters
(0.4-m pores; Corning Costar, Acton, MA) with 0.5 and 1.5 ml of media in
the apical and basolateral reservoirs, respectively. Cells were fed daily begin-
ning 2 d after initial seeding and used for experiments on the fourth or fifth
day after plating.
Quantitative Endocytosis Assay
Cells were grown to near-confluence in 12-well tissue culture plates until
80–90% confluent. Before incubations with ligand, the cells were serum-
starved for 20 min in Hank’s balanced salt solution (HBSS), 1.3 mM CaCl2, 0.8
mM MgSO4 (HBSS), 1% bovine serum albumin (BSA; Sigma, St. Louis, MO),
1 mM KI adjusted to either pH 5.9 or 8.0 with MES or HEPES (20 mM each),
respectively. [125I]FcY or [125I]Fc was added to a final concentration of 100
nM in HBSS at pH 5.9 or 8.0, and plates were incubated in a 37°C circulating
water bath for 45 min. For competitor studies, 20 M unlabeled IgY was
added during the preincubation and kept present throughout the experiment.
After incubation with the radioligand the cells were cooled on ice, washed
four times with ice-cold HBSS at pH 8.0 to remove surface-bound ligand,
and then lysed in 0.1 N NaOH. Total protein concentration in the lysates was
determined by BCA assay and the radioactivity present in the lysates was
counted on a Beckman 5500 -counter (Fullerton, CA) and converted to
picograms of protein using the specific activity of the radiolabeled ligand.
Transcytosis Assay
FcRY-IMCD and untransfected IMCD cell monolayers were grown on per-
meable filter supports as described previously (McCarthy et al., 2000). Polar-
ization of monolayers was confirmed by measuring a transepithelial electrical
resistance (TEER) of 350–500 cm2. Filters were preincubated for 20 min with
HBSS/BSA/KI at pH 5.9 on the loading surface and HBSS/BSA/KI at pH
8.0 on the nonloading surface. For competition experiments, unlabeled IgY (20
M) was present in the loading surface medium during the preincubation
step. Where indicated, cells were incubated with nocodazole (33 M) for 1 h
at 37°C in both the loading and nonloading surface medium. Nocodazole
treatment did not alter the TEER values across the monolayers (data not
shown). [125I]FcY or [125I]Fc was added directly to the loading media to a
final concentration of 100 nM. Plates were incubated for 90 min in a 37°C
circulating water bath. Media from the nonloading surface were collected and
precipitated with 10% trichloroacetic acid (TCA) at 4°C. TCA-insoluble (intact
ligand) fractions were counted on a Beckman 5500 -counter.
Recycling Assay
Filter-grown FcRY-IMCD and untransfected IMCD cells were treated as de-
scribed above for the transcytosis assay. After 90 min of incubation with
125I-ligand, the filters were cooled on ice and washed six times with ice-cold
HBSS/BSA at pH 8. Prewarmed HBSS/BSA at pH 8 was added, and the
cells were returned to 37°C for 1 h. The media from the loading surface were
collected, precipitated with TCA, and counted as described above.
Immunofluorescence and Microscopy
For immunofluorescence colocalization studies, FcRY-IMCD cells were grown
until polarized on permeable filters. Monolayers were washed once with
HBSS/BSA and treated with IgY or FcY (500 nM in HBSS/BSA, pH 5.9 or
8.0) for 45 min at 37°C. Cells were cooled on ice, washed twice with HBSS/
BSA, pH 8, and fixed with 4% paraformaldehyde before immunostaining.
Immunofluorescence was carried out as described previously (Tesar et al.,
2006). Commercial antibodies (anti-EEA1, anti-clathrin heavy chain, and anti-
Rab11) were used at 1:100 dilutions. The anti-FcRY polyclonal ascites was
used at 10 g/ml. Secondary antibodies were used at a 1:500 dilution.
Samples were imaged on an inverted Zeiss LSM 510 confocal microscope
equipped with a Zeiss Plan-Apochromat 100 oil immersion objective (NA
1.4; Thornwood, NY). Green fluorophores were excited with the 488-nm line
of an argon ion laser. Orange and far-red dyes were excited with the 543- and
633-nm lines of a He-Ne laser, respectively. Image processing was performed
using the Zeiss LSM Examiner software (v. 3.2) and arranged for presentation
in Photoshop 7.0 (Adobe Systems, San Jose, CA).
Potassium Depletion
Potassium depletion of FcRY-IMCD cells was performed essentially as de-
scribed (McGraw and Subtil, 1999). Briefly, filter-grown FcRY-IMCD mono-
layers were shocked in hypotonic medium (1:1 vol/vol MEM/water) for 10
min before being incubated in potassium-free HBSS/BSA, pH 5.9, for 30
min. Cells were then incubated for with 500 nM IgY in potassium-free
HBSS/BSA, pH 5.9, for 45 min and processed for immunofluorescence as
described above.
RESULTS
Functional Expression of FcRY in IMCD Cells
To study the behavior of FcRY in a cellular context, we
prepared a polarized cell line stably expressing the full-
length FcRY gene. Because an appropriate avian epithelial
cell line is not presently available, we considered two mam-
malian cell lines for FcRY expression: Madin-Darby canine
kidney (MDCK) cells and rat IMCD cells. Both cell lines can
be grown as polarized monolayers on filter supports and
have been used as model systems for studying transcytosis
and recycling by FcRn and other receptors (Praetor et al.,
D. B. Tesar et al.
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1999; McCarthy et al., 2000, 2001; Wu and Simister, 2001;
Claypool et al., 2002, 2004; Tesar et al., 2006). We were able to
obtain expression of FcRY in IMCD cells, but not MDCK
cells (data not shown); thus we proceeded to study FcRY
function in IMCD cells using untransfected IMCD cells as a
negative control. Western blot analysis of lysates of trans-
fected IMCD cells (hereafter abbreviated as FcRY-IMCD)
using a polyclonal ascites raised against the FcRY ectodo-
main detected a prominent band with an apparent molecu-
lar mass of 180 kDa (Figure 1A), corresponding to the antic-
ipated molecular weight of FcRY. Although two nonspecific
bands of 30 and 45 kDa were detected in FcRY-IMCD and
untransfected IMCD cell lysates, confocal immunofluores-
cence analysis of fixed cells showed that only FcRY-IMCD
cells were positively stained by the ascites under identical
treatment and imaging conditions (Figure 1, B and D, red
fluorescence) and that FcRY-positive staining colocalized
with internalized IgY (Figure 1D, green fluorescence and
merged panels). Untransfected IMCD cells do not internal-
ize detectable amounts of IgY or FcY when subjected to the
same treatment and imaging conditions as FcRY-IMCD cells
(data not shown).
We also examined pH-dependent binding and internal-
ization of FcRY ligands by FcRY-IMCD cells. FcRY-IMCD
cells were incubated with intact IgY or the Fc fragment of
IgY (FcY) at pH 6 or 8 at a concentration of 500 nM. Fixed
cells were imaged by confocal microscopy (Figure 1C). Both
IgY and FcY were efficiently internalized at pH 6, but not at
pH 8. This is consistent with previous surface plasmon
resonance-based binding studies, which showed that FcRY
bound to these ligands at acidic, but not basic, pH (West et
al., 2004), analogous to the pH-dependent binding properties
of FcRn.
Quantitative Analysis of FcRY-mediated Endocytosis
Having demonstrated that FcY and IgY could be internal-
ized by FcRY-IMCD cells (Figure 1, C and D), we next
sought to quantify endocytosis using radiolabeled FcY
([125I]FcY). Endocytosis of 100 nM [125I]FcY was observed in
FcRY-expressing cells, but not in untransfected cells (Figure
2A) when incubated at pH 6 (see Materials and Methods), but
not at pH 8, consistent with our confocal analysis (Figure
1C). FcRY-mediated endocytosis was specific, as we ob-
served no endocytosis of a recombinant Fc fragment from
rat IgG2a (Fc), which binds to FcRn but not to FcRY (West
et al., 2004). As expected for a receptor-mediated process,
endocytosis was saturable by addition of a 200-fold excess of
unlabeled IgY to the incubation medium (Figure 2A).
Clathrin-mediated Internalization and Delivery to Early
Endosomes
To investigate the potential involvement of clathrin in FcRY-
mediated endocytosis and the postendocytic fate of IgY, we
performed confocal immunofluorescence experiments on
polarized FcRY-IMCD monolayers. After incubation with
500 nM FcY at pH 6, cells were fixed and stained with an
antibody against chicken IgY to visualize the internalized
ligand and with antibodies against either the clathrin heavy
chain or the early endosome marker EEA1. As shown in
Figure 2, B and C, endocytosed IgY (green fluorescence) is
present in discrete compartments throughout the cell. A
single confocal section through a medial region of the mono-
layer showed that some clathrin-positive compartments
(Figure 2B, red fluorescence) contained endocytosed IgY
(yellow signal in merged image). Some of these doubly-
labeled structures may represent clathrin-coated vesicles
that had pinched off from the plasma membrane and were
en route to deliver their contents to the subcellular endoso-
mal network. To confirm that FcRY-mediated ligand inter-
nalization was via a clathrin-dependent pathway, we per-
formed IgY internalization experiments using cells in which
clathrin-mediated endocytosis was blocked by potassium
depletion (Larkin et al., 1983). When potassium-depleted
cells are treated with IgY and imaged under the same con-
Figure 1. Functional expression of FcRY in
IMCD cells. (A) Anti-FcRY Western blot of
detergent lysates from FcRY-transfected IMCD
and untransfected IMCD cells using a poly-
clonal ascites raised against the FcRY ectodo-
main. (B) Confocal immunofluorescence of
FcRY-IMCD and untransfected IMCD cells
stained with anti-FcRY polyclonal ascites. Im-
ages were collected with the same laser power,
exposure times, and detector settings. (C) Con-
focal images of FcRY-IMCD cells incubated
with 500 nM Alexa 488–labeled IgY or FcY at
pH 6 and 8. Internalized ligand was seen only
when incubated at acidic pH. (D) Confocal
images demonstrating colocalization of FcRY
and IgY. Filter-grown monolayers of FcRY-
IMCD cells were incubated with Alexa 488–
labeled IgY at pH 6 and stained with anti-
FcRY. Optical sections were taken 1 m
below the tight junctions (top panels) or 6
m below the tight junctions (bottom panels).
Scale bars, 10 m.
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ditions as the FcRY-IMCD cells, little or no intracellular IgY
was detected (Figure 2B, bottom-left panel). Staining of IgY-
treated cells with anti-EEA1 (Figure 2C, red fluorescence)
showed many double-positive compartments (yellow signal
in merged image). Taken together, these results demonstrated
that FcRY ligands were internalized via a clathrin-mediated
mechanism and subsequently entered the endosomal traffick-
ing network, most likely through postendocytotic delivery to
early endosomes.
FcRY Mediates Bidirectional Transcytosis
We next asked if FcRY expressed in IMCD cells could reca-
pitulate transcytosis, a canonical in vivo function of its mam-
malian cognate, FcRn. Radiolabeled FcY was added to the
loading surface of filter-grown monolayers, and cells were
allowed to transport [125I]-FcY into the nonloading surface
medium for 90 min. Transcytosis of [125I]FcY was observed
in both the apical-to-basolateral and basolateral-to-apical
directions of FcRY-IMCD cells, but not the control untrans-
fected cells (Figure 3, A and B). Buffering the loading surface
to pH 8 diminished transcytosis in FcRY-expressing cells to
the background levels observed for untransfected cells, as
did inclusion of a 200-fold excess of unlabeled competitor
IgY. Radiolabeled Fc, which does not bind to FcRY (West et
al., 2004), was not significantly transcytosed in either direc-
tion. Pretreatment of cells with the microtubule-depolymer-
izing agent nocodazole reduced observable transcytosis in
both directions to approximately one-half of the correspond-
ing specific (above-background) level. The reduction was
statistically significant in the apical-to-basolateral direction
(p  0.0007), but not in the basolateral-to-apical direction
(p  0.0943). These results suggest that directed movement
of cargo-loaded vesicles along microtubule tracts is required
for efficient FcRY-mediated apical-to-basolateral transport
across polarized cell monolayers.
Ligand Recycling by FcRY
Having shown that FcRY was capable of ligand transport
across polarized monolayers, we next sought to determine if
endocytosed ligands could be recycled from either the apical
or basolateral surfaces. Filter-grown cell monolayers were
treated with [125I]FcY as described for the transcytosis assay.
Cell were washed and returned to 37°C to allow recycling of
internalized ligands back into the loading surface media. As
shown in Figure 4A, we observed recycling at both the
apical and basolateral surfaces of FcRY-expressing cells that
had been incubated with ligand at pH 6. Consistent with
these results, confocal immunofluorescence of fixed, IgY-
treated cells using a mAb against the recycling endosome
marker Rab11 (Figure 4B, red fluorescence) confirmed the
presence of internalized IgY (green fluorescence) in Rab11-
positive recycling compartments in FcRY-IMCD cells (Fig-
ure 4B), but not in untransfected cells (data not shown). No
significant amount of recycling was observed when cells
were incubated with ligand at pH 8 or in the presence of
competitor IgY (Figure 4A). In addition, no recycling was
observed in untransfected IMCD cells. Interestingly, treat-
ment with nocodazole had no significant effect on [125I]FcY
recycling (Figure 4A), suggesting that recycling of FcY, un-
like transcytosis, does not rely on an intact microtubule
network.
DISCUSSION
The transfer of passive immunity from mother to young is a
pervasive feature of most, if not all, orders of mammals. The
mammalian neonatal Fc receptor, FcRn, has served as the
central model for nearly all biochemical and cell biological
investigations of this process to date, although it has been
known for many years that this process is not unique to
mammals (Brambell, 1970). The molecular characterization
of the functional equivalent of FcRn in birds, the yolk sac IgY
Figure 2. Quantitative endocytosis of FcY and delivery to clathrin- and EEA1-positive compartments. (A) Endocytosis of [125I]FcY by
FcRY-IMCD cells. FcRY-IMCD and untransfected IMCD cells were grown to near-confluence in 12-well plates. Cells were incubated at pH
6 or 8 with 100 nM [125I]FcY or [125I]Fc in the presence or absence of a 200-fold excess of unlabeled IgY. After washing at pH 8 to remove
surface bound ligand, cells were lysed and counted for 125I radioactivity. Bars, the mean SEM of triplicate measurements. *p 0.001 relative
to [125I]FcY, pH 6.0. (B) Clathrin-dependent endocytosis of IgY. Control or potassium-depleted FcRY-IMCD cells were incubated with 500 nM
IgY at pH 6 and then fixed and stained with antibodies against IgY (left panels, green fluorescence) and clathrin heavy chain (center panels,
red fluorescence). (C) Delivery of endocytosed IgY to EEA1-positive endosomes. IgY-treated cells were stained with antibodies against IgY
(green fluorescence) and EEA1 (red fluorescence). Scale bars, 10 m.
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receptor FcRY, yielded the unexpected result that FcRn and
FcRY were structurally distinct; FcRn being a homolog of
class I MHC molecules, and FcRY being a homolog of the
mammalian MR family member PLA2R (West et al., 2004).
Biochemical experiments using a recombinant FcRY ectodo-
main showed that it bound to the Fc region of IgY with the
expected pH dependence of an FcRn analog (West et al.,
2004), but whether FcRY could recapitulate FcRn function in a
cellular context remained unclear. Here we describe the devel-
opment of a cell culture model with which to study the cellular
function of FcRY using stably-transfected IMCD cells.
Our FcRY-expressing IMCD cells specifically and satura-
bly endocytosed FcY when it was added at pH 6, but not pH
8, as observed previously for endocytosis of Fc by FcRn
expressed in transfected cell lines (Ellinger et al., 1999;
McCarthy et al., 2000; Claypool et al., 2004; Tesar et al., 2006).
In addition to specific endocytosis of FcY, FcRY-expressing
IMCD cells bidirectionally transcytosed FcY across filter-
grown polarized monolayers in a saturable and specific
manner. To our knowledge, this represents the first obser-
vation of transcytosis by a member of the MR family. Ad-
ditionally, our results suggest that key components of the
cellular endocytotic/transcytotic machinery are conserved
in avians and mammals.
FcRn is one of the few transcytotic receptors known to carry
out physiologically relevant apical-to-basolateral transcytosis.
Quantitative analyses of transcytosis mediated by rat FcRn
expressed in IMCD (McCarthy et al., 2000) and MDCK cells
(Tesar et al., 2006) have shown that rat FcRn transports
significantly more ligand in the apical-to-basolateral than in
the basolateral-to-apical direction, consistent with its role in
transporting IgG in ingested milk from the luminal (apical)
surface of the intestinal epithelium of newborn rodents,
where the pH is acidic, to the serosal (basolateral) surface,
which is exposed to the slightly basic pH of the bloodstream.
By contrast, human FcRn transcytoses IgG more efficiently in
the basolateral-to-apical direction when expressed in trans-
fected cells (Claypool et al., 2002, 2004), perhaps owing to its
purported role in transferring antibodies from the host cir-
culation into luminal secretions by basolateral-to-apical
transcytosis. Once in the lumen, the antibodies can complex
with antigens, which can then be presented to dendritic cells
in the host circulation after reverse transcytosis (Yoshida et
al., 2004). Whether this difference between the human and
rat receptors gives rise to differences in the functions of these
molecules in their respective in vivo settings remains un-
clear. In the case of FcRY, a preferred apical-to-basolateral
directionality makes sense in light of the fact that the pH-
dependent interaction between FcRY and IgY would then
dictate unidirectional transport from the apical surface of
yolk sac membrane cells, where the pH of the yolk is 6
(Cutting and Roth, 1973), to the basolateral surface leading
to the circulation of the developing chick, where the pH is
7.4 (Dawes and Simkiss, 1969). Accordingly, we have
shown that FcRY-expressing IMCD cells transcytose more
FcY in the apical-to-basolateral than in the basolateral-to-
apical direction (Figure 3, A and B).
Biochemical and biophysical characterization of recombi-
nant FcRY suggested that the molecule undergoes a confor-
mational change at pH 6, assuming a more compact form
that binds IgY compared with an elongated form at basic pH
that does not bind IgY (West et al., 2004). This is consistent
with recent electron microscopy studies of the mannose
receptor and Endo180, which revealed that these molecules
undergo significant conformational changes upon incuba-
tion at acidic pH, with the mannose receptor in particular
assuming a more compact conformation at low pH (Rivera-
Calzada et al., 2003; Boskovic et al., 2006). Although the
functional relevance of the conformational change is unclear
for the mammalian MR family members, the body of evi-
dence strongly suggests that the pH-dependent conforma-
tional change in FcRY is required for its function in delivery
of maternal IgY to the chick. Thus acidic pH, either in
endosomes or in egg yolk, would cause FcRY to adopt a
conformation that allows IgY binding, whereas the slightly
basic pH of the bloodstream would result in a conformation
that promotes IgY release. In general, pH-dependent confor-
mational changes in MR family members could serve as a
driving force for activity modulation; e.g., by controlling
binding and dissociation of a receptor-ligand complex, acti-
vation of signal cascades through the receptor, and/or me-
diation of downstream trafficking events. Unlike FcRY,
mammalian MR family members must be capable of binding
to their cognate ligands at the neutral/slightly basic pH of
the extracellular environment; e.g., PLA2R binds circulating
PLA2 at the cell surface. FcRY may be unique among MR
Figure 3. Bidirectional transcytosis of FcY. FcRY-IMCD and un-
transfected IMCD cells were grown as polarized monolayers on
permeable filter supports. [125I]FcY or [125I]Fc was added to the
loading surface to a final concentration of 100 nM with or without
unlabeled competitor or nocodazole. Medium from the nonloading
surface was collected after 90 min, and levels of [125I] radioactivity
in the acid-insoluble fraction were determined. (A) Apical-to-baso-
lateral transcytosis. (B) Basolateral-to-apical transcytosis. Both sets
of histograms represent the mean SEM of triplicate measurements
from a representative experiment. Similar results were obtained in
two independent experiments. *p  0.05, **p  0.001 relative to
[125I]FcY, pH 6.0.
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family members in that the compact conformation assumed
at acidic pH is the functional ligand-binding state, whereas
the elongated conformation at neutral/basic pH is not per-
missive for ligand binding. Because the other MR family
members retain binding of their ligands at the cell surface,
the lack of a practical mechanism for ligand release makes it
unlikely that the mammalian MR proteins function to tran-
scytose ligands across polarized cells.
In addition to its function in bidirectional transcytosis, we
found that FcRY promoted ligand recycling at both the
apical and basolateral surfaces of IMCD cells (Figure 4A).
Consistent with this observation, confocal immunofluores-
cence experiments showed that internalized IgY was present
in Rab11-positive recycling compartments (Figure 4B). Given
that recycling is a common feature of MR family members
(East and Isacke, 2002), these results were not unexpected.
However, combined with the evidence for immunoglobulin
transcytosis by FcRY and the role of mammalian FcRn in
serum IgG homeostasis (Ghetie and Ward, 2002), this raises
the intriguing possibility that serum IgY homeostasis in
avian species is regulated by FcRY. Indeed, the observation
that a greater amount of FcY was recycled than transcytosed
under the same conditions (Figures 3 and 4) suggests that
ligand recycling is an important part of the in vivo function
of FcRY. Although mammalian FcRn can recycle serum al-
bumin as well as IgG, and is therefore proposed to serve as
a protection receptor for both types of ligand (Chaudhury et
al., 2003; Kim et al., 2006; Koltun et al., 2005), FcRY does not
appear to function as a protection receptor for albumin, as
we observed no binding of FcRY to ovalbumin in surface
plasmon resonance binding assays conducted at pH 5–6 and
at concentrations of up to 10 M (data not shown).
To investigate the importance of cytoskeletal elements in
FcRY-mediated transport, we asked whether intact microtu-
bules were required for FcRY transcytosis and recycling.
Although treatment of FcRY-IMCD cells with the microtu-
bule depolymerizing agent nocodazole appeared to reduced
specific transcytosis by approximately one-half in both the
apical-to-basolateral and basolateral-to-apical directions, only
in the apical-to-basolateral direction was this reduction sta-
tistically significant. The incomplete inhibition of transcyto-
sis in the absence of an intact microtubule network could
indicate that diffusion allows for the proper delivery of some
vesicles containing receptor-ligand complexes to the oppo-
site plasma membrane, but that the efficiency of cargo de-
livery is increased by the presence of intact microtubule
tracts. It should be noted, however, that in previous studies
of rat FcRn expressed in IMCD cells, nocodazole treatment
resulted in more complete inhibition of transcytosis in both
directions (McCarthy et al., 2000), perhaps reflecting a dif-
ference in the extent to which intact microtubules are re-
quired for transcytosis mediated by these two receptors. By
contrast to its effect on transcytosis, treatment with nocoda-
zole had no observable effect on the efficiency of FcRY-
mediated recycling (Figure 4). Taken together, these results
indicate that, in IMCD cells, FcRY mediates trafficking of
endocytosed ligands into both a microtubule-dependent
transcytotic pathway and a microtubule-independent recy-
cling pathway.
FcRY is an intriguing model for the evolution and func-
tion of Fc receptors and of transcytotic receptors in general.
Unlike other well-characterized transcytotic receptors, FcRY
and its mammalian cognate FcRn are capable of bidirec-
tional transcytosis, owing to the utilization of pH-dependent
ligand binding as an efficient mechanism to allow for ligand
release upon exposure to the neutral/slightly basic pH of the
extracellular environment. Additionally, FcRY represents the
incorporation of a new function, transcytosis, into the rep-
ertoire of functions performed by members of the MR fam-
ily. Like its mammalian counterpart FcRn, FcRY evolved
from a protein fold whose original function was of no ap-
parent relation to immunoglobulin transport. The compari-
Figure 4. Recycling of FcY occurs at both the
apical and basolateral surfaces. (A) Recycling
of [125I]FcY and [125I]Fc by polarized FcRY-
IMCD monolayers. Cells grown as polarized
monolayers on permeable filters were treated
as described for the bidirectional transcytosis
assay. After a 90-min incubation with a 125I-
ligand, the cells were cooled on ice, washed to
remove surface bound 125I-ligand, and re-
turned to 37°C to allow recycling of internal-
ized ligands into the loading surface medium.
Data are shown as the mean  SEM of tripli-
cate measurements from a representative ex-
periment in both panels. **p 0.001 relative to
[125I]FcY pH 6.0. (B) Confocal images demon-
strating trafficking of IgY to Rab11-positive
recycling endosomes. Filter-grown FcRY-
IMCD cells were incubated with 500 nM IgY at
pH 6. Cells were washed, fixed, and double-
stained for IgY (green fluorescence) and the
recycling endosome marker, Rab11 (red fluo-
rescence). Scale bar, 10 m.
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son of FcRY with other MR family members and with FcRn
offers a fascinating glimpse into the evolution of cross-spe-
cies functional equivalence in molecules that are structurally
distinct, illustrating how the key protein player within an
essential and intricate system can evolve from more than one
functional protein fold and, conversely, how certain folds can
evolve as versatile tools to be applied in more than one func-
tional setting.
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Chapter 4: 
 
A Freeze Substitution Fixation-Based Gold 
 
Enlarging Technique for EM Studies of 
 
Endocytosed Nanogold-Labeled Molecules 
 
In this paper we report the development of gold labeling and enhancement techniques for 
visualization of FcRn-mediated transcytosis in neonatal rat intestine.  My contribution was 
developing the initial conditions for the chemical labeling of recombinant Fc proteins with 
commercially available 1.4 nm Nanogold clusters.  This involved determining the proper 
conditions for gentle reduction of the hinge disulfides for reaction with mono-maleimido-1.4 
nm gold clusters and subsequent purification of the reaction products.  
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labeled Fc could be specifically enlarged to allow identification in 2D projections and in tomograms. These methods should be broadly
applicable to many endocytosis and transcytosis studies.
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Electron microscopy (EM) of cells often requires the use
of labeled proteins to identify particular intracellular com-
partments. For example, gold-labeled antibodies are used
to label compartment-specific antigens by immuno-EM.
For thick cells that require sectioning, such studies are usu-
ally limited to the visualization of antigen near the top and
bottom surfaces of a section (e.g., Griffiths et al., 1984;
Ladinsky et al., 2002). In studies of systems involving endo-
cytosis, labeled ligands are found in all depths of the cell,
thus labeling is not limited to the section surfaces. Recent
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69advances in EM tomography of cells allow cell sections to
be investigated in 3D rather than with 2D projections, and
methods for sample preparation that quickly immobilize all
structures involved in dynamic trafficking events, such as
rapid freezing, can generate a snapshot of complex cellular
events (McIntosh et al., 2005). With high pressure freezing
combined with freeze substitution fixation (HPF/FSF), one
can obtain ice crystal-free freezing of cultured cells or small
tissue samples (Sartori et al., 1993) and a fixation that pre-
serves many aspects of cell ultrastructure (Kellenberger,
1991). Thus studies of intracellular trafficking of labeled
ligands by EM tomography have the potential to accu-
rately reveal the 3D itineraries of endocytosed molecules.
Various labeling methods have or could be used to label
ligands for EM studies of endocytosis, including attach-
ment of large, electron-dense labels such as colloidal gold
(Harding et al., 1983; Murk et al., 2003), ferritin (Rode-
wald, 1973), or cadmium selenide quantum dots (Glep-
mans et al., 2005). Other methods involve attachment of
labels that are visualized after photooxidation of diam-
inobenzidine (DAB) and metal deposition (e.g., peroxidase
(Rodewald, 1980) and fluorescent labels for correlative
light and electron microcopy (Deerinck et al., 1994; Gaietta
et al., 2002)). None of these commonly used labels is well-
suited for high-resolution studies of dynamic events in
intracellular trafficking. For example, colloidal gold binds
to its ligand non-specifically and non-covalently, binds
multiple proteins at once, and tends to aggregate. Smaller
colloidal gold particles (1–3 nm) are especially prone to
aggregation, leading to large oligomeric gold-antibody
structures (Hainfeld and Powell, 2000). The large diameter
of ferritin (14 nm) and its multimeric nature promote
undefined ligand–ferritin stoichiometries and cross-linking,
which can interfere with the proper trafficking of a ligand
(Slade and Wild, 1971). Quantum dots, although promising
for correlated fluorescent and electron microscopic studies
(Glepmans et al., 2005), are often large (P10 nm) and most
methods for attaching them to proteins of interest either
lead to random attachment or, in the case of streptavidin
quantum dots, require biotinylation of the ligand and can
cause cross-linking resulting from binding to tetrameric
streptavidin. Although the labels visualized after photoox-
idation and metal deposition are generally smaller than col-
loidal gold, ferritin or quantum dots, the stain that
develops from these tags tends to be diffuse, reducing their
resolution. Moreover, they are currently incompatible with
HPF/FSF methods of sample preservation.
The ideal tracer for a study of endocytosis by electron
tomography is a small compound that binds covalently
to a ligand without blocking receptor binding, is non-toxic,
and does not alter trafficking after being taken up by live
cells through endocytosis. A tag with the potential to sat-
isfy these requirements is 1.4 nm Nanogold, a gold cluster
that can be conjugated covalently to macromolecules of
interest (Hainfeld and Furuya, 1992). However, Nanogold
is too small to see by EM in most cellular samples, so it
must be enlarged after it has been internalized and the cellshave been fixed. Methods to enhance Nanogold by deposi-
tion of silver or gold atoms on clusters in chemically fixed
samples are available (Danscher, 1981; Hacker et al., 1988;
Hainfeld and Furuya, 1995; Scopsi, 1989), but when we
applied them to chemically fixed tissue samples containing
an endocytosed 1.4 nm Nanogold–ligand, they resulted in
high backgrounds due to auto-nucleation, and none of
these techniques is compatible with HPF/FSF samples.
Thus, there is a need for methods for enhancing small gold
particles after either HPF/FSF or an optimized chemical
fixation and before cells are embedded in plastic for
microtomy.
Here we evaluated methods to enlarge 1.4 nm Nanogold
clusters bound to IgG Fc, a ligand of the neonatal Fc
receptor (FcRn). FcRn displays a binding affinity transi-
tion that is strongly pH-dependent, such that FcRn binds
ligand at the acidic pH found in the gut and intracellular
endosomes (pH 6 6.5) but not at the pH of blood (pH
7.4). This behavior is critical for FcRn’s functions both
in transporting maternal IgG across epithelial cell barriers,
which provides immunity to offspring, and in rescuing
serum IgG from degradation (Ghetie and Ward, 2000).
We verified that Fc proteins covalently labeled with
1.4 nm Nanogold (Au–Fc) are appropriate ligands to fol-
low FcRn trafficking inside cells by several tests. First,
we demonstrated that Au–Fc retains pH-dependent bind-
ing to FcRn, is monodisperse, and is endocytosed normally
into FcRn-expressing cells. We then used these tagged
ligands to develop pre-embedding gold enlarging tech-
niques that are compatible with chemical fixation or with
HPF/FSF of tissue samples. Our chemical fixation
enhancement method resulted in reduced auto-nucleation,
and our HPF/FSF method extended a new FSF-based sil-
ver enhancement method (Morphew et al., in press) by
using gold enhancement to gradually enlarge Nanogold
and render it impervious to osmium compounds used dur-
ing fixation. The resulting methods produced heavy metal
labels that were large enough to be visible in 2D projections
and tomograms but small enough to provide a spatial res-
olution that was about as good as EM tomography itself;
thus we could reliably identify individual FcRn ligands
inside intracellular vesicles in cells expressing FcRn. These
methods should also be applicable to a wide range of EM
tomography studies of endocytosis in other systems.
2. Methods
2.1. Preparation of 1.4 nm gold-labeled Fc (Au–Fc)
The Fc fragment from rat IgG2a was expressed in Chi-
nese hamster ovary cells and purified as described (Martin
and Bjorkman, 1999). Conditions to selectively reduce
hinge disulfides were obtained by evaluating the results of
different reduction protocols using Ellman’s Reagent
(Pierce Chemicals). 1.0–1.5 mg of Fc was reduced with
12–18 mg of mercaptoethylamine hydrochloride in 1 ml
of 0.1 M NaPO4, pH 6.0, 5 mM EDTA for 1.5 h at
W. He et al. / Journal of Structural Biology 160 (2007) 103–113 105
7037 C, then passed over a Superdex 75 size exclusion col-
umn (Pharmacia) in 20 mM NaPO4, pH 6.5, 150 mM
NaCl, 1 mM EDTA.
After concentration, the reduced Fc was labeled with
1.4 nm monomaleimido Nanogold (Nanoprobes, Inc.),
which reacts specifically with reduced sulfhydryls (Hainfeld
and Furuya, 1992), following the manufacturer’s protocol
for labeling IgG. Briefly, 30 nmol of 1.4 nm monoma-
leimido Nanogold was suspended in 1 ml deionized water,
then immediately incubated with the reduced Fc for 2–4 h
at room temperature. Labeled Fc (Au–Fc) was separated
from unlabeled Fc and free Nanogold by passage over
the Superdex 75 gel filtration column. Labeled Fc was fur-
ther purified by passage over an FcRn affinity column at
pH 6, followed by elution at pH 8, as described (Huber
et al., 1993). The molar concentrations of Nanogold and
Fc were determined spectrophotometrically at 420 and
280 nm, respectively, using extinction coefficients of
155,000 M1 cm1 for Nanogold and 60,900 M1 cm1for
Fc. The A280 for Fc was corrected for Nanogold absorption
at 280 nm as described in the Nanoprobes protocol.
2.2. Au–Fc uptake in neonatal rats
11- to 13-day suckling rats born to Sprague–Dawley rats
were separated from their mothers for 3 h, then fed
3 · 100 ll (at 45–60 min intervals) of Au–Fc (2 lM) in
20 mM NaPO4, 1.2 mM CaCl2, 0.5 mM MgCl2, 0.25 mM
MgSO4, pH 6.0 at 37 C. After 2–3 h, rats were anesthe-
tized with CO2, sacrificed, and the small intestine was
removed by dissection. From each intestine, a 4–5 cm seg-
ment of proximal small intestine, starting 2 cm from the
pylorus, and a 4–5 cm segment of the distal small intestine
(ileum), located 2 cm from the ileocecal valve, were
removed for chemical fixation or high pressure freezing.
Within the proximal small intestine, the jejunum can be dis-
tinguished from the duodenum by the presence of the char-
acteristic suspensory muscle of the duodenum (the ligament
of Treitz).
2.3. Gold enhancement of chemically fixed intestinal samples
Small intestine segments were quickly cut into small
pieces, then immediately fixed in 3% glutaraldehyde and
1% formaldehyde (Electron Microscopy Sciences) in
0.1 M sodium phosphate, pH 6.0, 2 mM CaCl2, 1 mM
MgCl2, 0.5 mM MgSO4 for 30 min at 20 C. Fixation
was continued for 3–4 h at 4 C in the same buffer at pH
7.4, and then segments were rinsed with 0.1 M sodium
phosphate, pH 7.4, before gold enhancing.
Initially, we used a gold enhancement kit, GoldEn-
hance-EM 2113 (Nanoprobes, Inc.), to enlarge Nanogold
internalized by the cells in intestinal segments, but the
solutions and protocol supplied by the manufacturer
resulted in rapid enhancement (2–3 min) and substantial
levels of auto-nucleation. Our modified protocol was as
follows: samples were washed 3 · 5 min with PBS includ-ing glycine (20 mM sodium phosphate, pH 7.4, 150 mM
NaCl, 50 mM glycine) to remove aldehydes, 3 · 5 min
with PBS–BSA–Tween (PBS containing 1% BSA and
0.05% Tween 20), and then 3 · 5 min with 5 mM sodium
phosphate, pH 5.5, 100 mM NaCl (Solution E). For gold
enhancement, we placed 1–5 intestinal samples
(1 mm · 1 mm) in a mixture of the manufacturer’s
Solutions A and B at a 2:1 ratio (80 ll of A and
40 ll of B). After 5 min, we added 200 ll of Solution
E with 20% gum arabic (Sigma–Aldrich) and then
80 ll of Solution C. After 7–15 min of development,
samples were transferred to 1–2% sodium thiosulfate to
stop the enhancement. Samples were then washed
3 · 5 min with buffer E. This protocol resulted in slower
development, reduced background and improved unifor-
mity of enhanced particle size, especially when the
enhancement was conducted at 4 C rather than room
temperature. In the absence of gum arabic, there were
variations in the sizes of enlarged gold particles
(Fig. 3b, left panel), perhaps resulting from differences
in the time it took for the sodium thiosulfate stopping
solution to reach different portions of the cell.
Gold-enhanced, chemically fixed samples were incu-
bated in 1% OsO4 in 0.1 M sodium phosphate, pH 6.1,
for 60 min, and then rinsed with distilled H2O prior to
1 h staining en bloc with 2% uranyl acetate. Samples were
dehydrated with progressive lowering of temperature as
described (Berryman and Rodewald, 1990; Gounon and
Rolland, 1998) in a Leica EM AFS machine (Leica
Microsystems).
2.4. HPF/FSF of intestinal samples
Intestinal samples were rapidly frozen with a BAL-TEC
HPM 010 High Pressure Freezing Machine (Bal-Tec, AG).
An intestinal segment was transferred into the 200 lm deep
side of a 100 lm/200 lm specimen carrier that was 2 mm
in diameter (Engineering Office M. Wohlwend GmbH,
Switzerland). The specimen chamber was filled with 1-hex-
adecene (Sigma–Aldrich) and then sandwiched against the
flat side of a 300 lm specimen carrier. This sandwiched car-
rier was placed in the sample holder, then high pressure
frozen at 2100 bar and transferred to liquid nitrogen for
storage. The time interval between initial cutting of the
sample and freezing was 30–40 s.
For conventional FSF of unenhanced samples, the spec-
imen carriers with frozen samples were transferred to
1.5 ml microcentrifuge tubes (Fisher Scientific, USA) con-
taining a frozen solution of acetone with 1% OsO4 and
0.1% uranyl acetate under liquid nitrogen. Tubes were
placed in a Leica EM AFS machine (Leica Microsystems)
at 140 C and gradually warmed to 90 C in 4 h. The
temperature was then gradually raised in 6 h transitions
in the Leica AFS system as follows: 90 C for 24–48 h,
60 C for 24 h, and 30 C for 18 h. After slowly warm-
ing to 0 C over 2 h, samples were washed three times in
pure acetone and warmed to room temperature.
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712.5. Silver enhancement/gold-toning/gold enhancement
during FSF of HPF samples
The FSF procedure described above was modified to
include a pre-embedding gold enlarging technique for
HPF cells by adapting approaches that involve silver or
gold enhancement at room temperature (Danscher,
1981; Hacker et al., 1988; Hainfeld and Furuya, 1995;
Scopsi, 1989), gold-toning (Sawada and Esaki, 2000),
seed-mediated gold enlarging (Busbee et al., 2003; Daniel
and Astruc, 2004; Gole and Murphy, 2004; Handley,
1989; Jana et al., 2001; Meltzer et al., 2001; Okitsu
et al., 2005; Zou et al., 2006) and a FSF-based silver
enhancement procedure (Morphew et al., in press). To
avoid the background that results from spontaneous
auto-nucleation, we designed a three-step enlarging pro-
tocol in which silver enhancement was used to slightly
enlarge the Nanogold, the silver shell was coated by
gold-toning to make it insoluble in osmium, and the par-
ticles were further enlarged to 10–16 nm using gold
enhancement.
Samples were first added to a 1.2 ml solution of ace-
tone including 0.5% glutaraldehyde and the temperature
was raised from 140 to 60 C as described above
for the conventional FSF protocol. Samples were then
washed with acetone at 60 C (3 · 4 h each) to remove
unreacted glutaraldehyde. An HQ or LI silver enhancing
solution (Nanoprobes, Inc.) was prepared at 4 C accord-
ing to the manufacturer’s instructions. Immediately after
preparation, 20 ll of enhancing solution was quickly fro-
zen by injection into liquid nitrogen. A silver enhancing
mixture was prepared by adding 50 ll of saturated
sodium citrate (0.1 g sodium citrate added to 10 ml of
acetone at 4 C) and 50 ll of saturated Na2CO3 (0.1 g
Na2CO3 added to 10 ml of acetone at 4 C) to 1 ml of
saturated AgNO3 (0.1 g AgNO3 added to 10 ml of ace-
tone–methanol solution (98%:2%) in a foil-covered tube)
on dry ice, then adding the frozen drop of HQ or LI sil-
ver enhancing solution. After mixing in a foil-sealed
tube, 1.2 ml of the silver enhancing mixture was added
to the intestinal samples at 60 C and incubated for
8–12 h.
After rinsing samples with acetone (3 · 2 h) at
60 C, gold-toning was done by incubating the samples
in 1.2 ml of a gold-toning mixture, 0.1% HAuCl4Æ3H2O
(Sigma–Aldrich) in acetone–methanol (98%:2%), for 8–
12 h at 60 C. The gold enhancement procedure used
a frozen 20 ll sample of a room temperature gold
enhancement reagent, GoldEnhance-EM 2113 (Nanop-
robes, Inc.), prepared by freezing 20 ll in liquid nitro-
gen as described for Silver LI and Silver HQ above.
Saturated solutions of L-ascorbic acid (kept in the dark)
and K2CO3 (Sigma–Aldrich) were prepared by adding
0.1 g of the relevant chemical to 10 ml acetone–metha-
nol solution on ice. A fresh solution of saturated
NaBH4 (Sigma–Aldrich) was prepared similarly on dry
ice in the dark. The gold enhancing mixture was pre-pared by adding the frozen drop of gold enhancement
reagent plus 80 ll of the ascorbic acid solution, 50 ll
of the K2CO3 solution, and 20–50 ll of NaBH4 solution
to 1 ml of 0.01–0.1% HAuCl4Æ3H2O in acetone–metha-
nol (98%:2%) on dry ice. The gold enhancing mixture
was applied to samples for 24 h at 60 C. Samples
were then rinsed with 1.2 ml acetone at the same tem-
perature (3 · 4 h), and then 1.2 ml of 1% OsO4 and
0.1% uranyl acetate in acetone was added to samples,
followed by warming to 30 C. Warming to room tem-
perature was done as described above for unenhanced
FSF samples.
Further optimization of the protocol might result in
increased reliability and a decrease in the number of
steps and/or reagents involved. For example, it might
be possible to replace the silver enhancement step
described above with the optimized protocol described
in Morphew et al. (in press). However, the current
protocol usually resulted in enlargement of 1.4 nm
Nanogold while avoiding significant background auto-
nucleation. If auto-nucleation did occur, it could usually
be prevented by diluting the saturated reducing solution
and/or reducing the development time in each of the
three steps. To prevent nucleation due to deposition of
silver or gold onto metal contaminants, we avoided
any external sources of metal particles during the
HPF/FSF and gold enlarging steps. Enlarged gold par-
ticles resulting from external seed particles were found
on rare occasions, but these were larger and more irreg-
ular in shape than enhanced 1.4 nm Nanogold. A quan-
titative analysis of gold particles in >50 tomograms in
HPF/FSF/enhanced intestinal cell samples revealed that
P98% of enlarged gold particles represented Au–Fc
bound to FcRn (He et al., in preparation).
2.6. Embedding and electron microscopy
Chemically fixed or HPF/FSF intestinal samples were
infiltrated, embedded, polymerized, sectioned and
stained as previously described (He et al., 2003).
Selected regions of 70–200 nm sections were examined
using an FEI T12 G2 Electron Microscope operating
at 120 kV, and projection images were recorded on a
Gatan 894 2 K · 2 K CCD camera (Gatan Corpora-
tion). Tilt series (±70, 1.0 angular increments) were
digitally recorded at 6500· (pixel size = 1.57 nm) and
at 700 nm underfocus about two orthogonal axes on
the Gatan camera, using the microscope control pro-
gram SerialEM as described (Mastronarde, 2005).
Tomograms were computed for each tilt axis using
the enlarged gold particles as markers for alignment,
and then aligned to each other and combined using
the IMOD software package (Kremer et al., 1996;
Mastronarde, 1997).
Additional methods. Further information on methods
and results related to studies in FcRn-expressing MDCK
cell is available in Supplementary Information.
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3.1. Au–Fc retained pH-dependent binding to FcRn
To obtain a homogenous preparation of labeled Fc that
retained binding to FcRn, we used a monomaleimido-
derivatized 1.4 nm gold cluster to label reduced cysteines
in the Fc hinge region, which can be selectively reduced
without affecting intradomain disulfides (Williamson and
Askonas, 1968). The hinge region is distant from the FcRn
binding site, which is located at the interface between the
Fc CH2 and CH3 domains (Martin et al., 2001) (Fig. 1a),
thus increasing the likelihood that the labeled proteins will
retain functional FcRn binding.
Our labeling protocol involved two sequential purifica-
tion steps: first, size exclusion gel filtration to separateFig. 1. Preparation of Au–Fc. (a) Ribbon diagram of the structure of Fc (p
monomaleimido Nanogold covalently attached to a reduced cysteine in the Fc h
Fc ratios obtained in most labeling reactions (0.8–1.1). The Nanogold cluster b
each Fc chain with a bracket). (b) S75 Superdex gel filtration profile following
(10% acrylamide gel) of non-reduced and unboiled unlabeled Fc (lane 1) and A
molecular weight in the Au–Fc sample, demonstrating covalent attachment of 1
FcRn-expressing MDCK cells after Au–Fc uptake (bar = 10 lm). Filter-grow
processed for immunofluorescence using antibodies against FcRn (green; lef
Methods. The merged image (right panel) shows regions of colocalization as ye
(see Section 2) suggested that most or all of the Fc detected by immunofluoresc
levels of fluorescence when subjected to the same incubation and staining prolabeled Fc (Au–Fc) from unlabeled Fc and free Nanogold,
and second, an FcRn affinity column (Huber et al., 1993)
to ensure that the Au–Fc retained pH-dependent binding
to FcRn. Results from size exclusion columns showed a
shift in migration consistent with covalent attachment of
Nanogold and no signs of Au–Fc aggregation (Fig. 1b).
Nanogold/Fc ratios after FcRn affinity chromatography
were typically 0.8–1.1, suggesting that most or all of the
Fc molecules were labeled, consistent with SDS–PAGE
analysis (Fig. 1c). Intact human IgG, however, demon-
strated poor labeling efficiency when subjected to the same
labeling protocol (data not shown). Since intact IgG and
Fc bind with similar affinities and pH-dependent binding
profiles to rat FcRn (Vaughn and Bjorkman, 1997), we
used the more efficiently labeled Au–Fc, rather than Au–
IgG, as a ligand for FcRn in subsequent experiments.db code 1I1c) with a gold sphere (drawn to scale) representing a 1.4 nm
inge region. One Nanogold is depicted, based on the calculated Nanogold/
ound in a region that is distant from the FcRn binding site (indicated on
incubation of reduced Fc with 1.4 nm Nanogold. (c) SDS–PAGE analysis
u–Fc (lane 2). The majority of Fc protein migrated at a higher apparent
.4 nm Nanogold. (d) Confocal images (5 lm below the apical surface) of
n monolayers were incubated with 1 lM Au–Fc for 1 h at pH 6 and
t panel) and Fc (red; middle panel) as described in the Supplementary
llow. The nearly equimolar ratio of gold to protein in our Au–Fc samples
ence contained gold. Untransfected MDCK cells showed only background
tocols (data not shown).
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line that expresses rat FcRn and had previously been
shown to bind, internalize, and bidirectionally transcytose
rat IgG and Fc (Tesar et al., 2006). Our results showed that
Au–Fc was bound by and endocytosed normally into these
polarized cells by FcRn (Fig. 1d and Supplementary Meth-
ods). Examination of these cells by EM, however, showed
that 1.4 nm Nanogold was too small to be routinely local-
ized in cells with 2D projections or tomograms (Supple-
mentary Figure 1 and Supplementary Information).3.2. Specific enhancement of endocytosed 1.4 nm Au–Fc in
chemically fixed intestinal cells
To facilitate locating 1.4 nm Au–Fc inside cells, we
used gold enhancement to deposit gold atoms specifically
on the 1.4 nm Nanogold, thereby enlarging the particles
to 10–20 nm. These experiments were done using intesti-
nal samples from neonatal rats that had been fed Au–Fc.
The concentration of Au–Fc that was fed to neonatal
rats was 2–3 lM, approximately equal to the IgG con-
centration in rat milk, because higher concentrations sat-
urate FcRn, resulting in degradation of excess IgG
(Benlounes et al., 1995). In this system for Au–Fc
uptake, we had two controls for the specificity of uptake
and gold enhancement: first, the presence or absence of
ingested Au–Fc, and second, the requirement that
enhanced gold particles should appear in physiologically
relevant locations in cells; e.g., in locations correspond-
ing to FcRn expression (apical cell surface, coated vesi-
cles and tubulovesicular compartments) in samples from
the proximal small intestine, and inside degradative com-
partments (e.g., giant lysosomes) in samples from theFig. 2. Gold-enhanced, chemically fixed intestinal segments. Thirteen-day-old
Au–Fc prior to extraction, fixation and gold enhancement of duodenal sample
following the manufacturer’s protocol. (b) Gold enhancement using a modifi
modified protocol showed a significant decrease of background color develo
sample prepared using the original protocol. (c) Projection EM image de
(bar = 200 nm). Randomly distributed 5–10 nm background gold particles we
FcRn-mediated endocytosis.neonatal distal small intestine (ileum), which does not
express FcRn (Rodewald, 1973).
Our original attempts to enhance chemically fixed tis-
sues resulted in significant background color develop-
ment, which came from auto-nucleation in both the
Au–Fc-fed intestinal sample and the control sample
(Fig. 2a and c). We therefore modified the enhancement
protocol to slow the development speed and to increase
the development time, resulting in specific enhancement
such that the control intestinal sample did not show sig-
nificant color development, and the Au–Fc-fed sample
retained color development (Fig. 2b). EM images con-
firmed specific enhancement in that enhanced gold parti-
cles were found in giant lysosomes within samples
derived from the neonatal ileum of Au–Fc-fed rats but
not in neighboring goblet cells of the same sample
(Fig. 3a). These results are consistent with the function
of neonatal ileal cells in fluid phase uptake and degrada-
tion, and the secretory, rather than uptake, function of
goblet cells (Rodewald, 1973). As another demonstration
of specific enhancement, we found enhanced gold parti-
cles at the apical cell surface and inside tubular intracel-
lular vesicles in the proximal small intestine (Fig. 3b),
consistent with FcRn-mediated uptake in this region. In
the distal small intestine, the majority of gold particles
were in large lysosomes (Fig. 3a), consistent with fluid
phase uptake in the distal small intestine, which does
not express FcRn (Rodewald, 1973). In both proximal
and distal intestinal samples, we did not see enhanced
gold particles in organelles such as the mitochondria or
the nucleus (data not shown), indicating that the
enlarged gold particles corresponded to specifically
enhanced Au–Fc that had been endocytosed into intra-
cellular vesicles.neonatal rats were fed 2 lM Au–Fc or a control solution not containing
s. (a) Gold enhancement using GoldEnhance-EM 2113 (Nanoprobes, Inc.)
ed protocol (Section 2; Methods). The control sample derived using the
pment, which resulted from auto-nucleation, compared with the control
rived from a 120 nm section of the control sample shown in Panel a
re found in mitochondria and regions of the cell that did not engage in
Fig. 3. Chemically fixed, gold-enhanced samples of intestinal segments prepared using the modified enhancing protocol. (a) Specificity of gold
enhancement in 70 nm sections derived from the distal small intestine (bar = 1000 nm). A region of the ileum (left) showed enhanced gold particles in giant
lysosomes, consistent with fluid phase uptake of Au–Fc. By contrast, gold particles were not found in secretion vesicles in an adjacent goblet cell (right),
demonstrating a lack of background resulting from auto-nucleation events. (b) Specificity of Au–Fc uptake and gold enhancement in sections derived from
the proximal small intestine (bar = 500 nm). The section on the right was derived from the enhanced segment shown in Fig. 2b. Gold particles were located
in coated vesicles near the basolateral region of the cell (left; section thickness = 200 nm), on the surface of microvilli, in coated vesicles, and in the
extracellular space near the apical surface of a cell (right; section thickness = 150 nm). The section on the left was gold-enhanced in the absence of added
gum arabic, resulting in specific enhancement of 1.4 nm Au–Fc, but a non-uniform particle size. The addition of gum arabic to the section on the right
resulted in a more uniform (20 nm) size of enhanced gold particle.
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FSF samples
Having used chemically fixed neonatal intestinal sam-
ples to confirm that Au–Fc is taken up through fluid phase
endocytosis in the distal small intestine and an FcRn-med-
iated pathway in the proximal small intestine, we next
worked out a method to enlarge Au–Fc in HPF/FSF sam-
ples. Of critical importance for our efforts was the recent
development of a silver enhancement method compatible
with FSF, the first demonstration that enlargement of
Nanogold is possible in organic solvents at low tempera-
ture (Morphew et al., in press). In this method, Nanogold
particles were enlarged to 3–8 nm in tissue samples using a
mixture of silver nitrate, hydroquinone, sodium citrate and
sucrose in cold acetone. The resulting particles could be
seen in tomograms, but were not large enough to be visu-
alized in 2D projections (Morphew et al., in press). In addi-tion, a general limitation of silver enhancement methods is
that osmium compounds, which improve the preservation
of membranes, cannot be added during fixation because
they dissolve the layer of added silver (Hainfeld et al.,
1999). To address both of these issues, we combined silver
enhancement during FSF with gold-toning and gold
enhancement to increase the size of the enlarged particles
and render them impervious to osmium compounds used
during fixation.
Silver-enhanced/gold-toned/gold-enhanced HPF/FSF
duodenal samples showed that the Nanogold was enlarged
to 10–16 nm and was easily visible in both projection
images (Fig. 4) and tomograms (Fig. 5). The ability to
directly visualize enlarged gold particles in projection
images allows one to choose a region containing Au–Fc
for subsequent tomography, and a tilt series can be
recorded at a magnification (e.g., 6500·) that enables the
reconstruction of a reasonably large portion of the cell.
Fig. 4. Projection images of HPF/FSF samples of intestinal samples after silver enhancement/gold-toning/gold enhancement of 1.4 nm Au–Fc. (a) Section
(150 nm) from the neonatal jejunum showing gold particles attached to inner surfaces of tubular vesicles, consistent with Au–Fc bound to FcRn
(bar = 300 nm). (b) Section (150 nm) from the neonatal duodenum showing gold particles attached to the inner surface of a multivesicular body
(bar = 300 nm). (c) Seventy nanometers section from the neonatal duodenum showing gold particles after release into the extracellular space from the
basolateral membrane (bar = 500 nm). (d) Section (120 nm) from the neonatal ileum showing enlarged gold particles distributed only inside apical vesicles
(bar = 500 nm). (e) Section (120 nm) from the neonatal jejunum showing auto-nucleation resulting in small (5 nm) background gold particles distributed
randomly inside and outside of vesicles (bar = 500 nm). Auto-nucleation in this case might have resulted from over-exposure to NaBH4 and/or too long of
a developing time.
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75Our enhancement protocol was compatible with the use of
OsO4 and uranyl acetate, thereby preserving contrast and
details of the ultrastructure. Both projections (Fig. 4) and
digital slices from tomograms (Fig. 5) showed high contrast
and smooth membranes in both vesicles and cells, thus the
gold enlarging procedure did not reduce the high-resolu-
tion possible with HPF/FSF. The enlarged gold particles
were in locations suggesting they represented enhanced
1.4 nm Nanogold attached to Fc that was bound to FcRn:
near the inner membrane leaflets of tubular vesicles (Figs.
4a and 5) and multivesicular bodies (Fig. 4b), and in the
extracellular space near the basolateral surface (Figs. 4c
and 5d). Notably, the majority of enhanced Au–Fc parti-
cles in duodenal samples were found within a 6–7 nm dis-
tance from a membrane, implying attachment to FcRn,
which has a 5 nm ectodomain (Burmeister et al., 1994).
In the ileum, we again saw enhanced gold particles inside
degradative vesicles (Fig. 4d), consistent with fluid phase
uptake in this region of the neonatal intestine. The specific-ity of gold enlargement is demonstrated by comparing
Fig. 4a–d with Fig. 4e, an example of non-specific enhance-
ment in an HPF/FSF sample that was reduced too harshly
and/or developed for too long. Such problems can usually
be avoided by diluting the saturated reducing chemicals
and/or reducing the developing times for the three steps
in the enhancement procedure.
4. Discussion
Here we have demonstrated that a 1.4 nm gold-labeled
Fc is a reliable tag for EM studies of receptor-mediated
endocytosis and transport by FcRn. A monomaleimido-
derivatized Nanogold was attached to Fc without affecting
FcRn binding or uptake into cells. Although the small size
of 1.4 nm Nanogold makes it ideal for preserving the
proper binding and function of a labeled ligand, these clus-
ters were not large enough to be located directly in EM
projection images and in most tomograms derived from
Fig. 5. Digital slices (1.6 nm) derived from tomograms of HPF/FSF samples of jejunal samples after silver enhancement/gold-toning/gold enhancement of
1.4 nm Au–Fc (bar = 300 nm). Dual axis tilt series were recorded at 6500· from 180 nm sections at 120 kV on a Tecnai T12 microscope. Panels (a–d) show
enhanced gold particles near the membranes of tubular and spherical vesicles. Panel (d) shows enhanced Au–Fc that was released into the lateral
intercellular space between adjacent intestinal cells.
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76stained cell sections. We therefore adapted auto-metallog-
raphy and nanoparticle seeding techniques that are used
to enlarge 1.4 nm Nanogold clusters by selectively deposit-
ing silver and/or gold atoms onto their surfaces (Busbee
et al., 2003; Daniel and Astruc, 2004; Gole and Murphy,
2004; Hainfeld and Furuya, 1995; Hainfeld et al., 1999;
Jana et al., 2001; Meltzer et al., 2001; Okitsu et al., 2005;
Zou et al., 2006).
We initially concentrated on gold enhancement of
neonatal rat intestinal samples that had been chemically
fixed in order to quickly screen for specific Au–Fc
uptake. Based on previous studies of IgG transport in
the neonatal rat intestine (Rodewald, 1973), we expected
to see FcRn-mediated uptake in the proximal small intes-
tine and fluid phase uptake in the distal small intestine of
a rat that has been fed Au–Fc. However, our first
attempts using published gold enhancing protocols
resulted in non-specific background deposition in both
types of sample. The modifications described here
reduced non-specific background in gold-enhanced chem-
ically fixed samples, and showed images confirming spe-
cific enhancement in the different regions of the
intestine. The reduction of auto-nucleation and improved
control over development with our method should bene-
fit other pre-embedding enhancement efforts involving
chemically fixed tissue samples.Having demonstrated that Au–Fc is a reliable marker
for receptor-mediated and fluid phase endocytosis follow-
ing chemically fixation, we next undertook to enlarge
Nanogold in tissue samples prepared by HPF/FSF meth-
ods, which is preferable to chemical fixation for studies
of dynamic events during intracellular trafficking (McIn-
tosh et al., 2005). Expanding upon a previously described
FSF-based method involving silver enhancement (Morp-
hew et al., in press), we developed a new gold enlarging
method for HPF/FSF samples that combines gold-toning
and gold enhancement, following an initial silver enhance-
ment step. Including gold enhancement in our method
offers two potential advances: First, unlike silver, gold is
not dissolved by osmium tetroxide (Hainfeld et al., 1999),
a commonly used fixative in EM applications that results
in optimal contrast of membrane structures. Second, by
using gold enhancement following silver enhancement, we
could enlarge the Nanogold clusters to 10–16 nm, which
allows for direct visualization of particles in 2D projections
prior to the selection of a region for tomography. By con-
trast, it was not possible to visualize enhanced particles in
2D projections using silver enhancement alone because the
particles were enlarged to 68 nm (Morphew et al., in
press). In principle, the gold-toning and gold enhancement
steps could be used without a prior silver enhancement step
in a HPF/FSF gold enlarging procedure. However, we
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77obtained optimal results (less auto-nucleation and a greater
uniformity in particle size) by combining the silver
enhancement step with gold-toning and gold enhancement.
When auto-nucleation did occur, we could distinguish
auto-nucleated particles from enhanced 1.4 nm Nanogold
in EM images because the former were smaller and ran-
domly distributed as compared with the latter.
We conclude that the combination of thiol-specific
Nanogold labeling to obtain a minimally perturbed ligand
with subsequent gold-enlargement allows the use of high-
resolution electron tomography to accurately trace recep-
tor–ligand complexes during endocytosis and intracellular
trafficking.
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Chapter 5: 
 
Investigation of FcRn Exocytosis by Total 
 
Internal Reflection Fluorescence 
 
Microscopy 
 
 
This chapter describes work done as part of a collaboration with Sandy Simon’s laboratory at 
The Rockefeller University in New York, New York. The goal of these studies was to 
visualize FcRn exocytosis at the plasma membrane and to determine if exocytosing FcRn-
positive vesicles remain partially clathrin-coated during the process. I traveled to Dr. Simons 
laboratory and performed the experiments described here. 
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Introduction 
 
The ability to sense and respond to environmental factors is one of the fundamental 
characteristics of living things.  These external factors can be in the form of small molecules, 
macromolecules (proteins and nucleic acids), or even other cells or organisms.  The 
important feature of such interactions between cells and their external environment is that 
they lead to chemical or structural changes through receptors or molecules at the cell surface 
that can in turn alter downstream molecules to give rise to larger-scale changes in protein 
and/or cellular structure and/or function.  The events that comprise such a process are often 
spatially localized within a small region of the cell, such as the plasma membrane or within 
an individual trafficking endosome.  Until recently, high-resolution techniques for the 
examination of cell-surface structures were limited to electron microscopy, which produces 
high resolution data but does not allow the visualization of dynamic processes in living cells, 
and confocal microscopy, which allows live cell visualization but lacks the resolution 
necessary to effectively study individual events occurring at the level of the plasma 
membrane.   
 
Recent electron tomography studies of the transcytosis of gold-labeled Fc (Au-Fc) molecules 
by FcRn in the neonatal rat gut performed in our laboratory provided insights into the 
structure and distribution of trafficking endosomes and vesicles containing FcRn-ligand 
complexes (He, et al., 2008).  One particularly surprising result was the presence of clathrin-
coated vesicles that had fused with the lateral membrane and contained Au-Fc.  Because the 
slightly basic pH and low concentration of Au-Fc in the lateral intracellular space (LIS) 
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should not be permissive for binding of Au-Fc to FcRn, it was hypothesized that these 
structures represented a glimpse of clathrin-mediated exocytosis.  This hypothesis contradicts 
the conventional view of exocytosis, in which trafficking vesicles fully uncoat prior to fusing 
with the target membrane (Altstiel and Branton, 1983; Brodsky et al., 2001; Conner and 
Schmid, 2003).  We wished to investigate this phenomenon in a system that was more 
amenable to experimental manipulation and that could be used to examine exocytotic events 
through time rather than at static moments, i.e., light microscopy of living cells. 
 
Conventional confocal microscopy can obtain axial resolution of about 200 nm, which is 
substantially thicker than the plasma membrane (4-6 nm) (Gandhavadi et al., 2002; Ruta et 
al., 2005; White et al., 2001).  Additionally, while the use of a pinhole to reject out-of-focus 
light has the advantage of increasing axial resolution, repeated excitation by the scanning 
beam results in slow image capture, which in turn increases photodamage and bleaching, 
making live-cell imaging application difficult to implement effectively.  Many of these 
drawbacks are minimized by spinning disk confocal microscopy in which an array of 
pinholes in a disk is used to scan through the entire field of view, generating a confocal 
image (Graf et al., 2005; Nakano, 2002).  This image can be captured by a charge-coupled 
device (CCD) camera rather than a photomultiplier tube (PMT), which greatly increases the 
speed of image acquisition.  Because CCD cameras are highly sensitive, images can be 
acquired with lower excitation intensity, which in turn reduces photodamage (Graf et al., 
2005; Nakano, 2002).  These advantages make spinning disk the technique of choice for live-
cell imaging.  However, spinning disk confocal is still subject to the limited resolution of 
confocal microscopy, making visualization of highly localized events difficult.   
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 Other attempts to improve the spatial resolution of conventional techniques have included 
image deconvolution, in which the point spread function is sharpened computationally, and 
two-photon microscopy, which improves resolution by varying the illumination non-linearly 
with position in the focal axis (for review see (Jaiswal and Simon, 2003)).  Both of these 
approaches are subject to their own limitations.  Image deconvolution, for example, is 
computationally intense and is prone to introducing artifacts (McNally et al., 1999).  Two-
photon microscopy allows for the collection of an optical slice with less noise from out-of-
focus photons, but the axial resolution is still limited by the long wavelength of the infrared 
light used.  Additionally, the high flux of photons necessary to achieve two-photon events on 
a reasonable timescale for imaging leads to heating and photodamage at rates that are often 
higher than conventional confocal microscopy (Jaiswal and Simon, 2003; So et al., 2000).   
 
Total internal reflection fluorescence microscopy (TIRFM) allows for the visualization of 
event taking place within close proximity (~100 nm) of the plasma membrane in living cells.  
This offers the advantage of visualizing dynamic events taking place at the cell surface 
without interference from out of focus light, which is an inherent limitation with 
epifluorescence and even confocal microscopy (Figure 1) (Jaiswal and Simon, 2003; 
Nishikawa, 2007).  TIRFM is able to simultaneously achieve the advantages of limiting out-
of-focus illumination, fast image acquisition, and selective illumination of the portion of the 
cell that is within ~100 nm of the contact surface.  These benefits have made TIRFM an ideal 
and preferred technique for investigating the dynamics of exocytosis and the roles played by 
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the various protein components of the exocytotic machinery (Holz, 2006; Jaiswal et al., 2004; 
Jaiswal et al., 2007; Oheim et al., 1998).   
 
In order to investigate the question of whether clathrin is involved in the exocytosis of FcRn-
Fc complexes I began a collaborative project with the laboratory of Dr. Sandy M. Simon at 
The Rockefeller University.   
 
 
Materials and methods 
 
Plasmids and construction of expression vectors 
The vectors encoding the clathrin light-chain fused to EGFP or DsRed were provided by 
Sandy Simon (The Rockefeller University).  The pCB6H mammalian expression vector 
containing rat FcRn and the pBJ1 vector containing rat β2m have been described previously 
(Tesar et al., 2006).  Superecliptic pHluorin-FcRn was generated by introducing a unique 
AgeI site after the nucleotides encoding the FcRn signal sequence in rFcRn-pCB6H.  
Superecliptic-pHluorin was amplified out of the pGEX-SE-pHluorin vector (a gift from 
Sandy Simon) by PCR using primers to add flanking AgeI sites.  This product was inserted 
into the rFcRn-pCB6H vector immediately 3’ of the signal sequence and 5’ of the FcRn 
coding sequence resulting in an superecliptic pHluorin being fused to the N-terminus of 
FcRn in the expressed protein.  The N-terminus of FcRn is located on the opposite side of the 
molecule as the ligand-binding site (Martin et al., 2001).  Construction, expression, and 
purification of the tdTomato-Fc protein is described in Appendix II. 
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 Cell culture and transfections 
Madin-Darby Canine Kidney (MDCK) type II cells were trypsinized and transfected in 
solution using Lipofectamine 2000 (Invitrogen).  Transfected cells were immediately plated 
onto poly-L-lysine-coated coverslips glued to the bottom of 60 mm plastic culture dishes 
(Matek).  Transfected cells grown at confluent or sub-confluent density before experiments. 
For experiments involving the internalization of ligands, cells were first rinsed in Hank’s 
Balanced salts with calcium and magnesium (HBSS+) supplemented with 1% ovalbumin and 
20 mM MES pH 5.9 (HOM medium).  tdTomato or Alexa633-Fc was added at a 
concentration of 100-1000 nM.  Cells were incubated for 15-60 minutes, rinsed several times 
and then imaged in cell imaging media (CIM, HBSS+/1% fetal bovine serum (FBS)/20 mM 
HEPES pH 7.4).  
 
Microscopy 
Through-objective TIRFM and epifluorescence microscopy were performed with an inverted 
Olympus IX-70 microscope with an APO x60, N.A. 1.45 TIR objective (Olympus Scientific) 
equipped with a 12-bit cooled CCD camera (ORCA-ER; Hamamatsu Photonics). The 
camera, the Mutech MV1500 image acquisition card (Mutech), and the mechanical shutters 
(Uniblitz; Vincent Associates) were controlled by MetaMorph (Molecular Devices). The 
microscope was enclosed in a home-built chamber for temperature control, and all imaging 
was performed at 37°C. For TIRFM experiments, GFP, superecliptic pHluorin, tdTomato, 
and DsRed were excited with the 488-nm line of an air-cooled tunable argon laser 
(Omnichrome; model 543-AP A01; Melles Griot) reflected off a dichroic beam splitter 
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(z488rdc).  For epifluorescence, the light of a xenon short-arc lamp [model UXL-150M0 
(Ushio)] was passed through a 480/40 band pass excitation filter. The emitted fluorescence 
for both TIR-FM and epifluorescence microscopy was passed through appropriate emission 
filters (green channel, 515/30 or 525/50; red channel, 580lp or 600lp) as indicated for each 
experiment. Simultaneous dual-color TIRFM imaging of GFP, or pHluorin and tdTomato, or 
DsRed was achieved by exciting the sample with the 488 nm laser line. The emission was 
spectrally separated by means of an emission splitter (Dual-View; Optical Insights) equipped 
with a 515/30 band pass filter and a 580lp filter. All filters, dichroics, and polychroics were 
from Chroma Technologies.  Images containing a region of interest were streamed to 
memory during data acquisition and saved to hard disk afterward. Data analysis was 
performed by using MetaMorph software (Molecular Devices). 
 
 
Results and discussion 
 
We wished to use TIRFM to investigate FcRn-mediated exocytosis at the plasma membrane 
and the possible involvement of clathrin therein.  For my initial experiments we tried to 
visualize labeled ligand and fluorescent clathrin simultaneously with the hope that we would 
see “puffs” of exocytosing ligand colocalizing with clathrin.  Glass-grown FcRn-MDCK 
cells were transfected with a construct encoding an EGFP-clathrin fusion protein.  Cells were 
treated with tdTomato-Fc 24-48 hours post-transfection and imaged in TIRF mode on a 
home-built TIRF microscopy system (see Methods).  For initial experiments, cells were 
treated with 500 nM ligand for 45 minutes.  The cells were then fixed and imaged in TIRF 
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mode to examine the distribution of EGFP-clathrin and tdTomato-Fc (Figure 2).  The 
principle limitation in these experiments was that the imaging set-up was not amenable to the 
clear visualization of tdTomato-Fc.  First, the only available laser to excite tdTomato was a 
1.5 mW 543 nm laser.  This laser is simply not strong enough to give good excitation, 
especially when one considers that the excitation maximum of tdTomato falls at 554 nm.  
Second, to avoid bleed-through of EGFP into the tdTomato channel it was necessary to use at 
least a 580 long-pass emission filter when imaging tdTomato, which cut off a significant 
portion of the emission spectrum.  Thus, long exposures were required to see tdTomato-Fc in 
the fixed specimen (~500 ms, Figure 2).  Exposure times of this length would not allow one 
to discern the individual movements of puncta in a living specimen simply because many 
such movements are likely too fast to be captured clearly under such conditions.  
Additionally, it was clear that much of the tdTomato-Fc had already been exocytosed into the 
intracellular space in the fixed sample.  This result indicated that shorter ligand incubation 
times followed by rapid washes would be necessary to visualize ligand in living cells. 
 
My next experiments attempted to use Alexa633-labeled Fc as a ligand. This seemed like a 
good choice of ligand (given the constraints of the imaging setup) due to its being spectrally 
well-separated from EGFP, thus allowing me to collect the full emission spectrum without 
fear of bleed through.  After ligand treatment (500 nM ALexa633-Fc), EGFP-clathrin/FcRn-
MDCK cells were quickly washed in cold buffer and placed on the microscope stage.  
Movies were collected with 200-300 ms exposure time over 200-400 frames.  A 
representative frame from one of these movies is shown in Figure 3.  The puncta of ligand 
fluorescence in these movies could be classified into two categories; fast-moving puncta that 
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move within and out of the plane of focus, and static puncta that move little or not at all.  We 
did not observe events that clearly resembled exocytosis – one would expect exocytosis to 
appear as a brief “puff” of fluorescence as the molecules are released into the extracellular 
environment and rapidly diffuses.  No such puffs were seen in any of the collected data. 
 
Despite the fact that a similar segregation into a fast- and slow- or non-moving populations 
was previously observed for clathrin (Rappoport et al., 2003a; Rappoport et al., 2003b), two-
color analysis of simultaneously imaged EGFP-clathrin and tdTomato-Fc or Alexa633-Fc 
failed to show any significant degree of colocalization.  It was later determined that the 
morphology of the non-moving spots was consistent with membrane-proximal lysosomes as 
seen in a previous study (Jaiswal et al., 2002).  Thus, I performed experiments varying the 
concentration of Fc during loading to see if we could preferentially load trafficking 
compartments and avoid overloading of lysosomes.  It was determined that with as little as 
10 nM Alexa633-Fc or tdTomato-Fc, moving spots could be visualized in TIRFM mode 
while accumulation of ligand in large, static structures was avoided.  Thus, in future 
experiments I used significantly lower ligand concentrations. 
 
At this point the principle constraint was being able to identify exocytosing Fc.  This proved 
to be very difficult, as with the limited signal we were unable to identify an unambiguous 
case of exocytosis based on morphology alone.  It became clear that direct visualization of 
FcRn-mediated exocytosis would require the use of pH-sensitive probes, such as 
superecliptic pHluorin, to unambiguously identify sites of receptor and/or ligand exit from 
the plasma membrane.  pHluorin is a mutagenized EGFP with high pH sensitivity.  When 
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excited at 488 nm it is brightly fluorescent at neutral pH (>7.0) but exhibits no fluorescence 
at acidic pH (<6.0) (Miesenbock et al., 1998).  It has been used as pH sensor for intracellular 
compartments in a variety of studies (Jankowski et al., 2001; Kuhn et al., 2007; Ohara-
Imaizumi et al., 2002; Schuster et al., 2005).  Superecliptic pHluorin is a brighter and slightly 
more pH-sensitive version of the pHluorin molecule (pKa = 7.18 versus 7.07 for regular 
pHluorin) (Sankaranarayanan et al., 2000).  To allow for visualization of receptor exocytosis 
directly, I generated a recombinant FcRn that has superecliptic pHluorin appended to its N-
terminus (Figure 4).  The N-terminus of FcRn is located on the opposite face of the molecule 
as the ligand binding site and should not interfere with ligand internalization (Martin et al., 
2001). 
 
MDCK cells transfected with pHluorin-FcRn and DsRed clathrin were imaged in TIRFM 
mode.  A plane from a movie showing pHluorin-FcRn and DsRed-clathrin expression in 
shown in Figure 5.  Many of these pHluorin-FcRn puncta can be seen that “puff” in the 
movie.  This is consistent with a labeled membrane protein within a vesicle fusing with the 
plasma membrane and diffusing radially within it (Jaiswal et al., 2007).  The DsRed-clathrin 
puncta are less mobile and do not “puff”, consistent with previous observations of labeled 
clathrin being imaged in TIRFM mode (Rappoport et al., 2003a; Rappoport et al., 2003b).  
Two classes of pHluorin-FcRn spots could be identified.  The first were spots that appear at 
the plasma membrane and immediately “puff”.  The average lifetime of the fluorescence 
form one of these “completely fusing” pHluorin-FcRn spots is 1-2 seconds.  Examining 29 
events such as this failed to find even one FcRn “puff” that colocalized with clathrin.  A 
representative puncta from this class is shown in Figure 6.  A second class of pHluorin-FcRn 
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spots are those that approach the membrane and partially fuse (as demonstrated by the 
evolution of bright pHluorin-FcRn fluorescence) but do not show the “puff” characteristic of 
complete fusion.  Analysis of 13 of these “incompletely fusing” spots revealed that they have 
an average lifetime of ~4-6 seconds and are less abundant than the “completely fusing” spots.  
None of the spots examined showed any colocalization with clathrin.  A representative 
example of this class is shown in Figure 7. 
 
Having failed to find difference in the presence or absence of clathrin in the two classes of 
pHluorin-FcRn spots, I sought to determine if pHluorin-FcRn and DsRed-clathrin colocalize 
to any degree by looking at the merged images throughout the recording.  This revealed that 
some spots of pHluorin-FcRn/DsRed-clathrin fluorescence were indeed present (Figure 8).  
The small panels in Figure 8A show a close-up of a single such event.  It is readily apparent 
that the pHluorin-FcRn fluorescence is much less bright than DsRed clathrin.  However, 
quantitative analysis of the fluorescence intensity values of both channels within the region 
of interest (Figure 8B) clearly shows that pHluorin-FcRn and DsRed-clathrin both appear and 
disappear at the same time.  The difficulty in interpreting these data is that we cannot be 
certain that this vesicle is not a newly-endocytosed CCV containing pHluorin-FcRn that 
happened to pass close to the membrane on its way to join the endosomal network and has 
yet to be acidified.  A similar problem prevents meaningful analysis of colocalizing spots that 
are present at the beginning of the recording and subsequently disappear; these very likely 
represent endocytotic events rather than exocytosis.  However, it is clear, at the very least, 
that FcRn and clathrin do colocalize in membrane proximal vesicles that can be imaged using 
TIRFM.  Future experiments will focus on identifying the origin and fate of these vesicles, 
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which will yield insight into the involvement of clathrin in the intracellular trafficking of 
receptors and their ligands.     
 
 
Conclusions and future directions 
 
While it is encouraging that we are now able to unambiguously identify sites at which FcRn-
positive vesicles are fusing with the plasma membrane, the lack of an efficacious labeled 
ligand for these studies continues to provide difficulties.  Because we are able to image only 
the receptor at this time it is impossible to conclusively say which types of events 
(completely fusing, incompletely fusing, those colocalized with clathrin, or some subset of 
the three) would actually be correlated with ligand release in a physiological setting.  To help 
resolve this issue for future TIRFM studies I am developing an additional reagent; an Fc 
molecule with a superecliptic pHluorin appended to both C- and N-termini of each chain.  
The pHluorin-Fc-pHluorin homodimer will have four pHluorins contributing to its 
fluorescence instead of the single pHluorin present in superecliptic pHluorin-FcRn.  This  
reagent will be used in concert with fluorescent clathrin expression to correlate the presence 
of clathrin-positive spots at the plasma membrane with exocytosis, visualized by the 
evolution of pHluorin fluorescence when pHluorin-Fc-pHluorin molecules are released into 
the extracellular environment.  This reagent will overcome the difficulty of interpreting a 
pHluorin-FcRn/clathrin spot such as that shown in Figure 8.  Because the extracellular pH is 
not permissive for the binding of Fc to FcRn and because no exogenous ligand will be 
present, any colocalizing pHluorin-Fc-pHluorin and DsRed clathrin, fluorescence must 
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represent an intracellular vesicle that has partially fused with the plasma membrane, 
eliminating the possibility that the vesicle represents newly endocytosed receptor-ligand 
complexes.  Furthermore, the Simon lab will soon have its TIRFM microscope outfitted with 
a three-way splitter, which will allow me to perform experiments in which three proteins are 
visualized; clathrin, FcRn, and a labeled ligand.  Also, the lab is in the process of installing a 
568 nm laser line with more power than the 546 nm 1.5 mW laser that was previously being 
used to excite tdTomato.  The use of a stronger 568 nm line may allow tdTomato-Fc to be 
visualized clearly, which has not yet been possible.  The combination of these improvements 
will allow a much more powerful analysis of Fc trafficking and the identification of sites of 
exocytosis without having to rely on changes in vesicle morphology alone, which are 
intrinsically more difficult to resolve in an unambiguous fashion. 
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Figure 1.  TIRF Microscopy.  (A) Relative degrees of axial resolution attainable by different 
microscopy techniques.  (B) Comparison of the illumination properties of epifluorescence 
and confocal imaging with TIRF imaging. (Adapted from (Jaiswal and Simon, 2007)) 
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Figure 2.  TIRFM of a fixed sample of FcRn-MDCK cells.  The transfected EGFP-clathrin is 
shown in green in the merged image.  tdTomato-Fc is shown in red.  Despite using a 580 
long-pass emission filter for tdTomato-Fc there is still a small amount of bleed-though of 
EGFP fluorescence into the red channel. 
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Figure 3.  Alexa633-Fc in FcRn-MDCK cells.  Cells were incubated with 500 nM Alexa633-
Fc for 25 minutes and then visualized in TIRFM mode.  Some puncta (white arrowhead) 
move fairly rapidly while other (red arrowhead) do not move at all. 
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Figure 4.  Superecliptic pHluorin-FcRn.  The superecliptic pHluorin was appended to the N-
terminus of FcRn, away from the ligand binding site.  pHluorins are excited by 488 nm light 
at neutral pH, but show no fluorescence at acidic pH.  (Spectra image adapted from 
http://www.bristol.ac.uk/synaptic/research/projects/mechanisms/phluorins.htm) 
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Figure 5.  Superecliptic pHluorin-FcRn and DsRed-clathrin expressed in MDCK cells.  
Individual puncta represent pHluorin-FcRn-positive or DsRed-clathrin-positive vesicles 
within the imaging plane.  pHluorin-FcRn spots should represent vesicles that are either 
fused with the plasma membrane or are recently internalized that have yet to be acidified.  
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Figure 6.  A completely fusing pHluorin-FcRn spot.  (A) Average intensity graphs of 
pHluorin-FcRn and DsRed-clathrin fluorescence over time in the region of interest 
surrounding a completely  fusing spot that shows the characteristic “puff” associated with 
complete fusion of a tagged receptor with the plasma membrane.  The white lines in the 
pHluorin intensity graph denote the position of the first and last frames from the region 
shown in (B).  The exposure time was 200 ms. 
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Figure 7.  An incompletely fusing pHluorin-FcRn spot.  (A) Average intensity graphs of 
pHluorin-FcRn and DsRed-clathrin fluorescence over time in the region of interest 
surrounding an incompletely fusing spot that enters the plane of focus and leaves without 
“puffing”.  The white lines in the pHluorin intensity graph denote the position of the first and 
last frames from the region shown in (B).  The exposure time was 200 ms. 
 
 
 
98
 
Figure 8.  A colocalizing pHluorin-FcRn/DsRed-clathrin spot.  (A) Merged image of the 
pHluorin-FcRn and DsRed-clathrin channels.  Several spots with both FcRn and clathrin 
present are visible.  Panels are close-up images of the spot indicated by the white arrow.  (B) 
Average intensity graphs of the pHluorin and DsRed channels for the region of interest 
shown in the small panels of (A). 
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Appendix I: 
 
Generation of a Recombinant Fluorescent 
 
Ligand for Live-Cell Imaging of FcRn 
 
Trafficking 
 
 
This chapter describes the construction, expression, and purification of a recombinant Fc 
molecule with a tandem dimer of fluorescent proteins attached to the N-terminus of each 
chain.  The purpose of this reagent was to allow for faster and more prolonged acquisition of 
spinning disk confocal images for live-cell imaging experiments. 
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Introduction 
Spinning disk technology is specifically suited for the fast acquisition of events in living cells 
that happen beyond the temporal resolution of conventional confocal microscopes.  The use 
of highly sensitive charge-coupled device (CCD) detectors allows for image acquisition 
under conditions of limited laser exposure, which greatly increases fluorophore lifetime over 
the course of an experiment (Graf et al., 2005; Nakano, 2002). We are currently using 
spinning disk technology to visualize rapid events during FcRn trafficking in living cells.  
The principle limitations of live-cell imaging techniques are that the fluorophore of choice 
must be bright and photostable in order to minimize exposure time required and thus 
maximize the temporal resolution achieved, and furthermore must be stable at the low pH (~ 
5.5) of endosomes.  As chemically labeled Fc proteins do not provide sufficiently bright 
labels I attempted to generate recombinant Fc ligands that are tagged with fluorescent 
proteins.  
 
 
Materials and methods 
 
Ligands 
Recombinant wild-type rat Fc (wtFc) was expressed and purified as described previously 
(Martin and Bjorkman, 1999).  wtFc was labeled directly with AlexaFluor 488 succinimidyl 
ester (Invitrogen) to obtain a dye:protein  ratio of 1.5–2.0:1.  Labeled ligands were desalted 
on Zeba spin columns (Pierce) and stored in phosphate buffered saline (PBS) or 
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HEPES/NaCl with 0.001% azide at 4 degrees.  Proteins were used within one month of 
labeling.   
 
Construction of tdTomato-Fc expression vector 
The pTT5 mammalian expression vector encoding the Fc fragment of human IgG1 was 
kindly provided by Anthony West (Bjorkman Lab, Caltech).  The tandem dimeric Tomato 
(tdTomato) construct described previously (Shaner et al., 2004) was kindly provided by Dr. 
Robert Campbell from the University of Alberta, Canada.  The tdTomato gene was amplified 
out of this vector by PCR using primers which added a 5’ PacI site and a 3’ FseI site.  The 
amplified product was inserted in-frame to the 5’ end of the human Fc gene in pTT5 by 
Paci/FseI double-digest and ligation.  The entire open reading frame was verified by DNA 
sequencing. 
 
Expression and purification of tdTomato-Fc 
tdTomato-Fc in the pTT5 expression vector was used to transfect 293EBNA cells in 
suspension culture with Lipofectamine 2000.  The supernatant from 500 mL of culture was 
acidified to pH 5.9 using MES (100 mM final concentration) and passed over an FcRn-
column overnight in the cold room.  After washing exhaustively with buffer (25 mM 
MES/150 mM NaCl/0.002% sodium azide) the column was eluted with 25 mM HEPES pH 
8/150 mM NaCl/0.002% azide.  The eluate was concentrated and ~ 2 mg of protein was 
passed over an SD200 gel filtration column into 20 mM HEPES pH 7.4/150 mM NaCl/ 
0.002% sodium azide.  The concentration of tdTomato-Fc in the final sample was determined 
using the extinction coefficient of tdTomato at 554 nm (ε = 138,000 M-1cm-1), correcting for 
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the fact that there are two tdTomato chains in each intact tdTomato-Fc dimer.  Both the 
aggregate and monomer peak from the SD200 elution were analyzed by SDS-PAGE on a 
10% acrylamide gel.  Two microliters of each concentrated peak were run under both 
reducing and no-reducing conditions. 
Cell culture and ligand treatments 
The FcRn-MDCK cell line has been described previously (Tesar et al., 2006).  Cells were 
grown at confluent or sub-confluent density on poly-L-lysine-coated coverslips glued to the 
bottom of 60 mm plastic culture dishes (Matek).  For internalization of ligands, cells were 
first rinsed in Hank’s Balanced Salts with calcium and magnesium (HBSS+) supplemented 
with 1% ovalbumin and 20 mM MES pH 5.9 (HOM medium).  tdTomato or Alexa488-Fc 
were added at a concentration of 100–500 nM.  For experiments directly comparing 
fluorphore lifetimes, the fluorophores were both added at a concentration of 100 nM.  Cells 
were incubated for 15–60 minutes, rinsed several times and then imaged in HOM or 
HBSS+/1% fetal bovine serum (FBS)/20 mM HEPES pH 7.4.  
 
Spinning disk confocal microscopy 
FcRn-MDCK cells treated with tdTomato-Fc or Alexa488-Fc at pH 5.9 were imaged in a 37 
°C chamber enclosing a Zeiss AxioObserver equipped with an UltraVIEW spinning disk 
confocal system.  A PlanApo 100x 1.46 NA oil immersion objective was used.  The center 
quarter of a 1Kx1K CCD camera chip was used for data collection with no binning.  
tdTomato-Fc was excited with the 568 nm laser line.  Laser power was set to 18% with 75% 
output.  Frames were collected continuously over 180–300 sec with exposure times varying 
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from 50–400 msec.    
 
Results and discussion 
 
My previous efforts to visualize trafficking events in living cells have been limited to the use 
of primary amine-reactive fluorescent dyes to label Fc proteins.  While these reagents offer 
the ability to visualize a recombinantly expressed ligand that lacks an endogenous tag, they 
have thus far not provided the brightness or photostability required to visualize trafficking 
events with high spatial and temporal resolution.  Indeed, getting a “good” image using 
Alexa-labeled Fc proteins often requires exposure times of 400 milliseconds or more.  As 
such, exposure times must be decreased (and image quality thereby sacrificed) in order to 
image fast events within the cell.  In order to obtain an FcRn ligand that has better 
fluorescent properties than the Alexa dyes, I decided to create a recombinant Fc fusion 
protein in which a fluorescent protein was fused to the N-terminus (in the position where the 
Fab would normally reside).  After a failed attempt to do this with regular EGFP due to the 
fact that EGFP is virtually non-fluorescent at the acidic pH of endosomes (Scharnagl et al., 
1999), I identified tdTomato as a good candidate due to its brightness and superior pH 
stability (pKa = 4.7) (Figure 1A and B) (Shaner et al., 2004). tdTomato is a tandem dimer of 
a variant of the DsRed fluorescent protein.  Whereas DsRed is normally a tetramer, tdTomato 
contains a series of mutations that disrupt one of the two dimer interfaces within the tetramer.  
The resulting molecule will homodimerize, allowing the expression of two fluorophores in a 
single compact structure (Shaner et al., 2004). 
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Purification of tdTomato-Fc 
The tdTomato gene was fused such that the protein was attached to the N-terminus of human 
Fc in the pTT5 mammalian expression vector (Figure 1C).  Rat FcRn binds and internalized 
human Fc as efficiently as it does rat Fc (Tesar et al., 2006).  tdTomato-Fc was purified out 
of 293EBNA supernatants by FcRn affinity chromatography and gel filtration 
chromatography on an SD200 column.  The elution from a single passage of the tdTomato-
Fc supernatant over the FcRn column contained approximately 7 mg of protein. About 1.5 
mg of this was run over the SD200 column.  Two peaks, one corresponding to the void 
volume and likely representing aggregates (Peak 1) and the other running just behind where 
intact IgG elutes (Peak 2) were collected and analyzed by 10% SDS-PAGE (Figure 2A and 
B).  It is apparent from PAGE analysis that although both Peaks 1 and 2 contain tdTomato-Fc 
(Figure 2B), Peak 1 contains less tdTomato-Fc, despite having a higher absorbance at 280 nm 
(Figure 3A and C).  Whether the presence of tdTomato-Fc in the aggregate peak simply 
represents normally aggregated protein or whether there is some propensity of tdTomato-Fc 
to aggregate via trans associations of the dimeric Tomato fluorescent protein modules with 
other tdTomato-Fc molecules is unclear.  Regardless, it seems that approximately two-thirds 
of the expressed tdTomato-Fc remains in the stable dimeric form.  
 
Imaging of tdTomato-Fc and AlexaFluor 488-Fc in FcRn-MDCK cells 
To evaluate the utility of tdTomato-Fc as a ligand for live cell imaging in FcRn-MDCK cells, 
cells were grown on lysine-coated coverslips and allowed to internalize tdTomato-Fc or 
Alexa488-Fc (100 nM) at 37 degrees prior to being mounted in a heated chamber for imaging 
on the UltraVIEW spinning disk confocal system.  Images were collected from either single 
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planes or multiple planes spaced 0.5 µm apart.  Using a 150 ms exposure time, tdTomato-Fc 
is readily visible with relatively low laser power (18%) (Figure 3).  Samples were imaged for 
180–300 seconds of continuous exposure (~ 700–2000 images) and, although the 
fluorescence does significantly decrease over time, small structures are still clearly visible 
and the background remains low.  This was compared to imaging data in which Alexa488-
labeled Fc was visualized using 400 ms exposure times (required to get appreciable signal) 
(Figure 3).  After 137 exposures the sample has been significantly bleached with a 24% 
reduction in average pixel intensity (Figure 3, left panels), whereas tdTomato-Fc is still very 
bright after 137 scans (8% average pixel intensity reduction, Figure 3, right panels).  Only 
after 784 scans does the tdTomato-Fc sample exhibit a reduction in average intensity (27%) 
comparable to that seen in the Alexa488-Fc samples after 137 scans.  Thus, these data 
suggest that, under exposure conditions that provide roughly equal amounts of emission 
signal, tdTomato-Fc can be imaged six times as long as the corresponding Alexa-labeled 
ligand or, conversely, can be imaged equally as long with six times the temporal resolution as 
the Alexa-labeled Fc.  Additionally, being a recombinantly expressed molecule, the 
tdTomato-Fc should offer the advantage of eliminating sample-to-sample variability that is 
inherent to chemically labeling protein molecules with fluorescent dyes.  
 
Future directions 
The usefulness of tdTomato-Fc for live cell imaging will be further tested by varying 
parameters such as exposure time and imaging interval to determine what conditions provide 
the optimum combination of good signal and good temporal resolution.  Data from these 
experiments will be analyzed using the Imaris image analysis package with the end goal 
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being to achieve automated tracking of tdTomato-Fc-positive vesicles during intracellular 
trafficking. 
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Figure 1. tdTomato.  (A) A series of mutations at the dimer interfaces of the natively 
tertrameric DsRed can be used to generate dimeric or monomeric DsRed.  Mutagenesis of 
wild-type DsRed was used to create a library of variants with different fluorescent properties, 
including tdTomato (red arrow).  (B) Fluorescent properties of tdTomato. Ex: excitation 
maximum, Em: emission maximum, E: extinction coefficient, QY: quantum yield. (C) 
Schematic representation of the tdTomato-Fc homodimer.   Panel A adapted from Shaner et 
al., 2004. 
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Figure 2  Purification of tdTomato-Fc.  (A) After purification on an FcRn-affinity column 
tdTomato-Fc was subjected to gel filtration chromatography on an SD200 column. The 
elution profile is shown.  Two peaks, one running with the void volume (Peak 1) and the 
other running slightly slower compared with IgG (Peak 2) were collected. (B) SDS-PAGE 
analysis of both peaks from the SD200 column elution.  (C) Concentrated protein from peak 
1 and peak 2.  Absorbance curves for each sample show an absorbance maximum at 554 nm, 
the excitation maximum of tdTomato.  More tdTomato-Fc is present in peak 2 despite an 
overall lower absorbance at 280 nm compared to peak 1. 
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Figure 3  Relative bleaching rates of Alexa-labeled Fc and tdTomato-Fc.  FcRn-MDCK cells 
were incubated with either Alexa488-Fc or tdTomato-Fc for 45 minutes prior to imaging on a 
spinning disk confocal system.  Scans were taken continuously with 400 ms and 150 ms 
exposure times for Alexa488-Fc and tdTomato-Fc, respectively.  The mean intensity of each 
image is indicated below the panels. 
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Appendix II: 
Attempts to Detect FcRn Homodimers Using 
Förster Resonance Energy Transfer and 
Bimolecular Fluorescence Complementation 
This chapter describes my work to determine if FcRn can dimerize at the cell membrane.  
Two different biophysical assays, FRET and BiFC, were chosen for these studies because 
both are well-established methods for the detection of protein-protein interactions. 
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Introduction 
 
A structure-based hypothesis was previously proposed to account for the ability of cells to 
distinguish endosomes containing FcRn-IgG complexes destined for recycling or transcytosis 
from endosomes destined for a degradative pathway (Raghavan and Bjorkman, 1996). The 
hypothesis suggests that an oligomeric ribbon of FcRn dimers bridged by the homodimeric 
Fc regions of IgG molecules, as seen in the crystal structure of an rFcRn/Fc complex 
(Burmeister et al., 1994b), forms inside acidic trafficking vesicles.  Formation of the 
oligomeric ribbon between the adjacent membranes of a tubular endosome could act as an 
intracellular trafficking signal, designating vesicles containing such complexes for entry into 
the transcytotic or recycling pathways. A requirement for formation of the oligomeric ribbon 
is a homodimeric Fc or IgG molecule capable of bridging between FcRn proteins on 
opposing membrane faces. Consistent with this hypothesis, previous studies have 
demonstrated that a heterodimeric Fc molecule (hdFc), consisting of one FcRn-binding chain 
and one non-FcRn-binding chain, is less efficiently transcytosed across neonatal mouse 
intestine (Kim et al., 1994) and exhibits a shorter serum half-life (Popov et al., 1996) than a 
wild-type homodimeric Fc molecule (wtFc).  These results could indicate that both FcRn 
binding sites are required for the purposeful movement of vesicles containing FcRn-Fc 
complexes through the transcytotic pathway of the polarized gut epithelium.  However, it is 
not possible to ascertain whether the decreased trans-intestinal transfer of the hdFc results 
from the disruption of a trafficking signal that requires a homodimeric ligand capable of 
bridging between two FcRn molecules, or from the fact the monovalent hdFc cannot form 
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high avidity 2:1 FcRn/Fc complexes, thereby reducing the amount of hdFc that is bound and 
internalized by FcRn.   
 
We previously used in vitro experiments involving rFcRn-transfected MDCK cells to 
demonstrate that hdFc is transcytosed across monolayer in significant quantities, but that the 
transport is rendered less efficient by virtue of increased degradation of hdFc in lysosomes 
(Tesar et al., 2006).  This suggests that avidity plays a key role in FcRn-mediated transport 
by keeping the ligand bound to the receptor throughout the entire transport process rather 
than allowing it to dissociate within the endosome and be transported to the lysosome with 
other fluid-phase components.  While these results make it clear that the formation of an 
oligomeric ribbon is not strictly required for transport of Fc by FcRn, it does not completely 
rule out ribbon formation or receptor dimerization as important parts of the transport process.  
Previous studies using co-immunoprecipitations have suggested that FcRn molecules form 
dimers in cells co-transfected with two different epitope-tagged forms of FcRn (Praetor et al., 
2002).  However, these studies are less than convincing due to the fact that the dimers 
appeared to be covalent, and covalent dimers of FcRn are known to form when the co-
expression of the β2m light chain is not in balance with expression of the heavy chain 
(Claypool et al., 2002; Praetor and Hunziker, 2002).  Furthermore, disulfide-linked FcRn 
dimers are known to be retained in the endoplasmic reticulum (Claypool et al., 2002; Praetor 
and Hunziker, 2002), making it highly unlikely that they hold any functional relevance for 
the receptor in vivo.  However, it has been reported that phosphorylation of serine-313 in the 
FcRn cytoplasmic tail is required for efficient apical to basolateral transcytosis (McCarthy et 
al., 2001), consistent with a physiologically relevant role for dimerization of FcRn in vivo.  
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We wanted to test for the presence of FcRn dimers on the surface of transfected cells.  We 
performed experiments using two biophysical assays; Förster Resonance Energy Transfer 
(FRET) and Bimolecular Fluorescence Complementation (BiFC).   
 
FRET has long been used as an effective tool for detecting protein-protein interactions 
(Jares-Erijman and Jovin, 2003).  A typical FRET experiment involves generating fusion 
proteins in which donor and acceptor molecules (often cyan fluorescent protein [CFP] and 
yellow fluorescent protein [YFP], respectively) are attached to two potentially interacting 
partners.  Excitation of the donor molecule results in non-radiant energy transfer to the 
acceptor, which in turn will fluoresce if the donor and acceptor are in close (~ 5 nm) 
proximity with their dipole moments aligned parallel to one another (Dale et al., 1979). 
(Figure 1)  While FRET can theoretically be detected directly by observing the presence of 
acceptor fluorescence upon donor excitation, this approach is potentially confounded by 
bleed-though excitation of the acceptor at the donor excitation wavelength.  To circumvent 
this problem, an acceptor bleaching protocol can be used.  In this approach, the donor 
molecule is visualized to assess a baseline intensity.  In the presence of FRET some of the 
donor emission is lost to the acceptor and is thus not observed.  After heavily bleaching the 
acceptor molecule the intensity of the donor is re-evaluated.  An increase in donor 
fluorescence after bleaching of the acceptor is an indication that FRET was occurring and 
that the two molecules of interest interact.   
 
We employed an acceptor bleaching approach to use FRET to evaluate potential interactions 
between FcRn proteins that had CFP or YFP recombinantly fused to their C-termini.  The 
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cytoplasmic tail of these constructs was removed in order to promote the accumulation of 
FcRn at the cell surface and increase the readout signal.  CFP and YFP fusions of the α- and 
β-chains of HLA-DR, a class II MHC protein that is an obligate heterodimer, served as a 
positive control (Figure 2). 
 
BiFC is another assay for protein-protein interactions that has gained popularity in recent 
years.  In this assay proteins of interest are fused to one of two recombinant halves of YFP 
(designated YN for the N-terminal half and YC for the C-terminal half).  When these halves 
are brought into close proximity they combine to form the active YFP fluorophore, providing 
positive readout for the association of their fusion partners (Figure 5A).  This technique has 
been used to probe the interaction of several proteins including various transcription factors 
and G-protein subunits (for review see (Kerppola, 2008)).  I generated FcRn fusion proteins 
of the YN and YC halves (Figure 5B).  YN and YC were fused to the C-terminus of the FcRn 
cytoplasmic tail separated by the RSIAT linker (Hu et al., 2002; Hu and Kerppola, 2003).  
The bJunYN and bFosYC constructs consisting of the bZip family members Fos and Jun 
attached to the BiFC proteins were kindly provided to me by Dr. Chang-Deng Hu of Purdue 
University for use as positive controls. 
 
 
 
 
Materials and methods 
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Generation of expression vectors 
The plasmids encoding the full-length rat FcRn heavy chain with GFP fused to the C-
terminus and the rat β2-microglobulin light chain in the pCB6H and pBJ1 mammalian 
expression vectors, respectively, have been described previously (Tesar et al., 2006).   
The cytoplasmic tail-less mutant of FcRn was made by using site-directed mutagenesis 
(SDM) to introduce an XhoI site after Arg304 of the coding sequence of FcRn-GFP (Arg304 
is the last residue of the stop-transfer motif in FcRn).  This allowed the cytoplasmic tail to be 
removed by XhoI digest to remove the coding bases between the first residue of the 
cytoplasmic tail and the first residue of the GFP cassette. In the absence of endocytotic 
motifs encoded within the cytoplasmic tail, FcRn is endocytosed much less efficiently than 
full-length FcRn, causing the tail-less form to accumulate at the cell surface (Dickinson et al., 
2008).  
 
The FcRn-YFP and FcRn-CFP constructs, along with their respective cytoplasmic tailless 
variants were constructed by subcloning the EYFP or ECFP genes from the pEYFP-1 and 
pECFP-1 vectors (Clontech) into the FcRn-GFP or FcRn-tail-less-GFP vectors by a 
XhoI/HindIII double digest and ligation.  FcRn-tail-less-YFP DNA was cotransfected into 
MDCK cells along with an expression vector for rat β2m, and cells stably expressing both 
chains were isolated via FACS. The vectors encoding CFP fusions were amended by the 
addition of an N-terminal FLAG epitope tag to allow FACS of cells expressing both CFP and 
YFP FcRn variants. The YFP and CFP portions of the fusion proteins included the A206K 
substitution, which prevents the potentially confounding homodimerization of GFP and its 
variants (Zacharias et al., 2002).  
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 For the generation of the bimolecular fluorescence complementation (BiFC) constructs, the 
FcRn-YFP construct was modified by PCR to introduce either a HindIII or XhoI site between 
residues 172 and 173 of EYFP.  Digestion with HindIII (removing the C-terminal 66 residues 
of EYFP) or with XhoI (removing the N-terminal 172 residues of EYFP) followed by re-
ligation yields the FcRn-YN (EYFP residues 1–172) and FcRn-YC (EYFP residues 172–238) 
expression constructs, respectively.   
 
Antibodies 
The mouse monoclonal antibodies 1G3 (anti-rFcRn heavy chain) and 4C9 (anti-rat b2m) 
were generated in our laboratory (Raghavan et al., 1994) and can be purchased from the 
American Tissue Culture Collection. 2B10C11, a mouse monoclonal antibody against rat 
ß2m, was the kind gift of Lennart Lögdberg. A polyclonal rabbit anti-serum used for Western 
blotting was raised against purified rFcRn/ß2m heterodimers. AC17 mouse mAb against the 
canine lysosomal-associated membrane protein-2 (LAMP-2) was a gift from Dr. Enrique 
Rodriguez-Boulan of Cornell University.  Rabbit polyclonal antisera against the tight 
junction-associated protein ZO-1 was obtained from Zymed.  A mouse monoclonal antibody 
against EEA1 was from BD Transduction.  AlexaFluor 488-, 546-, and 633-labeled 
secondary antibodies (goat anti-mouse, goat anti-rabbit, and goat anti-rat) were purchased 
from Molecular Probes.  
 
Endocytosis of fluorescently - labeled ligands 
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For fluorescent ligand uptake, cells were pre-incubated in HBSS+/MES pH 5.9 as described 
above, and fluorescently - labeled ligand (500 nM) was added to the input surface.  After 
incubating for 30 minutes at 37°C, cells were placed on ice, briefly rinsed with ice-cold MBS 
(10 mM MES pH 5.9, 150 mM NaCl), and then washed twice with HBS (10 mM HEPES pH 
8.0, 150 mM NaCl) to remove surface-bound ligand prior to being fixed and processed for 
immunofluorescence.  
 
 
Immunofluorescence 
Cells were washed briefly with ice-cold PBS+ (PBS supplemented with 1 mM CaCl2, 0.5 
mM MgCl2, and 0.25 mM MgSO4) and fixed using a pH-shift protocol (Apodaca et al., 
1994). Briefly, cells were incubated for 5 min at room temperature in 4% paraformaldehyde 
(PFA) in 80 mM PIPES pH 6.5, 5 mM EGTA, 2.0 mM MgCl2, and then transferred to 4% 
PFA, 100 mM sodium borate pH 11.0 for 10 minutes. After quenching excess aldehyde with 
freshly - prepared 75 mM NH4Cl, 20 mM glycine in PBS for 10 min, the cells were washed 
twice with PBS and blocked for 30 minutes at room temperature in PBS containing 8% 
normal goat serum and 0.025% saponin. Cells were then incubated overnight at 4°C in 
blocking buffer containing primary antibodies diluted in block buffer. Cells were washed and 
then incubated with the appropriate AlexaFluor-conjugated secondary antibodies diluted 
1:500 in blocking buffer for 1 hour at room temperature. For experiments involving 
localization of internalized Fc proteins, unlabeled ligands were detected after internalization 
using AlexaFluor-conjugated goat anti-rat IgG antibodies. After extensive washing with PBS, 
cells were treated with 0.1% Triton X-100 for 5 minutes, washed once with PBS, and then 
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post-fixed with 4% PFA in 100 mM sodium cacodylate pH 7.4 for 30 minutes at room 
temperature. The cells were washed twice more with PBS and the filters were cut out of their 
holders using a scalpel and a fine-tipped pair of forceps. Excised filters were mounted on 
glass slides using ProLong Gold antifade medium (Molecular Probes), sealed with beeswax, 
and stored at -20°C until viewing on a confocal microscope. 
 
Confocal Microscopy 
All experiments were conducted using an inverted Zeiss LSM META confocal microscope 
equipped with a Zeiss Plan-Apochromat 100× oil objective (NA 1.4). Green fluorophores 
were excited with the 488 nm line of an argon ion laser. Orange and far-red dyes were 
excited with the 543 nm and 633 nm lines of a He-Ne laser, respectively. Fluorescence was 
detected through a variable confocal pinhole set to 1.0 Airy units for the longest wavelength 
used within a given experiment, and the pinholes of other channels were adjusted to maintain 
a constant optical section thickness across all channels. The gain and offset of the 
photomultipliers was adjusted for each channel individually so that the observed fluorescence 
signal filled the linear range of the detectors, with the background being slightly positive and 
saturation being minimized 
 
Bimolecular fluorescence complementation 
Untransfected MDCK II cells were seeded on poly-L-lysine-coated glass coverslips and 
grown for 24 hours until ~ 70% confluent.  Cells were transfected with FcRn-YN and FcRn-
YC BiFC constructs along with the rβ2m expression vector using Lipofectamine 2000 
reagent (Invitrogen) in serum-free medium.  Cells singly transfected with either FcRn-YN or 
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FcRn-YC along with rβ2m served as negative controls.  Transfection complexes were 
removed after 8 hours and replaced with complete growth medium.  Cells were fixed and 
processed for immunofluorescence ~ 48 hours post-transfection.  Separate coverslips of 
parallel transfections were stained with antibodies against rFcRn (1G3 mAb), rβ2m 
(2B10C11 mAb), and GFP (anti-GFP polyclonal antibody from BD Transduction Labs).  
Another set of coverslips were treated with 500 nM wtFc at pH 6 for 30 minutes to allow 
internalization by FcRn-YN or FcRn-YC, and stained with Alexa-546-conjugated goat anti-
rat antibody to visualized endocytosed wtFc.  BiFC was examined using setting appropriate 
for visualization of EYFP (Hu et al., 2002). 
 
 
Results and discussion 
 
The requirement of receptor dimerization to initiate intracellular responses has been 
extensively documented both for receptors that mediate endo-/transcytotic processes (e.g., 
the polymeric Ig receptor, pIgR) (Luton and Mostov, 1999), and those that do not (e.g., the 
EphRTKs) (Himanen et al., 2001; Stapleton et al., 1999), and often involves dimerization 
followed by phosphorylation of serines, threonines, or tyrosines in the cytoplasmic tail 
domain of the participating receptors upon binding of their cognate ligands (Heldin, 1995; 
Kalo and Pasquale, 1999; Okamoto et al., 1994).  Dimers of FcRn were observed in the 
crystals of the rat receptor alone and in complex with Fc (Burmeister et al., 1994a; 
Burmeister et al., 1994b).   At least one study has reported the presence of FcRn dimers in 
transfected cells (Praetor et al., 2002).  However, subsequent studies demonstrated that the 
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findings in this study were likely an artifact due to the lack of balanced co-expression of β2m 
(Claypool et al., 2002; Praetor and Hunziker, 2002).  In order to clarify these results we 
sought to use two biophysical assays to detect dimerization of FcRn in living cells. 
 
FRET experiments using live FcRn-CFP/YFP co-transfected and HLA-DR-αCFP/βYFP 
MDCK cells were performed using the acceptor photobleaching method, in which the 
emission intensity of the donor (CFP) is evaluated before and after bleaching the acceptor 
(YFP) with multiple scans of intense 514 nm laser light.  After bleaching of the acceptor, the 
intensity of the donor should increase if FRET occurs between the non-bleached 
donor/acceptor pair, as the acceptor is rendered unable to capture energy from the donor 
fluorescence.  Photobleaching experiments were carried out both in the presence and absence 
of IgG to determine if FcRn may form a constitutive or an induced dimer. In some 
experiments, I used the Zeiss LSM 510 Meta to obtain complete fluorescence spectra from 
the cells during 458 nm excitation of CFP. My initial experiments attempted to detect FRET 
in cells expressing the tail-less forms of FcRn-CFP/YFP.  Because the FcRn FRET constructs 
lacked cytoplasmic tails, these molecules should be restricted to the cell surface, thus 
allowing FRET data to be collected from a relatively constant population of molecules, rather 
than a labile population that is constantly entering and leaving the confocal imaging plane.  
As shown in Figure 3, several regions of interest (ROIs) were evaluated for the CFP donor 
intensity before and after the photobleaching of the YFP acceptor.  It is apparent from visual 
examination of the CFP panels in Figure 3A that there is not a significant, if any, increase in 
the intensity of CFP after the acceptor has been substantially bleached (Figure 3A, YFP 
panels), indicating that FRET was not occurring.  This was confirmed by calculating the 
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FRET efficiency for several ROIs in the image.  FRET efficiency by the acceptor 
photobleaching method is given by the equation 
 
with values for this quantity varying from ~ 15–50% for real FRET depending on the starting 
intensities of the donor and acceptor molecules (Jares-Erijman and Jovin, 2006; Piston and 
Kremers, 2007; Van Munster et al., 2005; Vogel et al., 2006).  The FRET efficiencies of 
ROIs in the FcRn experiment varied between -19.3% and 7.2%.  Negative FRET efficiencies 
are not possible for real interactions.  Additionally, 7.2% is much lower than published 
values for protein-protein interactions detected in this way (Van Munster et al., 2005).   
 
In order to determine if the negative result obtained in the FcRn FRET assay could be 
considered true evidence that FcRn does not dimerize at the cell surface, we conducted 
positive control experiments using MDCK cells cotransfected with CFP and YFP fusions of 
the α and β chains, respectively, of the MHC class II molecule HLA-DR, an obligate 
heterodimer.  The results of a representative experiment are shown in Figure 4.  The FRET 
efficiency for the cells shown was 7.7%, which is fairly low for what should be a positive 
control.  FRET efficiency values for other experiments using the HLA-DR system ranged 
from ~ 0.5%–7.7% (not shown).  Thus, it is difficult to conclude on the basis of these 
experiments alone that FcRn does not dimerize.  Possible reasons for the lack of observed 
FRET include the orientation of the fluorophores relative to one another in both the potential 
FcRn dimer and the HLA-DR positive control—efficient FRET requires that the dipole of the 
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donor and acceptor not be oriented orthogonally to one another, with optimum FRET 
occurring when they are aligned parallel to one another (Dale et al., 1979).  
 
After obtaining the inconclusive results from the FRET-based FcRn dimerization assay I 
attempted to examine the capacity of FcRn to form dimers by utilizing a different assay, so-
called Bimolecular Fluorescence Complementation (BiFC).  This assay exploits the fact that 
two recombinantly split halves of YFP (an N-terminal half, and a C-terminal half, referred to 
as YN and YC, respectively) which are non-fluorescent on their own, can combine and 
mature into the active YFP fluorophore when brought into close spatial proximity with the 
appropriate geometry (Hu et al., 2002).  This approach has been used to examine the 
dimerization of the bZIP transcription factors Fos and Jun in living and fixed cells (Hu et al., 
2002; Hu and Kerppola, 2003), as well as interactions between members of the 
Myc/Mad/Max family of transcription factors (Grinberg et al., 2004). 
 
Wild-type MDCK cells grown on poly-L-lysine-coated glass slides were transfected with 
FcRn-YN and FcRn-YC constructs along with the β2m light chain, and visualized for YFP 
fluorescence ~ 48 hours post-transfection.  Cells singly transfected with either FcRn-YN/β2m 
or FcRn-YC/β2m served as negative controls.  As shown in Figure 6, YFP fluorescence 
resulting from BiFC is observed in neither the FcRn-YN/YC/β2m transfection nor the control 
transfections.  Since this negative result could be due to improper expression and/or folding 
of the mutant constructs, immunofluorescence was used to assess the expression of the 
mutant proteins.  As seen in Figure 6, both the singly and doubly - transfected cells are 
positive for staining with the anti-FcRn antibody 1G3.  FcRn positive compartments are seen 
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throughout the cells, indicating that the expressed protein is not misfolded in the ER.  Similar 
results were also seen in stainings performed with a mAb against β2m, and a polyclonal anti-
GFP antibody.  Lastly, to confirm that the expressed mutant receptors are able to traffic to the 
cell surface and functionally internalize ligand, a third set of transfected cells was incubated 
at pH 6 with 500 nM wtFc.  Staining of these cells with an anti-rat IgG antibody confirmed 
that the FcRn-YN and FcRn-YC fusions were able to reach the cell surface and endocytose 
ligand, further suggesting that the absence of BiFC signal was not due to a defect in the 
expression or folding of these proteins.  These controls were also performed on MDCK cells 
singly transfected with either the FcRn-YN or FcRn-YC construct (along with β2m) to 
confirm that each construct expressed properly (data not shown).  Whether the absence of 
BiFC is due to the absence of FcRn dimerization or due to an experimental flaw is unclear.  
The failure to detect BiFC was not due to the imaging conditions, as BiFC is seen in a non-
homologous positive control system using bFos-YN and bJun-YC (data not shown).  A more 
ideal positive control not used here would have been an HLA-DR α-YN/β-YC system.  
However, the failure to detect the association of these two chains in the FRET-based assay 
makes it seem less promising.  Furthermore, while the results of the FcRn BiFC experiment 
do seem unintepretable without a solid positive control, it would still be difficult to prove the 
relevance of a negative result from this assay.  Factors such as linker length and the relative 
placement of the YN and YC halves in the putative FcRn dimer could cause a negative result 
in the presence of a true dimer.  Thus, it seems reasonable to argue that only a well-
controlled positive result can be interpreted for these types of experiments.  
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Figure 1. Schematic representation of the FRET assay.  When a donor molecule (CFP) and 
acceptor molecule (YFP) are brought into close (~ 5 nm) spatial proximity, excitation of the 
donor results in non-radiative transfer to the acceptor.  This can also be read out as an 
increase in donor intensity after bleaching of the acceptor molecule.  
131
 
 
 
 
Figure 2.  Schematic representation of FRET-based FcRn dimerization assay.  (A) CFP and 
YFP fusions of the α- and β-chains of HLA-DR, an obligate heterodimer, serves as a positive 
control for FRET readout.  (B) CFP and YFP fusion of a cytoplasmic tail-less form of FcRn 
will be tested for dimerization-induced FRET.  Three types of dimers may form.  Only the 
heterodimeric FcRn-CFP/FcRn-YFP dimer should exhibit FRET. 
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Figure 3. FRET measurement of tail-less FcRn-YFP/FcRn-CFP co-expressing MDCK cells.  
(A) A representative field of cells is shown before and after bleaching of the YFP acceptor.  
(B) Seven regions of interest (ROIs) were defined and the FRET efficiencies of those regions 
was determined by the change in donor intensity after acceptor bleaching. 
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Figure 4.  FRET measurements of an HLA-DR α-CFP/Β-YFP heterodimer expressed in 
MDCK cells.  The α-CFP and β -YFP chains were co-transfected into MDCK cells and 
imaged after 48 hours.  One representative cell is shown before and after bleaching of the 
YFP acceptor. Emission spectra before and after bleaching using 453 nm excitation are 
shown.  FRET should be detected by recovery of the CFP donor after bleaching.  The ratio of 
donor fluorescence before and after acceptor bleaching gives a FRET efficiency of 7.7 %.   
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Figure 5. The principle of Bimolecular Fluorescence Complementation (BiFC) for the 
detection of protein-protein interactions.  (A) Yellow fluoresent protein (YFP) is 
recombinantly split into two non-fluorescent halves.  The N-terminal and C-terminal halves 
(YN and YC, respectively) are fused to proteins of interest (A and B).  When the proteins 
interact, the YN and YC halves are brought into close spatial proximity, where they combine 
to form an active YFP fluorophore, providing readout for the interaction of their fusion 
partners.  (B) FcRn fusions of the YN and YC truncations used for BiFC experiments. 
(Figure 3A adapted from Kerppola, Nat Rev Mol Cell Bio,  2006.) 
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Figure 6.  BiFC experiments using FcRn-YN/FcRn-YC co-transfected MDCK cells.  Cells 
transiently transfected with the BiFC constructs were stained with antibodies against the 
FcRn heavy chain, β 2m light chain, and GFP to verify full-length expression of the 
constructs.  Cells were treated 500 nM at pH 6 and stained with AlexaFluor 568 goat anti-rat 
IgG to verify functional internalization of ligand by the FcRn constructs.  
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